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Heaven and Hell are just one thing 
Heaven is what you make of it, 
Hell is what you go through. 
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Crop loss due to phytopathogenic fungi is an important economical problem in 
modern agriculture. Crop protection against various diseases is mainly 
dependent on the use of chemical pesticides (50). Due to growing concerns 
about negative environmental and health effects of these products, the use of 
chemicals is being restricted. For example, in 2003 the European Union has 
banned 60% of the chemical pesticides which were allowed in 1996. This 
measure increased the demand for alternatives. A number of alternatives for the 
use of chemical pesticides is available, such as the use of pest-resistant plants. 
The use of these genetically engineered plants is limited, and although Europe 
has recently opened its markets for some products from genetically engineered 
plants, such products still have to cope with a strong negative public perception. 
Another alternative is the use of naturally occurring micro-organisms to control 
plant pathogens. Using microbes naturally antagonistic to plant pathogens will 
limit the need for pesticides. Some of these microbes produce anti-fungal 
factors. These are produced locally, in minimal amounts and are biodegradable 
(45, 51, 149). A number of micro-organisms are already in use as commercial 
products against a range of pathogens (45). One of the drawbacks of the use of 
micro-organisms to control plant diseases is the fact that these biocontrol agents 
do not always give consistent disease suppression (30, 67, 117, 120, 133).  
 
 
1.2 Mechanisms of biocontrol 
The discovery of naturally disease-suppressive soils led to the identification of 
bacteria suppressing plant diseases (82, 234, 235, 269). The activity of these 
suppressive soils is considered to be the result of the activity of these micro-
organisms suppressing the pathogen in conjunction with the host plant (213). 
Four mechanisms have been described to be active in the suppression of 
pathogens (45, 241): (i) competition for niches and nutrients, (ii) predation and 
parasitism, (iii) antibiosis, and (iv) induction of systemic resistance in the host 
plant.  
Competition for niches and nutrients is based on a failure of the pathogen to 
effectively compete with a biocontrol agent for sites on the root and/or for the 
available nutrients sources. This will limit the opportunities of the pathogens to 
propagate. The rhizosphere contains a relative high amount of nutrients as a 
result of exudate compounds leaking from the root (150, 153). Especially the 
intracellular junctions between root epidermal cells are thought to be rich in 
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nutrients (44). Therefore, efficient colonisation of these sites by beneficial 
organisms is considered to be a mechanism of biocontrol. 
Predation and parasitism is based on the production of exo-enzymes which, for 
example, can degrade cell wall constituents of fungi, thereby enabling the 
biocontrol microbes to utilise the degradation products. Predation may act 
synergistically with anti-fungal metabolites (58, 65, 147), and includes, for 
example, the production of proteases (66, 70, 237), chitinases (68, 69, 221, 
260), β-glucanases (118, 205), and cellulases (40).  
Antibiosis via production of antifungal metabolites by micro-organisms is 
based on the direct inhibition of the growth of pathogens. These secondary 
metabolites are produced by a wide range of micro-organisms and are often 
directly responsible for the observed biocontrol activity of these strains. These 
metabolites include 2,4-diacetylphloroglucinol (9, 76, 126, 127, 259), 
phenazines (9, 44), pyrrolnitrin (103, 109), pyoluteorin (108, 164), and HCN 
(261).  
Systemic resistence in plants can be induced by non-pathogenic 
rhizobacteria. This induced systemic resistence (ISR) is phenotypically similar 
to the induction of plant responses to the presence of pathogenic micro-
organisms (systemically acquired resistance, SAR). Activation of ISR results in 




1.3 Biocontrol and root colonisation of Pseudomonas bacteria  
Root colonisation is one of the prerequisites for efficient biocontrol activity 
(43). Root colonisation is defined as “the proliferation of micro-organisms in, 
on, or around the growing root” (54). In biocontrol this means that efficient 
colonisation of a plant root will result in bacteria being present at the right time 
at the right place to occupy potential niches on the root and to inhibit the 
propagation of pathogens. Pseudomonas fluorescens WCS356 (82) was isolated 
as an efficient root coloniser and was extensively studied for traits involved in 
root colonisation (151, 152). These studies show that, among other traits (46, 
152), mutation of the sss gene, encoding a site-specific recombinase, reduced 
tomato root tip colonisation both in quartz sand and in potting soil and the 
occurrence of morphological variants (56). The observation that this enzyme 
also plays a role in phenotypic variation during rhizosphere colonisation was 
later confirmed for Pseudomonas fluorescens F113 (55). In addition, it was 
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shown that introduction of sss into Pseudomonas fluorescens WCS307 and 
P. fluorescens F113 improved root colonisation (55) and that mutation of a sss 
homologue in the phenazine-1-carboxamide producing bacterium 
P. chlororaphis PCL1391 abolished control of tomato foot and root rot by this 
strain (43). For P. fluorescens WCS365, it was hypothesised, that the mutation 
of sss locked the bacteria in a phenotypic state not well suited for competition in 
colonisation of the rhizosphere (56). In P. fluorescens F113 the sss gene plays a 
role in phenotypic variation. Analysis of three different variants, isolated from 
an sss mutant, showed that these variants have different root colonisation 
patterns (209).  
The xerC/sss homologue is a member of the λ integrase family of site-
specific recombinases (48, 102, 206). Site-specific recombinases have been 
described to promote homologous recombination between two small repeated 
DNA sequences. Depending on the orientation of the sequences, recombination 
results in inversion or excision of the DNA fragment between the small repeats 
(206). Such recombination processes can play a role in phase variation. For 
example, site specific recombinases can regulate the expression of type 1 
fimbriae in Escherichia coli (1), flagella in Salmonella typhimurium (181), 
surface antigenic variation in Mycoplasma penetrans (105), and variation of the 
major outer membrane protein Omp1 of Dichelobacter nodosus (177) (Table 2). 
The observation that DNA rearrangements can influence efficient root 
colonisation, and therefore biocontrol (43, 55), prompted us to study phase 
variation as a possible reason for the inconsistency of field results. 
 
 
1.4 Phase variation  
Phase variation has been defined by Saunders et al. (211) as a process of 
reversible, high-frequency phenotypic switching that is mediated by DNA 
mutations, reorganisation or modification. Phase variation is used by several 
bacterial species to generate population diversity that increases bacterial fitness 
and is important in niche adaptation including immune evasion. Phase variation 
occurs at a high frequency of >10-5 switches per cell per generation (98) and can 
result in reversible ON or OFF switching of traits or in the variation of surface 
phenotypes. The main advantage of phase variation, by altering the expression 
of traits or by varying the character of these traits, in the survival of micro-
organisms, is the ability to adapt to an environment or to cope with host defense 
systems. Phase variation is one of the mechanisms enabling pathogens to 
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survive in the host by escaping the immune respons (52). This is illustrated by 
the fact that phase variation poses a problem in vaccine production due to the 
high frequency of variation in epitopes exposed by the pathogen (163, 188). 
Although phase variation, or antigenic variation, is primarily being associated 
with host-pathogen interactions, a number of reports describe phase variation in 
a broader context. These reports show that phase variation is also involved in 
the production of exo-enzymes and secondary metabolites (38, 250) indicating 
that phase variation can have a much broader impact on the ecology of bacteria, 
affecting a high number of traits and processes, and therefore phase variation is 
not only relevant in host-pathogen interactions but also in more ecological and 
industrial processes. The aim of this thesis is to study the mechanism of phase 




1.5 Mechanisms of phase variation  
Phase variation is a phenomenon encompassing a variety of mechanisms. These 
can be divided into programmed and un-programmed variation (27).  
Programmed variation is characterised by two properties, (i) a family of genes 
encoding proteins with the same or similar function, which is combined with (ii) 
the ability to express only one of the gene family members at a time and alter 
the expression of these members from time to time (27). Programmed variation 
entails regulated DNA conversions as the result of slipped-strand mispairing 
(slipped-strand mispairing is, despite the fact that the variation is based on 
errors during DNA replication, considered to be programmed due to the 
requirement of a specific repeat tract) or genomic rearrangements (including 
inversions, deletions, recombinational events and gene conversions) but can 
also be epi-genetic when based on differential methylation. Un-programmed 
phase variation is based on DNA alterations through the accumulation of errors 
during DNA replication, imperfect DNA repair, the recombination between 
non-identical genes, or reassortment of gene segments if the genome is not in 
one piece (27).  
A number of mechanisms of phase variation have been studied in detail in a 
range of micro-organisms. Four mechanisms of phase variation will be 
discussed, namely slipped-strand mispairing (§1.6.1), genomic rearrangements 
(§1.6.2), differential methylation (§1.6.3), and un-programmed phase variation 
(§1.6.4). Paradigms will be given for each of these mechanisms: the regulation 
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of opacity genes in Neisseria gonorrhoeae via slipped-strand mispairing 
(§1.6.1.1), variation of type 1 fimbriae in E. coli (§1.6.2.1) and type IV pili in 
Neisseria spp. via genomic rearrangements (§1.6.2.2), pap phase variation via 
differential methylation in E. coli (§1.6.3.1) and capsule variation in 




1.6 Programmed variation 
1.6.1 Slipped-strand mispairing 
Slipped-strand mispairing uses short sequence repeats to regulate gene 
expression at the translational or transcriptional level. These repetitive DNA 
sequences are increasingly being identified in prokaryotes (6, 212, 243, 248) 
and can consist of homopolymeric repeat tracts or multimeric, heterogeneous 
repeats (98, 143). The stability of these repeat tracts is influenced by a number 
of factors. (i) The repeat number. With an increase in the number of repeats the 
mutation rate will increase. (ii) Repeat unit length. When the repeat unit is less 
than 5 bp the mutation rate will be suppressed by mismatch repair (MMR). (iii) 
The repeat sequence composition and the purity of the tract. (iv) DNA 
replication and processes associated with replication such as proofreading. (v) 
DNA transcription. (vi) MMR, which has a strong impact on the stability of the 
repeat tract (15-17, 77, 143, 148).  Repeats associated with a single locus, 
present in the promoter region or within the coding region, can alter gene 
expression by changing the number of repeats (Fig. 1A). The number of repeats 
is varied via a RecA independent mechanism through the formation of 
heteroduplex DNA (H-DNA) which is induced by superhelical coiling (18, 72, 
148). This H-DNA consists of a triple-stranded region, based on the formation 
of triple residue bonds within the repeat region, with as a result a single-
stranded region which will stimulate slipped-strand mispairing (18, 98). 
Altering the number of repeats will result in an incomplete gene product due to 
a shift in reading frame (Fig. 1A).  
In addition to regulation by an ON – OFF switch, slipped-strand mispairing 
mechanism can also regulate at the level of transcription. This regulation is 
mediated by the presence of repeats upstream of the encoding gene which, upon 
variation of the number of repeats, results in an increase or decrease in 
expression by varying the promoter spacing (Fig. 1B). 
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Table 1. Examples of phase variable traits regulated via slipped-strand mispairing 
 
Mechanism Locus Species Property affected Reference 
Slipped-strand mispairing ON↔OFF   
 fucT2 
(AF076779) 
H. pylori LPS antigenicity, 










H. influenza LPS antigenicity (104) 
 lgtC (U32772) H. influenza LPSa antigenicity,  (104) 















P. putida Flagellum export (219) 








Bordetella spp. Two component 
sensing 
(231) 





M. fermentans ABCc transporter (239) 
 tcpH (X74730) V. cholerae ToxR regulon (36) 
 hpuA 
(AF031495) 

















 vlp(U35016) M. hyorhinis Virulence? (47) 
  E. coli Unknown (244) 
Abbreviations: a Lipo-poly saccharide (LPS), b Lipo-oligo saccharide (LOS), c ATP 
Binding Cassette (ABC) 
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Table 1. Continued 
Mechanism Locus Species Property affected Reference 
Volume control OFF→ON+/ON++→OFF   
 opc (A44611) N. 
meningitides 
Adhesion/invasion (210) 
 porA (P13415) N. 
meningitides 
Solute transport (251) 
 hifAB 
(U19730) 
H. influenza Fimbrial 
expression 
(255) 
  H. influenza Pilus expression (172) 
 Hmw1a/2a 
(U08876) 
H. influenza Adhesion (12) 
 
 
Slipped-strand mispairing as a regulatory mechanism is present in a wide range 
of bacteria regulating various traits. Examples of traits regulated via slipped-
strand mispairing are presented in Table 1. 
 
 
1.6.1.1 Opacity genes in Neisseria gonorrhoeae, regulated via 
slipped-strand mispairing 
Neisseria gonorrhoeae is the causative agent of gonorrhoea in humans. The 
opacity proteins (Opa) play an important role in the host pathogen interactions 
(180). The expression of specific opa genes leads to the adherence to, and 
invasion of, epithelial cells (157), while other Opa proteins do not promote 
adherence but confer Opa-specific binding to human leukocytes (129, 199). 
Furthermore, the susceptibility to killing by normal human serum is influenced 
by the Opa proteins produced (42, 115). The variation of opa genes is confined 
to a RecA independent ON and OFF switching (179, 230), and a result of 
slipped-strand mispairing (230). Multiple copies of the opa genes exist within 
the genome. For example, gonococci posses the highest number of opa genes, 
approximately eleven to twelve (49), meningococci only posses three to four 
genes, and Neisseria lactamica only two (90). A high variety of proteins can be 
produced since each opa gene can be switched ON or OFF, and different 
combinations can be expressed (171). Independent N. gonorrhoeae isolates 
rarely posses opa genes of the same sequence (90), suggesting that the 
repertoire of variant opa genes within a population will be substantially larger 
than within a single strain (171). Major differences have been identified among 
these loci, which are confined to two short regions, designated hypervariable 
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regions 1 and 2 (4, 49, 89). The regulation of expression, switching loci ON and 
OFF, is based on changes in the number of pentameric repeat elements (5’-
CTTCT-3’) with which the expression state of the opa gene(s) changes. For 
example 6, 9 or 12 repeats are equivalent to an Opa+ phenotype in which the 
gene is in frame (Fig. 1A). All other numbers (for example 7, 8 or 13) shift the 
gene out of frame, resulting in incomplete gene products and an Opa- phenotype 
(230) (Fig. 1A).  
Apart from the high frequency switch between Opa- and Opa+ phenotypes, 
the Opc outer membrane protein of Neisseria meningitidis undergoes a second 
form of regulation. A polyC tract is present adjacent to the promoter region. The 
number of bases in this repeat influences the promoter strength. 
 
 
Figure 1. Model for phase 
variation via slipped-strand 
mispairing. A. Model for ON and 
OFF switching of traits via 
slipped-strand mispairing. 
Variations in the number of 
repeats (ڤ) within the coding 
region of the gene results in a 
shift of reading frame in or out of 
frame. A shift out of frame will 
introduce premature stop codons 
(*). B. Model for volume control 
via slipped-strand mispairing. 
Variations in the number of 
repeats within the promoter 
region of the gene will vary 
promoter -10 and -35 spacing, thereby increasing (ON++) or decreasing (ON or OFF) 
promoter efficiency. For more details see text 1.6.1 and 1.6.1.1. 
 
 
The expression of a promoter containing a polyC tract of 12 or 13 bases is 10 
fold increased (Opc++ phenotype) when compared to a promoter with a polyC 
tract of 11 or 14 bases (Opc+ phenotype) (Fig. 1B). This is due to changes in 
promoter spacing. When the number of repeats exceeds 15 or becomes less than 
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10 no expression of opc is detected anymore (210) (Fig. 1B). This means 
slipped-strand mispairing can not only switch a gene ON and OFF but in 




1.7 Genomic rearrangements 
Genomic rearrangements combine a wide range of processes involved in phase 
variation, these include inversions, deletions, gene duplication, and gene 
transfer using silent copies (recombinational deletion) (27). Control of 
expression of, for example, type 1 fimbriae in E. coli is based on the presence of 
inverted repeats and the action of site-specific recombinases (Fig. 2). The 
presence of inverted repeats within the promoter region facilitates the inversion 
of the promoter switching expression ON or OFF (1). On the other hand when 
the promoter itself is flanked by inverted repeats, as described for H1 and H2 
flagellin genes of Salmonella typhimurium, different sets of genes can be 
expressed. One orientation of the promoter will result in the expression of h2 
and the repressor Rh1 of the h1 promoter. Upon inversion both h2 and rh1 are 
no longer expressed, lifting the repression of h1 by rh1 (281).  
A second form of variation based on genomic rearrangements, regulating 
for example variation of type IV pili in N. gonorrhoeae (122, 220) and the 
expression of surface proteins in Borrelia spp. (11), uses deletions, gene 
duplications and gene transfer to create a large potential of proteins to express. 
Although in many systems recA mutants are not yet available, those mutants 
analysed show that these rearrangements are dependent on the recA gene, and 
based on the deletion of one allele present in an active locus, which is 
subsequently replaced by transcriptionally inactive alleles present elsewhere on 
the genome (72, 98, 171). This is often combined with the presence of highly 
variable regions within these alleles, thereby increasing the variation potential 
of the gene product (171). Examples of traits regulated via genomic 
rearrangements are presented in Table 2. Two well studied examples of gene 
regulation via genomic rearrangements are variation of type 1 fimbriae in 







1.7.1 Type 1 fimbriae variation in E. coli by genomic 
rearrangements 
Phase variation of type 1 fimbriae in E. coli plays an important role in the 
infection of the urinary tract, mediating the ability of E. coli to adhere to the 
uroepithelium (197). In general, fimbrial phase variation, in different organisms, 
can occur by at least four different mechanisms: (i) site-specific recombination 
(1), (ii) slipped-strand mispairing (274), (iii) general recombination or gene 
conversion (122, 236) and (iv) DNA methylation patterns (See §1.6.3.1). Phase 
variation of type 1 fimbriae in E. coli is based on a site-specific recombination 
event inverting a 314 bp segment of chromosomal DNA which includes the 
promoter for transcription of the gene encoding FimA, the structural subunit of 
the fimbriae (1) (Fig. 2). The inversion of this DNA fragment is dependent on 
the products of fimB and fimE, encoding site-specific recombinases sharing 
homology with the lambda integrase family of site-specific recombinases (165, 
166). These recombinases recognise a 9 bp inverted repeat flanking the 
promoter region (1) (Fig. 2). FimB and FimE act independent of each other in 
the inversion. FimE will preferentially invert the promoter from the ON to the 
OFF configuration (229), while FimB can inverse the promoter both from ON 
to OFF as well as from OFF to ON (166). The expression of FimB and FimE is 
regulated by a histone like protein (H-NS), an Integration Host Factor (IHF) and 
the Leucine responsive protein (Lrp) (23, 60) (Fig. 2). According to the model 
(Fig. 2) binding of Lrp to three Lrp-binding sites present within the invertable 
region (22) changes the DNA conformation and facilitates inversion (203). 
Binding of the IHF will bend the DNA to align the recombinational sites to 
enable strand exchange (23) and, through action of either FimB or FimE, the 
promoter region is inverted. At this moment the exact mechanism is not clear, 
which is illustrated by the observation that locking the invertable region in an 
ON configuration by removal of one of the inverted repeats, did not abolish 
phase variable fimbrial expression (165).  
 
 
1.7.2 Neisseria species and expression of variant type IV pili 
Neisseria species are Gram negative diplococci, including a variety of 
commensal species beside the two pathogenic species N. gonorrhoeae and N. 
meningitides (171). Phase variation in these pathogenic Neisseria species is 




Table 2. Examples of phase variable traits regulated via genomic rearrangements 
 
Mechanism Locus Species Property affected reference 
Site-specific inversion  ON ↔ OFF    
 mrp (Z32686) P. mirabilis Fimbrial 
expression 
(280) 
 fimA (Z37500) E. coli Fimbrial 
expression 
(1) 
 omp1(U02462) D. nodusus Major outer 
membrane protein 
(177) 
 p35 family 
(L38250) 
M. penetrans Surface lipoprotein 
antigens 
(105) 
 vsa (U23947) M. pulmonis Surface antigens (20) 





C. fetus S-layer expression (71) 
 hsd1 
(AF003541) 






M. pulmonis DNA restriction (73) 
ONa/OFFb ↔ONb/OFFa    
 hin (V01370) Salmonella spp. Flagellar 
expression 
(281) 
 piv (M34367) M. lacunata Type IV fimbriae (96, 161) 


























M. agalactiae Surface proteins (86) 
 vsp/vlp 
(AF049852) 
Borrelia spp. Surface proteins (11) 
 
Type IV pili are believed to be responsible for the initial attachement to the 
mucosal epithelium of the human host (180). Variation of type IV pili via 
homologous recombination is based on the presence of multiple, silent, variant 
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pilS genes, and one active pilE gene (89, 220, 236). The silent pilus genes 
contain a semivariable and a hypervariable region flanked by conserved regions 
involved in gene conversion between the pilS genes (89). This enables the 
bacteria to produce approximately 107 variant PilE proteins (90). The 
rearrangements are RecA, RecO and RecQ dependent (135) and are promoted 




Figure 2. Model for phase variation via a 314 bp invertable element. Inversion of a 314 
bp promoter fragment will switch expression of fimA ON or OFF. The inversion is 
facilitated by two site-specific recombinases FimE and FimB, recognising the two 9 bp 
inverted repeats (IR, the orientation is indicated with an arrow). FimE promotes the 
switch from ON to OFF, while FimB can invert the fragment in both directions. An 
Integration Host Factor (IHF) is required for efficient expression. Since mutation of one 
of the subunits of the IHF locks the expression of fimA either in an ON or the OFF 
configuration, the IHF is also involved in the inversion of the fimA promoter (60). 
Histone like protein (H-NS) is directly involved in suppression of the fimB gene, 
suppressing the inversion from OFF to ON (59, 184). The Leucine Responsive protein 
(Lrp) stimulates expression of fimB and slightly decreases expression of fimE, 
stimulating inversion in both directions as shown by a decrease in the frequencies of 
inversion, upon mutation of lrp (22). For more details see text 1.6.2.1. 
Conserved regions encoding cysteine residues within the pilS genes are used in 
the recombination (110, 220), and all silent copies can donate their sequences to 
the expressed locus (220). The precise mechanism allowing this high frequency, 
21 
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non-reciprocal chromosomal recombination between the different loci is still in 
discussion (110, 220).  
 
 
1.8 Differential methylation 
Phase variation of pap fimbriae and expression of antigen 43 in E. coli is 
dependent on a differential DNA-methylation pattern and represent therefore an 
epigenetic mechanism of phase variation (98, 252). Methylation of GATC sites 
in the genome is dependent on deoxyadenosine methylase (dam) which binds to 
the GATC site and methylates adenosine at the N6 position (187). Normally, 
methylation provides the organism with a regulatory mechanism for DNA 
repair, protection from restriction endonucleases, and timing and targeting of 
cellular events (160).  Methylation of GATC sites within regions involved in 
gene regulation can inhibit or facilitate the binding of regulatory proteins at 
specific sites, and thus alter gene expression (183). Examples of gene 
expression, controlled via differential methylation, are presented in Table 3 
Phase variation via differential methylation of a pyelonephritis-associated pilus 
has been studied extensively in E. coli and is the best described mechanism for 
regulation of this kind.  
 
Table 3. Examples of phase variable traits regulated via differential methylation 
 
Mechanism Locus Species Property affected Reference 
ON ↔ OFF     
 agn43 (U24429) E. coli Autoaggregation (186) 
 pap (X03391) E. coli Pilus expression (25) 
 sfa (M35273) E. coli S-pili (254) 
 clp (L48184) E. coli CS31A adhesive 
factor 
(53) 





1.8.1 Pap phase variation in E. coli via differential methylation 
In uropathogenic E. coli strains expression of the pyelonephritis-associated pilus 
(Pap) allows the bacteria to attach to uroepithelial cells, facilitating colonisation 
of the upper urinary tract (182, 185). The expression of pap is regulated via 
differential methylation. The pap operon consists of nine gene products 
involved in the assembly and expression of pilus complexes at the bacterial cell 
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surface (252). The regulation is dependent on the transcriptional regulators PapI 
and PapB and the global regulator Leucine responsive regulatory protein (Lrp), 
and also on the catabolite activator protein CAP, the histone like protein H-NS, 
and on deoxyadenosine methylase (Dam) activity (252) (Fig. 3). Phase variation 
of the pap operon is dependent on a reversible switch between an ON and OFF 
state which is controlled by differential methylation of two GATC sites present 
within the regulatory region of the pap locus (25) (Fig. 3). Methylation of 
GATC1130, and an unmethylated GATC1028 site, enables the expression of the 
pap locus. The reverse situation, in which GATC1028 is methylated and 
GATC1130 unmethylated, renders the operon inactive (25) (Fig. 3). Dam 
methylase activity is essential for this switch and mutation of the dam gene 
abolishes all papA transcription (25). Lrp is a 19 kDa DNA binding protein, 
which can bind within the pap-regulatory region to six Lrp binding sites (Fig. 
3). Since the methylation sites are overlapping with the Lrp binding sites, 
binding of Lrp will prevent methylation (28, 29). Binding of Lrp to sites 1, 2, 
and 3 will protect GATC1130 from methylation, rendering the system in an OFF 
configuration (25, 28) (Fig. 3). Alternatively, binding to sites 4 and 5 will 
render the system in an ON configuration by protection of GATC1028 from 
methylation. Translocation of Lrp will switch the system to an ON or OFF 
configuration. This is facilitated by the PapI protein which, when bound to Lrp, 
reduces the affinity of Lrp for binding sites 1, 2, and 3 to 50% while increasing 
the affinity for binding sites 4 and 5 (183). Upon a subsequent translocation of 
the Lrp, the free GATC sites are methylated by dam activity.  
This leads to the following model of pap phase variation (Fig. 3). Starting 
from a pap DNA fragment without any bound protein, a basal level of papBA 
expression can be detected (78, 253). Lrp will bind with the highest affinity to 
sites 1 to 3, protecting GATC1130 from methylation. Subsequent methylation of 
GATC1028 results in an OFF configuration. The switch to an ON configuration 
involves binding of PapI to Lrp, changing the affinity of the Lrp binding, which 
is only achieved by physical presence of GATC1028 (183). Since the Lrp-PapI 
complex will bind to hemi-methylated DNA present after replication (183), it is 
hypothesised that DNA replication is involved to generate an unmethylated 
GATC1028, to allow the Lrp to translocate (29, 183). Dam activity will methylate 
GATC1130, and render the system in an ON configuration, thereby increasing 
transcription about eight fold (253). CAP plays a role in this process by 
interacting with RNA polymerase (252, 270). The physiological role of H-NS in 
pap expression is not yet clear, but is reported to be an important environmental 
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regulator for fimbrial transcription (273). Switching from an ON configuration 
to an OFF configuration occurs at a 100-fold higher frequency, and is likely to 
be the result of replication, after which sites 1 to 3 are hemi-methylated, 





















Figure 3. Model for phase variation via differential methylation. Differential 
methylation of two GATC sites, GATC1028 and GATC1130, regulates expression of 
papBA. Methylation of GATC1130 will inhibit papBA expression. The regulation is based 
on competition for binding sites since Lrp and methylation sites overlap. Binding of 
PapI to Lrp will reduce the affinity for binding to sites overlapping with GATC1130. The 
Lrp-PapI complex will preferentially bind to the sites overlapping GATC1028, probably 
after replication, and thus facilitate methylation of GATC1130 to enable papBA 
expression. Binding of CAP and PapB will lift H-NS suppression (78) and enable 
transcription of papI. In addition, binding of PapB upstream of the papI promoter will 






1.9 Un-programmed variation 
Random un-programmed variation is dependent on the introduction of 
mutations due to imperfect replication. For example viruses use this high 
plasticity to overcome host defenses and do not suppress spontaneous mutation. 
One of the draw-backs of a mechanism stimulating diversification based on 
imperfect replication is a high mutational load. Higher organisms had to evolve 
a mechanism of mutation while controlling the mutation rate using mechanisms 
like mismatch repair pathways (27, 217), or, although still under discussion, 
specific error prone DNA polymerases transcribing specific genomic regions 
(131, 167, 178, 238). Most organisms use this strategy to create diversity in for 
example antibody genes (81) but, this mechanism has also been suggested to 
play a role in adaptive evolution in microorganisms (178). The mutations 
accumulating in these regions  can consist of small deletions (50 to 500bp), 
mismatches, and duplications  (92, 175, 249, 263). Examples of spontaneous 
mutations in phase variation, switching genes ON and OFF are presented in 
Table 4. An example of phase variation via spontaneous, reversible duplications 
has been described in Streptococcus pneumonia to regulate capsule production.  
 
 
1.9.1 Capsule phase variation in Streptococcus pneumonia 
Streptococcus pneumonia is a Gram positive human pathogen causing otitis 
media, pneumonia, scepsis and meningitis. The presence of this pathogen is 
wide-spread. It is carried as a biofilm in the throat or nasopharynx. On average, 
carriage rates range from 40 to 50% in children and 20 to 30% in adults (8, 26, 
84). The actual invasion of host cells by pneumococci is a multistage process 
initiated by adherence (26). The capsule plays a role in virulence, anti-
phagocytosis and protective immunity (116, 196, 202, 226). Regulation of the 
capsule production is suggested to play a role in the transition from carriage to 
invasive disease (125, 202, 226). At a high frequency (between 10-6 and 10-3) 
small, transparent, acapsular colonies can be isolated from tissue-based 
biofilms, of which the majority can revert to the capsular, opaque phase upon 
subculturing to fresh plates (263). These opaque variants are unable to colonise 
the nasopharynx, while the translucent variants are stable and efficient 
colonisers (267). Cloning and sequencing of the first gene in the biosynthetic 
operon (cap3A, type 3 capsular polysaccharide) (7) revealed that random 
duplications of 11 to 239 bp, are present in different regions of the cap3A open 
reading frame in acapsular isolates, shifting the gene out of frame (263).  
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Table 4. Examples of phase variable traits regulated via un-programmed variation and 
traits for which the exact mechanism is unknown  
 
Mechanism Locus Species Property affected Reference 
Spontaneous duplications ON ↔ OFF    




S. pneumoniae Capsule production (263, 262) 
 pheN 
(U95300) 




 D1 (X13547) Synechosystis spp. D1 protein 
photosystem II 
(132) 
Spontaneous mutations ON ↔ OFF    









Mechanism unknown    
  P. aeruginosa Motility/flagella / 
biofilm formation 
(57) 




  P. fluorescens 
WCS365 
Root colonisation (56) 
  P. fluorescens 
F113 
Root colonisation / 




The same was shown for serotypes 8 and 37, in which spontaneous sequence 
duplications are responsible for phase variation of the capsular phenotype (262). 
The switch back to a capsular phase coincided with a precise excision of the 
duplications from the open reading frame (262, 263). Still unclear, in this 
example of phase variation, is the exact mechanism by which the capsule locus 
is switched ON again, which factors determine the switch OFF, and the 
relevance of this mechanism in disease. 
 
 
1.10 Phase variation and Pseudomonas  
Phase variation in Pseudomonas bacteria is a relatively unexplored 
phenomenon, but sofar some interesting examples of traits affected by phase 
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variation in pseudomonads have been described. In the pathogenic 
P. aeruginosa species, phase variation regulates the variation of the 
phosphocholine epitope of a 43 kDa protein in a temperature dependent manner 
(266), and the expression of type IV pili. Phase variation of these pili affects 
swimming, swarming and twitching motility and, as a result biofilm formation 
(57) (Table 4). P. tolaasii was shown to switch colony morphology and 
pathogenicity by a spontaneous duplication in pheN (92) (Table 4). With respect 
to non-pathogenic Pseudomonas species, phase variation has been described in 
P. putida DOT-T1E to control expression of the flhB gene via slipped-strand 
mispairing in response to environmental changes. FlhB is a protein involved in 
flagellin export. This type of regulation is probably not very conserved since for 
example in P. putida KT2440 this regulation was not observed (219). In 
addition, reversible phenotypic variants have been described in P. fluorescens, 
which are correlated with adaptation to heterogeneous growth conditions, which 
show that identical populations diversify morphologically under non restrictive 
conditions, resulting in niche specialists (193). 
In several Pseudomonas sp. phase variation regulates the expression of exo-
enzymes and plays a role in root colonisation (Table 4).  In Pseudomonas 
brassicacearum, two morphologically distinct colonies (small mucoid phase I 
and large, flat nonmucoid phase II cells) have been isolated. An extra-cellular 
alkaline protease, a serine protease homolog and a lipase are only expressed in 
phase I cells. The genes coding for the protease and lipase are organised in a 
single operon, but a mechanism responsible for the ON and OFF switching of 
this operon is not yet described (38). Phase variation of P. brassicacearum 
affects root colonisation of Arabidopsis thaliana, the phase II bacteria show, 
due to an over production of flagellin, a higher ability to swim and swarm when 
compared to phase I bacteria. In root colonisation these bacteria are found at the 
root tip and on secondary roots, while the phase I bacteria are localized at the 
basal parts of the root. Based on these results phenotypic variation is suggested 
to be a strategy, increasing the colonisation ability of P. brassicacearum (2). 
The effect of phase variation on root colonisation was also suggested by the 
observation of a reduced competitive tomato root tip colonisation upon mutation 
of sss (a site specific recombinase) in P. fluorescens WCS365 (56). The link 
between phase variation, root colonisation and sss was also analysed in 
P. fluorescens F113. During root colonisation of alfalfa by P. fluorescens F113, 
phenotypic variants were isolated. The sss gene is responsible for the majority 
of the phenotypic variation, which is combined with a phenotypic selection for 
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gac mutations. Three morphologically different variants were isolated which 
showed a difference in colonisation pattern, and in the production of cyanide, 
exo-protease, and siderophores (209).  
These examples show that phase variation in Pseudomonas sp. is regulating 
a wide range of traits, which affect biofilm formation, root colonisation, and 
production of secondary metabolites, suggesting that phase variation is a 
mechanism, relevant in the ecology and behaviour of these species.  
 
 
1.11 Regulation of phase variation 
To allow expression under relevant conditions, phase variation itself is often 
regulated by environmental factors. In pathogenic micro-organisms the 
expression can be linked to conditions in the host, at the site of infection. For 
example, phase variation of the type 1 fimbriae (§ 1.6.2.1) is influenced by 
temperature and medium composition such that expression of type 1 fimbriae is 
enhanced upon infection of mouse urinary tract by E. coli (233). FimB-
promoted inversion is increased between 37 to 41 degrees, and FimE promoted 
ON to OFF inversion at lower temperatures (80, 218). Also pap phase variation 
(§ 1.6.3.1) is influenced by environmental factors. Temperature regulates 
expression of pap via RimJ, a N-acetyltransferase which modulates both papBA 
and papI expression. This results in the expression of pili at 37 degrees, and 
suppression of expression at 23 degrees (272). In addition, H-NS is thought to 
be an important environmental regulator for fimbrial expression allowing 
environmental factors such as low temperature, high osmolarity, glucose as a 
carbon source, and rich medium to influence phase variation and expression of 
pap. Mutation of H-NS lifted the negative effect on transcription by these 
factors (273). Since phase variation is influenced by specific conditions in the 
host it can regulate the expression of traits during infection and enable a 
pathogen to express specific traits at the right place. But, the regulation of phase 
variation is not only linked to infection processes. For example, phase variation 
is strongly influenced by stress conditions. This is illustrated by the observation 
that RpoS, a general stress response sigma factor facilitating adaptation to stress 
and controlling the expression of many genes during exponential and stationary 
growth (99), enhances the frequency of inversion in phase variation of type 1 
fimbriae in E. coli and was shown to suppress expression of the fimA gene (61). 
In phase variation of a plasmid encoded fimbriae in S. typhimurium (pef), which 
is dependent on differential methylation, expression of pef was suppressed by 
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RpoS (181) and, in Vibrio cholerae, RpoS and RpoN affect the switch between 
the rugose and smooth colony variants (279). Under stress, or growth limiting 
conditions the frequency of stationary phase mutations will increase (131, 146). 
This is caused by down regulation of MMR (201, 247), spontaneous mutations 
of MMR components (106, 222, 223), and, possibly, the activity of error-prone 
polymerases like DinB (167, 232). As a result mechanisms like slipped-strand 
mispairing (201), introduction of spontaneous mutations (146) and genomic 
rearrangements (61) will be influenced and result in divers phenotypes enabling 
a population to cope with the growth limitations (31). It was suggested by 
Moxon et al. (178), that the combination of specific contingent regions and 
stable regions in the genome, facilitates efficient exploration of phenotypic 
solutions to unpredictable aspects of the (host) environment while minimizing 
deleterious effects on fitness. Thus, phase variation as a mechanism is first of all 
regulated by environmental factors, defining, for example, the site of infection 
and to cope with the host immune system. In addition, under stress or growth 
limiting conditions, it can lead to a diversification of a population, creating 




1.12 Outline thesis 
The research, presented in this thesis is aimed at the identification of the 
mechanism of phase variation in antagonistic Pseudomonas species in relation 
to biocontrol. It was hypothesised that the occurrence of frequent variations in 
for example the expression of antifungal metabolites or the switching between a 
rhizosphere competent and a less competent phase could influence biocontrol in 
the field. For this purpose a collection of antagonistic Pseudomonas bacteria 
was isolated from the rhizosphere of maize plants grown on agricultural fields 
in Totontepec Mixe, Oaxaca, Mexico. These strains were characterised for 
biocontrol traits and since the majority displayed phase variation between a 
phase I and phase II colony morphology, affecting the expression of major 
biocontrol traits, the effect of phase variation on biocontrol was studied 
(Chapter 2). The molecular basis of phase variation in Pseudomonas sp. 
PCL1171 was studied and led to the identification of a mechanism, in which the 
accumulation of spontaneous mutations in the gacA and gacS genes, and 
subsequent removal of these mutations, forms the basis for phase variation 
(Chapter 3). To identify factors involved in the accumulation of these 
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mutations in gacA/S, the role of GacS, RpoS and MutS in phase variation was 
studied (Chapter 4). Phase I and phase II are two morphological distinct 
phenotypes. In the identification of factors determining these differences prtI 
and prtR homologs were isolated. Their role in colony morphology and phase 
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Biocontrol and colony phase variation 
ABSTRACT 
 
Of 214 Pseudomonas strains isolated from maize rhizosphere, 46 turned out to 
be antagonistic, of which 43 displayed clear colony phase variation. The latter 
strains formed both opaque and translucent colonies, designated as phase I and 
phase II, respectively. It appeared that important biocontrol traits, such as 
motility and the production of antifungal metabolites (AFM), proteases, lipases, 
chitinases, and biosurfactants are correlated with phase I morphology and are 
absent in bacteria with phase II morphology. From a Tn5luxAB transposon 
library of Pseudomonas sp. strain PCL1171 phase I cells, two mutants 
exhibiting stable expression of phase II had insertions in gacS. A third mutant, 
which showed an increased colony phase variation frequency was mutated in 
mutS. Inoculation of wheat seeds with PCL1171 bacteria of phase I morphology 
resulted in efficient suppression of take-all disease, whereas disease suppression 
was absent with phase II bacteria. Neither the gacS nor the mutS mutant was 
able to suppress take-all, but biocontrol activity was restored after genetic 
complementation of these mutants. Furthermore, in a number of cases, 
complementation by gacS of wild-type phase II sectors to phase I phenotype 
could be shown. A PCL1171 phase I mutant defective in antagonistic activity 
appeared to have a mutation in a gene encoding a lipopeptide synthetase 
homologue and had lost its biocontrol activity, suggesting that biocontrol by 
strain PCL1171 is dependent on the production of a lipopeptide. Our results 
show that colony phase variation plays a regulatory role in biocontrol by 
Pseudomonas bacteria by influencing the expression of major biocontrol traits 
and that the gacS and mutS genes play a role in the colony phase variation 
process. Therefore phase variation not only plays a role in escaping animal 
defense but it also appears to play a much broader and vital role in the ecology 
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INTRODUCTION 
 
In commercial agriculture, crop protection against phytopathogens relies 
heavily on chemical pesticides. There is a growing concern for negative health 
and environmental effects of such pesticides. For example, the European Union 
has decided that 60% of the chemical pesticides that were allowed in 1996 will 
be banned in 2003. Therefore, alternatives for the use of chemicals are needed. 
The use of genetically engineered disease-resistant plants is perceived poorly by 
the public, especially in Europe. Therefore, the use of microorganisms to 
control plant pathogens is the most attractive alternative. Sofar however, 
success in the field is limited due to variable results.   
The control of phytopathogenic fungi by biocontrol microbes depends on a wide 
variety of traits, such as the production of antifungal metabolites (AFMs) (32, 
44, 127, 164, 192, 240), production of exo-enzymes such as proteases, lipases, 
chitinases, and glucanases (32, 67, 245) production of hydrogen cyanide (HCN) 
(261), production of siderophores (142) of biosurfactants (228), and competitive 
root colonization (43, 152). Previous results have indicated that mutation of a 
xerC/sss homologue from the efficiently root colonizing P. fluorescens strain 
WCS365 resulted in a decrease in the frequency of colony phase variation and a 
severe decrease of its competitive root tip colonizing abilities (55, 56). The 
xerC/sss product has been reported to be involved in DNA rearrangements (48). 
Phase variation is a regulatory process by which bacteria undergo frequent and 
(often) reversible phenotypic changes resulting from genetic alterations in 
specific loci of their genome. Phase variation is based on structural changes at 
the DNA level and results in sub-populations of bacteria, as is often 
demonstrated by the presence of distinct morphological phases between 
colonies or within a colony (72, 98). In general, phase variation, thought of as a 
random event, occurs at frequencies of >10-5 per generation (98). Phase 
variation, as a regulatory system, can influence the production of diverse traits 
such as the production of proteases and lipases (38), of pili (170), outer 
membrane proteins (170), fimbriae (1), surface lipoproteins (204), flagella 
(123), and other surface-exposed antigenic structures (72, 98).   
The finding in our group that phase variation can negatively influence 
competitive root tip colonization (55, 56) and, therefore, biocontrol (43) has 




MATERIAL AND METHODS 
 
Microbial strains and plasmids 
Bacterial strains and plasmids are listed in Table 1. Pseudomonas strains were 
grown on King’s medium B (KB) (128) at 28°C. Solid growth media contained 
1.8% (wt/v) agar (Difco Laboratories, Detroit, MI). Kanamycin, gentamicin, 
tetracycline, and cyclohexamide (Sigma, St Louis, MO) were added for 
antibiotic selection in final concentration of 50, 10, 40, and 100 µg/ml, 
respectively, when appropriate. Fungi were grown on KB or Potato Dextrose 
Agar (PDA) (Difco Laboratories, Detroit, MI). BM (Minimal Basic medium) 
(152) with 0.2% glycerol as carbon source was used for the screening for 
mutants without antagonistic activity.  
For the isolation of Pseudomonas strains from the rhizosphere, roots from maize 
plants were shaken twice for 30 minutes in phosphate buffered saline (PBS) 
(208). The resulting suspensions were plated and grown overnight in 
Pseudomonas isolation medium (Difco Laboratories, Detroit, MI) at 28°C. 
Colony morphology and ARDRA (258) were used to identify the strains and 
select Pseudomonas spp. 
For strain identification of PCL1171 phase I and phase II, colony PCR (275) 
was used for amplification of the 16S rDNA from colonies with a phase I or 
phase II morphology. The PCR products were sequenced by BaseClear (Leiden, 
The Netherlands) or ServiceXS (Leiden, the Netherlands) and analyzed for 
homologies using the BLAST (5). 
 
Measurement of phase variation frequencies 
Bacteria with a phase I or phase II morphology were inoculated in a volume of 
5 ml KB to an optical density at 620 nm (OD620) of 0.05 and grown shaking 
overnight at 28°C. By measuring the optical density and subsequent dilution 
and plating on KB medium, an average of 500 colonies per plate was obtained. 
For estimation of frequencies at least 1,500 colonies were counted. To obtain 
the frequency of switching, the number of switches was divided by the number 
of generations passed. 
 
Construction, selection, and complementation of mutants  
A mutant library of strain PCL1171 phase I was constructed using the plasmid 
pRL1063a, which harbors a Tn5 transposon with promotorless luxAB genes and 
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a kanamycin resistance marker (277). Electro-competent phase I cells were 
obtained by scraping the cells from the plates, washing them three times with 
sterile water, followed by two washings with 10% glycerol. pRL1063a plasmid 
DNA (1 to 2 µg) was used for electroporation of electro-competent cells using a 
pulser device (settings: 25 µF, 100Ω, and 2.5 kV) (Biorad Lab, Richmond, CA, 
U.S.A). The transformation mixture was grown in SOB medium (208) for 2 h 
and, subsequently, plated on selective medium and grown at 28°C. The obtained 
transposants were judged after at least two days of growth on KB plates for 
altered colony morphology. Mutants lacking colony phase variation or showing 
an increased frequency of colony phase variation were selected. Furthermore, 
mutants expressing a phase I morphology but that had lost their antagonistic 
activity were selected, using BM agar plates on which eight mutants were 
grown surrounding an inoculum of the fungus G. graminis pv. tritici (83). 
Mutants unable to inhibit the fungus were selected after 7 days of growth.  
DNA regions flanking the transposon were isolated by excision of the 
transposon from the chromosomal DNA of the transposants using EcoRI or 
ClaI, followed by ligation and transformation with E. coli strain DH5α. Since 
the Tn5 transposon harbors an origin of replication (p15A), the plasmid can 
replicate and maintain itself in E. coli. The plasmids were reisolated. The 
flanking chromosomal regions were sequenced using unique primers oMP458 
(5’-TACTAGATTCAATGCTATCAATTGAG-3’) and oMP459 
(5’-AGGAGGTCACATGGAATATCAGAT-3’) directed outwards of the 
transposon ends. Sequencing was carried out by BaseClear (Leiden, The 
Netherlands) or ServiceXS (Leiden, the Netherlands). General DNA 
modification techniques were performed according to Sambrook et al. (208).  
 
Complementation of the gacS mutant strains 
Primers oMP658 (5’-GGAATTCAGGATGTCCATCAACACCA-3’) and 
oMP618 (5’-GGAATTCATCGTTGATGAAGGCACACA-3’) were used to 
amplify the complete gacS gene from PCL1171 by PCR. The obtained PCR 
fragment was cloned into pGEMTeasy (Promega Corp. Madison, WI, U.S.A) 
and was subsequently cloned in pME6010 using EcoRI. This construct, 
pMP6562, was used to transform PCL1563 and PCL1572 by electroporation. In 
addition, phase II bacteria of wild-type strains PCL1157, PCL1182, and 





Analysis of cell envelope proteins and lipopolysaccharides 
To analyze LPS and membrane protein patterns, cells with a specific phase I or 
phase II morphology were harvested separately from plate after two days of 
growth at 28°C and re-suspended in 50 mM Tris-HCl, 2 mM EDTA pH 8.5. To 
isolate cell envelopes, cells were sonicated and centrifuged for 20 minutes at 
2,700 rpm and for one hour at 10,000 rpm, to isolate preparations for the 
analysis of LPS and total membrane proteins, respectively. The obtained pellets 
were resuspended and stored in CE-buffer (2 mM Tris-HCl, pH 7.8). To 
visualize LPS patterns, the cell envelope preparation was incubated for 15 
minutes at 100°C in 125 mM Tris/HCl pH 6.8, 4.0% SDS, 20% glycerol, and 
0.02% bromophenol blue, followed by proteinase K treatment. The LPS 
fractions were separated in a denaturing 11% SDS-PAGE gel using a Mini-
ProteanTM 3 Cell system (BioRad Lab). The LPS pattern was visualized by 
silver staining (246). Cell envelope proteins were denatured by adding β-
mercaptoethanol to the cell envelope mixture to a final concentration of 0.1%, 
followed by incubation for 10 minutes at 100°C. Proteins were separated on a 
11% SDS-PAGE denaturing gel using a Mini-ProteanTM 3 Cell system 
(BioRad Lab) and visualized with Coomassie-Blue staining (208).  
 
Analysis of biocontrol traits 
Antagonistic activity against the fungi Fusarium oxysporum f. sp. radicis-
lycopersici, Rhizoctonia solani, Rosellinia necatrix, and G. graminis pv. tritici 
was analyzed, using an agar plate on which the fungus was inoculated in the 
center of a petri dish, whereas four bacterial strains were spot-inoculated at a 
distance of 2 to 3 cm. After 7 days of growth at 28°C the plates were examined 
for growth inhibition zones of the fungus surrounding the bacterial spot (83).  
For the detection of secreted bacterial protease, β-glucanase, lipase, and 
cellulase, 1.8% agar plates containing 5% skim milk, 0.1% lichenan (Sigma) 
(264), 2% Tween 80 (107), or 0.5% carboxymethylcellulose (94) were used, 
respectively. The plates were inspected for degradation zones as judged by 
clearing or precipitation zone in case of lipase activity, after 5 days of growth at 
28°C.  
For the detection of secreted chitinase activity chitinpentaose (Seikagaku, 
Tokyo, Japan) was O-acelytated with 14C-Acetyl CoA (Amersham Life 
Sciences, Cleveland, OH, U.S.A.) using the O-acetyl transferase NodL as 
described by Bloemberg et al. (21). Samples consisting of cell-free supernatant 
fluid of overnight cultures were loaded on a NH2F245s Thin Layer 
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Chromatography plate (Merck, Darmstadt, Germany) and chromatographed 
using a 65% acetonitril/35% water (vol/vol) mixture. The distribution, e.g. 
breakdown, of chitinpentaose of radioactivity was measured after 4 to 7 days of 
exposure, using a Phosphor Imager (Biorad Lab). 
Hydrogen cyanide was detected by growing the bacterial strains on agar plates 
in the presence of 3MM paper (2 x 2 cm) drenched in a solution of copper(II) 
ethyl-acetoacetate (5 mg/ml) and 4,4’-methylene-bis-(N,N-dimethylaniline) (5 
mg/ml) (37). Hydrogen cyanide turns the indicator paper blueish purple.  
Production of biosurfactant was determined using a drop-collapsing assay, in 
which a small amount of bacteria was taken from a bacterial colony with a 
toothpick and resuspended in 15 to 30 µl drops of water placed on parafilm. The 
presence of biosurfactant decreases the surface tension and therefore results in 
the collapse of the drop (114). 
Bacteria were tested for motility after spot inoculating of cells in the middle of a 
plate containing 1/20 KB solidified with 0.3% agar. The plates were examined 
for the presence of migration zones after overnight incubation at 28°C (56). 
 






Bacterial strains  
PCL1171 Antagonistic Pseudomonas strain isolated from 
the rhizosphere of maize from Mexican 
agricultural fields. Colony morphology varies 
between two distinct phases, defined as phases I 
(opaque) and II (translucent). Model strain 
chosen for genetic studies 
This study 
PCL1152, 55, 
57, 59,61, 63, 
66, 69, 173, 75, 
77, 80, 82, 84 
Other antagonistic Pseudomonas strains isolated 
from the rhizosphere of maize from Mexican 
agricultural fields. Colony morphologies vary 
with different frequencies between two distinct 
phases defined as phase I and phase II 
This study 
PCL1572 Derivative of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a gacS 
homologue 
This study 
PCL1563 Derivative of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a gacS 
homologue 
This study 












PCL1555 Derivative of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a mutS 
homologue 
This study 
PCL1556 PCL1555 complemented with pMCS5-mutS  This study 
PCL1391 Pseudomonas chlororaphis. Efficient 
biocontrol strain and good competitive 
colonizer of tomato roots, which produces 
phenazine-1-carboxamide. 
(44) 
PCL1666 Derivate of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a 
lipopeptide synthetase homologue 
This study 
PCL1656 Derivate of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into the 
thiolation domain of a lipopeptide synthetase 
homologue 
This study 
PCL1663 Derivate of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a 
condensation domain of a lipopeptide 
synthetase homologue 
This study 
PCL1660 Derivate of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a region 
preceding a adenylation domain of a 
lipopeptide synthetase homologue 
This study 
DH5α E. coli endA1 gyrSA96 hrdR17(rK-mK-) 
supE44 recA1; general purpose E. coli host 
strain 
(93) 
Fungal strains  
ZUM2407 Fusarium oxysporum f.sp. radicis-lycopersici; 
causes tomato foot and root rot 
IPO-DLO  
3R4FNA Rhizoctonia solani; causes damping-off and 
fruit rot 
IPO-DLO  
400 Rosellinia necatrix; causes white root rot or 
Rosellinia root rot in a wide range of host 
plants 
(189) 
R3-11A Gaeumannomyces graminis pv. tritici; causes 
take-all disease of wheat and of other cereals 
(192) 
Plasmids   
pRL1063a Plasmid harboring a promoterless Tn5luxAB 
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pGEM-T Easy Vector system for cloning PCR products, Cbr Promega, 
Madison 
USA 
pME6010 E. coli / Pseudomonas shuttle vector, stably 
maintained in Pseudomonas species, with an 
estimated copy number of 4-8, Tcr
(95) 
pMP6562 pME6010 harboring a 3.2kb PCR product from  
strain PCL1171 which contains the gacS 
homologue from PCL1171,Tcr
This study 
pMP5565 pME6010 harboring a 1.2kb PCR product from 
Pseudomonas sp. strain PCL1446 which contains 
a gacA homologue  
Kuiper et al., 
unpublished 
data 
pMCS5-mutS pBBR1 MCS-5 containing the mutS gene from 





For root attachment experiments, tomato seeds were sterilized by incubating the 
seeds for 3 min in 5% sodium hypochlorite, followed by five rinses for 25 min 
in 20 ml of sterile water. Subsequently, the seeds were incubated for 3 min in 
70% ethanol, followed by five rinses with sterile water. After a second 
incubation for 1 h in 5% sodium hypochlorite, the fluid was removed, and the 
seeds were left for 1 h in sterile water. The latter procedure was repeated once. 
Sterilized wheat and tomato seeds were stored on PNS (101) agar plates at 4°C 
and were allowed to germinate on PNS agar at 28°C. Seedlings were grown in a 
PNS solution in magenta vessels (Sigma, Bornhem, Belgium) holding a 
perforated stainless steel tray, for seven days at 20°C. Bacteria scraped from 
agar plates were resuspended in PBS to an OD620 = 1.0. The roots were 
incubated for 45 minutes in the bacterial suspension, were removed and were 
washed in PBS to remove all nonattached bacteria. The roots were shaken 
vigorously for 15 minutes in a suspension of PBS in the presence of sand in an 
Eppendorff shaker (Eppendorff, Hamburg, Germany) to remove attached 
bacteria from the root. Appropriate dilutions of the suspensions were plated on 






Biocontrol of take-all of wheat caused by Gaeumannomyces graminis pv. 
tritici  
The G. graminis pv. tritici-wheat system as described by Weller et al. (269) was 
used to test biocontrol activity. Briefly, an inoculum was prepared by growing 
G. graminis pv. tritici on sterilised oat for 3 to 4 weeks. The inoculum was dried 
overnight in a flow cabinet and stored at 4°C. The inoculum for the biocontrol 
assay was prepared following the method of Weller et al. (1985). A bacterial 
suspension (2×109 CFU/ml) and a 2.0% (w/v) methylcellulose solution were 
mixed (1:1 vol/vol) and used to coat wheat seeds (Triticium aestivum, cultivar 
Residence). Wheat seeds were sown (nine seeds per pot) on a mixture of potting 
soil and chemically pure sand, in a 1:1 ratio, containing a predetermined 
percentage of inoculum, which results in 60 to 80% diseased plants, and 
covered with approximately 1 cm of inoculum-free potting soil. After 2 to 3 
weeks of growth at 15°C, the number of diseased plants was determined based 
on the characteristic disease symptoms of take-all (192). Plants were scored as 
diseased or healthy. 
 42
Biocontrol and colony phase variation 
RESULTS 
 
Selection of antagonistic Pseudomonas spp. strains which undergo phase 
variation 
A collection of 214 Pseudomonas strains was isolated from the rhizosphere of 
maize plants from an agricultural field in Totontepec Mixe, Oaxaca, Mexico. 
They were preliminary characterized as pseudomonads based on their growth on 
Pseudomonas isolation medium, colony morphology, and Amplified Ribosomal 
DNA Restriction Analysis (ARDRA). Using an antifungal activity plate assay 
(83), it was shown that 46 (21%) of the strains inhibited the growth of 
Gaeumannomyces graminis pv. tritici R3-11A, Fusarium oxysporum f.sp. 
radicis-lycopersici, Rhizoctonia solani, and Rosellinia necatrix. Another 33 
strains (15%) showed slight antagonistic activity, i.e., the colonies were not 
overgrown by the fungus. The remaining 135 strains (63%) did not exhibit 
activity towards the fungal species tested.  
Forty-three (93%) of the 46 selected strongly antagonistic strains showed 
colony phase variation, as judged after 4 days of growth on King’s medium B 
(KB) agar at 28ºC. Two morphologically different colony types were found for 
all strains. Colonies, referred to as phase I, are thick and opaque (majority of 
colonies in Fig. 1A and B), whereas those of phase II are flat and translucent 
(Fig. 1C). After separation of the two different phases by re-streaking on KB 
agar and subsequent growth for two days at 28ºC, roughly three classes with 
distinct but somewhat fluctuating frequencies of phase variation could be 
distinguished. Fluctuating frequencies of phase variation could be distinguished 
in liquid culture with average frequencies of >9.0 x 10-2, around 10-3, and 
<1.5 x 10-4 switches per generation. For the latter class, consisting of strains 
PCL1152, PCL1157, PCL1159, PCL1166, PCL1169, PCL1177, PCL1182, and 
PCL1184, both colony types can be maintained separately. A low frequency of 
switching (<5.0x10-4) was observed from phase I to phase II, whereas a slightly 
higher switching frequency (around 10-3) was observed from phase II back to 
phase I. PCL1171 and PCL1173 exhibit a low frequency of switching (<5.0x10-
4) from phase I to phase II. However, a high frequency (>9.0x10-2) for the 
reverse switch was observed, since restreaking of phase II colonies with a single 
phase appearance immediately resulted in phase I colonies out of which phase II 
sectors are again formed after two days of growth. For the most instable strains, 
PCL1155, PCL1161, PCL1163, PCL1175, and PCL1180, both phases are 
instable, and re-streaking of one of the phases always resulted in a mixture of 
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phase I and phase II colonies. Based on the differences in colony morphology 
and the distinct frequencies of phase variation, fifteen strains were selected 




Figure 1. Colony phase variation of PCL1171 and its mutants. A, wild-type PCL1171, 
in which colonies with a phase I morphology are dominant; B, enlargement of a single 
colony of this strain in which phase II appears as a sector; C, enlargement of a single 
colony of this strain in which a phase I sector appears; D, stable phase II colony 
morphology of PCL1572 (Tn5luxAB::gacS); E, colony morphology of PCL1555 
(Tn5luxAB::mutS) in which the frequency of colony phase variation is increased; F, 
colony morphology of PCL1556 (Tn5luxAB::mutS) complemented by pMCS5-mutS 
which decreases the frequency of colony phase variation of the mutant to wild-type 
levels. The arrows indicate phase I (I) and phase II (II) colonies, respectively. 
 
Biocontrol traits expressed in different phases  
Each of the 15 selected strains showed a different lipopolysacharide (LPS) 
ladder pattern on SDS-PAGE (sodium dodecylsulfate polyacrylamide 
gelelectrophoresis), but no difference in LPS patterns were found between the 
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Figure 2. SDS-PAGE analysis of cell envelope 
proteins of phase I and phase II bacteria of strain 
PCL1171. SDS-PAGE gel of the cell envelope 
proteins isolated from colonies of PCL1171. 
Lane 1, protein markers (sizes indicated in kDa 
on the left); lane 2, cell envelope proteins 
expressed by phase I cells; lane 3, cell envelope 
proteins expressed by phase II cells (arrows 
indicate differences in expression of proteins 
between phase I and phase II cells). Clear 
differences in protein expression were observed 
for proteins with apparent molecular weights of 





two colony phases of a single strain (data not shown). One of the strains, 
Pseudomonas sp. PCL1171, was examined for differences in cell envelope 
proteins between its two phases. SDS-PAGE analysis showed that proteins with 
apparent molecular masses of 5 and 30 kDa were enhanced in phase I, whereas 
proteins with apparent molecular masses of 12, 72, and 84 kDa were enhanced 
in phase II cells (Fig. 2). The ability of PCL1171 cells of the separate phases to 
attach to roots of wheat or tomato was analyzed in a time course, but no 
differences were observed. Both phase I and phase II bacteria were tested on 
motility plates. Overnight incubation of the bacteria resulted in a clear motility 
circle for phase II bacteria and in an irregular movement of the bacteria over the 
plate for phase I bacteria (Fig. 3).  
Phase I and phase II bacteria of the 15 selected strains were tested in a 
plate assay for inhibition of the growth of the phytopathogenic fungi G. 
graminis pv. tritici, Fusarium oxysporum f.sp. radicis-lycopersici, Rhizoctonia 
solani, and Rosellinia necatrix. Only phase I bacteria inhibited growth of the 
fungal species tested. Furthermore, the production of chitinase and biosurfactant 
was also found to be correlated with phase I morphology for all 15 strains. 
Protease and lipase were primarily produced by bacteria with a phase I 
morphology, although, for seven strains, phase II bacteria still produce protease 
45 
Chapter 2 
or lipase activities, or both. None of the selected strains produced hydrogen 
cyanide, cellulase, or β-glucanase (Table 2).  
 
Preliminary genetic characterization of colony phase variation by strain 
PCL1171 
One of the 15 selected Pseudomonas strains, strain PCL1171, was chosen for 
preliminary genetic characterization of the colony phase variation phenomenon. 
This choice was based on the strain’s relatively stable expression of phase I 
morphology on KB agar plates. Phase II sectors were only found after  
 
 
Table 2. Phase variation characteristics and biocontrol traits of fifteen antagonistic 
Pseudomonas strains isolated form the rhizosphere of maize plants from an agricultural 








Chitinase Protease Lipase 
I + + + + + A 
II - - - - - 
I + + + + + B 
II - - - + - 
I + + + + + C 
II - - - - + 
I + + + + + D 
II - - - + + 
 
1 Group A consists of strains PCL1155, PCL1157, PCL1169, PCL1171, PCL1177, 
PCL1180, PCL1182, and PCL1184, Group B consist of strains PCL1152, and 
PCL1163, Group C consists of strains PCL1159, and PCL1166, and group D consists 
of strains PCL1161, PCL1173, and PCL1175. 
2 None of the strains produced β-glucanase, cellulase, or hydrogen cyanide (HCN)  
3 Colony morphology, phase I (I) or phase II (II) 
4 Antifungal activity (AFA) towards G. graminis pv. tritici R3-11A, F. oxysporum 
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Figure 3. Motility of PCL1171 
phase I and phase II cells. Cells of 
PCL1171 phase I (A) and phase II 
(B) were inoculated on 1/20 King’s 








approximately two days at the border of PCL1171 phase I colonies (Fig. 1A and 
B). Later, we observed that re-streaking of these phase II sectors coincided with 
a high frequency of switching back to a phase I phenotype, resulting in mainly 
phase I morphology on agar medium. The strain was further identified using 
polymerase chain reaction (PCR) amplification and subsequent sequencing of 
the 16S rDNA of phase I and phase II colonies, which yielded identical 
sequences. This sequence data has been submitted to Genbank under accession 
number AY236959. Comparison of these sequences with those in the Genbank 
database revealed similarity with sequences of Pseudomonas sp. RNA group I, 
which includes P. aeruginosa, P. chlororaphis, P. fluorescens biovars, and 
P. putida. Based on 16S rDNA sequence, similarity (up to 99 % identity) was 
found to a large group of P. tolaasii strains (with 100 % identity). However, this 
16S rDNA sequence clearly branches off from these Pseudomonas species (data 
not shown) and is therefore considered to be closely related to P. tolaasii 
species. 
A Tn5luxAB transposon library of phase I of strain PCL1171 was 
constructed. Mutants that exhibited a phase-locked colony morphology or an 
altered phase variation frequency were selected. Three mutants were selected 
out of 900 transposants. Two of these mutants, strains PCL1563 and PCL1572, 
appeared to be locked in a phase II colony morphology (Fig. 1D). Consistent 
with what we found for phase II cells of wild-type strain PCL1171, the mutants 
PCL1563 and PCL1572 did not produce protease, lipase, or biosurfactant and 
were not antagonistic (data not shown).  
Sequencing of the regions flanking the Tn5luxAB transposon of mutants 
PCL1563 and PCL1572 revealed that their transposons had inserted at different 
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positions in the same gene (Fig. 4A). The mutated gene, predicted to encode a 
protein of 918 amino acids (aa), showed highest homology (82% identity and 
89% similarity at the amino acid level) to the gacS gene product of  
P. chlororaphis (Genbank accession no.AAF06332) (Fig. 4A). Downstream of 
gacS, an open reading frame (ORF) transcribed in the same direction as gacS, 
was revealed, the predicted protein product of which shows 65% identity and 
74% similarity at the amino acid level to D-lactate dehydrogenase of 
P. aeruginosa (PA0927) (Fig. 4A). Upstream of the gacS gene an ORF, 
transcribed in the opposite direction, was predicted to encode a protein with 
50% identity and 70% similarity at amino acid level to a response regulator of a 
two component regulatory system (PA0929) (Fig. 4A). For complementation, a 
PCR product was constructed, containing the complete gacS homologue, 
including 390 bp upstream of the ATG to include the promoter region as well as 
230 bp downstream of the stop codon, which includes a fragment of 169 bp of 
D-lactate dehydrogenase. This PCR fragment, cloned into pME6010 (estimated 
copy number 4 to 8) resulting in pMP6562, restored phase variation in strains 
PCL1563 and PCL1572 to the wild-type level. In addition, PCL1157, PCL1182, 
and PCL1184 were used to test whether a spontaneous phase II phenotype can 
be based on a gacS mutation. Phase II bacteria from strains PCL1157, 
PCL1182, and PCL1184, could be (partially) complemented using pMP6562. A 
mixture of phase I and phase II colonies was obtained on plate. 
Complementation using pMP5565 harbouring a gacA homologue from 
Pseudomonas sp. strain PCL1446 resulted in a mixture of phase I and phase II 
colonies (data not shown). Only phase II colonies were obtained after 
transformation of the empty parental vector.  
The third mutant, strain PCL1555, displayed an increased switching 
frequency between phase I and II in comparison to the wild type (Fig. 1E), in 
such a way that neither of the phases could be obtained as colonies with a single 
phase appearance. Sequencing of the flanking regions of the Tn5 insertion in 
PCL1555, showed that the transposon had inserted in a gene encoding a protein 
of 865 aa with 85% identity and 91% similarity at the amino acid level to the 
mutS gene product of P. aeruginosa (Genbank accession no. AE004782), which 
was therefore designated mutS (Fig. 4B). Sequencing downstream of the mutS 
gene revealed an ORF, transcribed in the same direction, the predicted protein 
product of which showed 92% identity and 94% similarity at the amino acid 
level to a hypothetical protein in P. fluorescens (Genbank accession no. 
ZP_00085195) (Fig. 4B). Upstream of the mutS gene, an ORF transcribed in the 
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opposite direction was predicted to encode a protein with 88% identity and 93% 
similarity at the amino acid level to a hypothetical protein of P. fluorescens 
(Genbank accession no. ZP_00085197) (Fig. 4B). After transformation of 
PCL1555 with pMCS5-mutS, which contains the complete mutS gene and a 
downstream 203-bp fragment of ferrodoxin A from P. aeruginosa, the phase 
variation frequency of PCL1555 was restored to wild-type levels (Fig. 1E and 
F). The sequence data of gacS and mutS has been submitted to the Genbank 
databases under accession no. AY236957 and AY236958, respectively. 
 
Figure 4. Schematic representation 
of the chromosomal regions of 
PCL1171 surrounding the transposon 
insertions of mutants A, PCL1572 
(Tn5luxAB::gacS) and PCL1563 
(Tn5luxAB::gacS) and of B, PCL1555 
(Tn5luxAB::mutS). The arrows of the 
indicated genes and transposons 







Effect of colony phase variation on biocontrol ability strain PCL1171  
Cells of the different colony phases of strain PCL1171 were tested for their 
biocontrol activity of wheat take all caused by G. graminis pv. tritici. 
Inoculation of the wheat seeds with phase I bacteria resulted in a significant 
reduction of the disease (Fig. 5A). PCL1171 phase I or phase II cells, tested in 
the absence of a pathogen, did not cause disease of wheat plants (data not 
shown). Inoculation of wheat seeds with phase II bacteria did not result in a 
statistically significant biocontrol, when compared to the untreated control seeds 
(Fig. 5A). Inoculation of the seeds using the well-described biocontrol strain, 






Role of antagonism in biocontrol ability of strain PCL1171 
The Tn5luxAB transposon library of PCL1171 phase I was used to screen for 
genes involved in the antagonistic activity of PCL1171 towards G. graminis pv. 
tritici. A total of 2,000 mutants were screened for the loss of antagonistic 
activity in an antifungal plate assay (83). This screening only included mutants 
expressing phase I morphology with a phase variation frequency comparable to 
PCL1171. Four mutants, selected for the loss of antagonistic activity, were 
genetically characterized by sequencing the regions flanking the Tn5luxAB 
transposon. These sequences revealed that the transposon of all mutants had 
inserted in a lipopeptide synthetase homologue, but in different domains of this 
gene (88). The partially sequenced gene product showed highest homology to a 
syringomycin synthetase (Genbank accession no. AF47828). Domains in this 
gene include adenylation, thiolation and condensation domains, which are all 
needed to incorporate a single amino acid in the lipopeptide (158). Sequencing 
of the flanking regions of the transposon insertion in PCL1656 (2574 bp 
surrounding the Tn5 with 75% identity and 64% similarity at the amino acid 
level), PCL1660 (942 bp surrounding the Tn5 with 75% identity and 71% 
similarity at the amino acid level), PCL1663 (783 bp surrounding the Tn5 with 
62% identity and 53% similarity at the amino acid level), PCL1666 (1947 bp 
surrounding the Tn5 with 50% identity and 60% similarity at the amino acid 
level) showed highest homology to thiolation, adenylation, and condensation 
domains, and a region preceding an adenylation domain, respectively, of 
lipodepsipeptide synthetase of P. syringae pv. syringae. In contrast to wild-type 
strain phase I cells, mutant PCL1666 phase I cells tested in the G. graminis pv. 
tritici - wheat system did not result in biocontrol (Fig. 5A).  
 
Role of phase variation genes in biocontrol 
The PCL1171 mutant derivatives PCL1572 (gacS::Tn5luxAB) and PCL1555 
(mutS::Tn5luxAB) were tested in biocontrol. Neither of the mutants showed 
significant biocontrol activity (Fig. 5B and C). Complementation of PCL1572 
and PCL1555 using pMP6562 and pMCS5-mutS, respectively, resulted in 
restoration of the wild-type colony phase I phenotype (Fig. 1F) as well as in 
corresponding levels of disease suppression (Fig. 5B and C). 
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Figure 5. Biocontrol of wheat take all caused by Gaeumannomyces graminis pv. tritici. 
Wheat seeds were coated with bacteria and grown in a 1:1 mixture of potting soil and 
quartz sand amended with G. graminis pv. tritici. Seeds were coated with cells of the 
indicated wild type or mutant or with cells of the indicated phase. Experiments using 
PCL1171 phase I and phase II cells to coat the seeds, but without G. graminis pv. tritici, 
did not result in diseased plants. The negative control consisted of seeds coated without 
bacteria. After 12 days of growth the plants were scored for disease symptoms. For each 
strain, 108 plants were tested. Data were analyzed for significance using after arcsine 
square root transformations with analysis of variance followed by a Fischer’s least 
significant difference test (p=0.05, n=12). Values with different letter indications denote 






Isolation and preliminary characterisation of antagonistic Pseudomonas 
spp. strains which undergo phase variation 
Performance of biocontrol microorganisms in the field is variable. Elucidation 
of the mechanism behind this phenomenon will contribute to defining the traits 
required for robust biocontrol strains and, therefore, enhanced performance. Our 
group has found that phase variation mediated by the xerC/sss gene has a 
profound effect on a Pseudomonas strain’s ability for competitive root 
colonization (55, 56) and biocontrol (43). We therefore initiated a study on 
phase variation among Pseudomonas rhizosphere strains with the aim to 
identify other genes and traits involved in phase variation.  
Maize in Totontepec Mixe, Mexico has been grown successfully for over 
700 years without the application of chemicals. Since the climate in this region 
is warm and humid, conditions are ideal for the proliferation of fungi. A 
possible explanation for the excellent yields of maize could be a high incidence 
of biocontrol microbes protecting the plants against diseases caused by 
pathogenic fungi. Therefore, microbes derived from the maize rhizosphere of 
plants from this region were investigated. From 214 isolated putative 
Pseudomonas strains 46 isolates (21%) were found to inhibit the growth of a 
number of important crop pathogens including G. graminis pv. tritici, which 
causes wheat take-all, and F. oxysporum f.sp. radicis-lycopersici, which causes 
tomato foot and root rot. Indeed, this frequency of biocontrol strains is 
extremely high. For comparison, we previously found that the frequency of 
biocontrol pseudomonads in the rhizosphere of tomatoes from a commercial 
agricultural field in Andalusia (Spain) is approximately one percent (44).  
A striking phenomenon was that 43 out of the 46 antagonistic isolates 
showed reversible colony phase variation (Fig. 1B and C). The reversible 
character of the colony phase variation is illustrated by the occurrence of phase 
II sectors originating from phase I colonies (Fig. 1B) and phase I sectors 
originating from phase II colonies (Fig. 1C). We selected 15 clearly different 
strains and tested these on the influence of phase variation on other biocontrol 
traits and found that the production of such diverse metabolites as antifungal 
metabolite, chitinase, biosurfactant, protease, and lipase are subject to phase 
variation. The majority of these molecules are synthesized by the opaque 
phase I colony form but not by the translucent form (Table 2). Other differences 
between these colony forms were found in motility (Fig. 3) and cell surface 
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proteins (Fig. 2). It should be noted that the difference in motility may be 
caused by the effect of phase variation on biosurfactant production since 
biosurfactant can influence motility by enabling bacteria to break the colony 
boundary more easily resulting in irregular swimming (169). 
Since the majority of the factors mentioned in Table 2 are synthesized in 
opaque phase I cells under control of the gac system, it is likely that the factor 
determining opacity of phase I colonies is under the same control. Consistent 
with this notion is the finding that opacity proteins (opa genes) in Neisseria 
gonorrhoeae are also regulated by phase variation (230). Therefore, it is 
conceivable that one or more of the cell surface proteins which is/are relatively 
strongly expressed in phase I colonies (Fig. 2) are determining the colony 
opacity. It should also be realized that, if a strain does not produce this opacity 
factor, phase variation may occur but may not be visible as a change in colony 
morphology.  
 
Genetic characterization of colony phase variation of PCL1171 
One of the 15 strains, Pseudomonas sp. PCL1171, was chosen for a preliminary 
genetic characterization of colony phase variation. Since phase I colony 
morphology is dominant in PCL1171 (Fig. 1A), mutants locked in phase II (Fig. 
1D) can relatively easily be detected. Both analyzed phase II-locked mutants 
appeared to have the transposon inserted in a gacS homologue (Fig. 4A). GacS 
is the sensor kinase of a two component regulatory system that, in combination 
with the response regulator GacA, controls the production of a wide range of 
secondary metabolites (271), including the production of AFM, chitinase, 
protease, HCN, and virulence factors (139, 156). The gacS/gacA regulatory 
system belongs to the FixJ family of transcriptional regulators (139). Our results 
indicate that the gacA/gacS system is one of the key players in phase variation, 
since mutation of gacS locks the bacteria in phase II. This is supported by the 
complementation by gacS and gacA of spontaneous phase II bacteria from wild-
type strains PCL1157, PCL1182, and PCL1184. 
Recent reports on gacA/gacS have shown that both genes are targets of 
point mutations, small deletions and insertions. For example, P. fluorescens 
grown in nutrient rich liquid media to stationary phase accumulates spontaneous 
stable gacA and gacS mutants (33). Furthermore a homologue of gacS, the pheN 
gene of P. tolaasii, was shown to be regulated by phase variation through an 
internal 661-bp duplication (92). Bull et al. (33) reported a selective advantage 
under laboratory conditions for the loss of gacA function which might represent 
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another example of phase variation via gacA/gacS. In addition, Chancey et al. 
(39) reported that gacA/gacS mutants can survive in the rhizosphere and, when 
present in wild-type populations, will increase the survival of these mixed 
populations. Also, in this case, phase variation could be the cause of these 
mixed populations. It is therefore conceivable that, in the heterogeneous and 
changing microenvironment of the rhizosphere, the ability to adapt by changing 
the expression of specific traits to reduce metabolic load via gacA/gacS, 
combined with the beneficial effect of these mutants on population survival in 
the rhizosphere, could be advantageous for the bacterium. 
Mutant PCL1555 shows a strongly increased frequency of switching 
between phases I and II (Fig. 1E). Genetic analysis showed that its transposon is 
inserted into a homologue of the mutS gene (Fig. 4B). MutS is involved in 
methyl-directed recognition of DNA mismatches related to replication. MutS 
recognizes base mismatches and small insertions or deletion mispairs 
originating from replication. Upon recognition of these mismatches by MutS, a 
repair pathway involving MutLH is activated, resulting in excision of the 
mismatch by exonucleases. Strand specificity in excision and resynthesis of the 
excised strand is determined by the hemimethylated state of the DNA (174). 
Mutation of mutS is reported to result in the persistence of mutations due to the 
lack of repair (35). For example, mutation of the mutS gene resulted in a 100- to 
1,000-fold increase in the frequency of mutations found in E. coli (106). 
Whereas our results strongly suggest that the gacA/gacS system is a key 
regulator in colony phase variation, we hypothesize that the high frequency of 
phase variation in mutS mutant PCL1555 is the result of the lack of repair of 
mutations in the gacA and gacS genes. Considering the data obtained for our 
gacS and mutS mutants we hypothesize that introduction of mutations in 
gacA/gacS is the basis for the phase I to phase II switch. It is likely that the 
reverse switch from phase II to phase I, is based on repair of these mutations in 
gacA/gacS, and is likely to involve mutS. 
 
Effect of colony phase variation on biocontrol ability strain PCL1171 
It appeared that PCL1171 phase I cells, but not phase II cells, are active as a 
biocontrol agent of wheat take-all (Fig. 5). The activity of phase I cells of 
PCL1171 is even slightly better than that of the well-known tomato foot and 
root rot biocontrol strain P. chlororaphis PCL1391 (Fig. 5A) (44). This is the 
first report which shows that strain PCL1391 also controls a disease of a 
monocot plant. The gacS mutant PCL1572, which only exhibits phase II 
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morphology (Fig. 1D), is as inactive in biocontrol as phase II wild-type cells 
(Fig. 5B). Both phase I colony appearance and biocontrol activity by the mutant 
(Fig. 5B) are restored by genetic complementation. In conclusion, there exists a 
strong correlation between phase I and biocontrol ability. These results show 
that PCL1171 requires a functional Gac system for efficient biocontrol of wheat 
take all. Previously, it was shown that a gacA mutant of P. fluorescens CHAO 
exhibited biocontrol in a Ggt system, presumably due to the (upregulated) 
production of siderophores, which is not dependent on GacA (215). Also, mutS 
mutant PCL1555 is impaired in biocontrol and, in this case, this phenomenon 
can be restored by genetic complementation (Fig. 5C). Possible advantageous 
effects of a high mutation rate on the fitness of cells are short-term effects. In 
contrast, in the long term, especially in heterogeneous environments, a high 
mutation rate will reduce the overall fitness due to the high mutation load (85). 
It is therefore conceivable that the high mutation frequency in mutant PCL1555 
leads to a higher percentage of disabled cells, which are poorly rhizosphere 
competent and therefore, will hardly contribute to biocontrol. 
 
Role of antagonism in biocontrol ability of strain PCL1171 
Mutant PCL1666 lacks antagonistic activity (Fig. 5A) but is still expressing a 
wild-type phase I morphology. Genetic analysis of this mutant showed that its 
transposon is inserted in a homologue of a lipopeptide synthetase gene. This 
gene has been described as being responsible for the production of a 
lipodepsipeptide (19, 88). Some lipopeptides are known as host-specific toxins 
that play an important role in the virulence of, for example, P. syringae (19). In 
this context, it should be stressed that PCL1171 phase I cells, tested in a 
biocontrol experiment in the absence of G. graminis pv. tritici, did not cause 
disease symptoms on wheat (data not shown). The lack of antagonistic activity 
of mutant PCL1666 (Fig. 5A) is consistent with published data which show that 
a number of lipopeptides, including syringomycin, can have fungicidal activity 
(19, 242). Based on our observations, we conclude that the production of the 
antifungal metabolite of PCL1171 is a prerequisite for the biocontrol activity of 
this strain. The genetic analysis of PCL1666 strongly suggests that the mutation 
resides in the structural gene for a lipopeptide, which is switched off in phase II 
and that this is one of the reasons for the lack of biocontrol activity of this phase 
variant. This hypothesis is supported by the observation that both the phase 
switch in strain PCL1171 (Fig. 5A) as well as the production of a variety of 
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toxins by P. syringae (14) and lipopeptide production in Pseudomonas sp. strain 
DSS73 (134) is dependent on gacS activity.  
We have shown that Pseudomonas sp. PCL1171 can control wheat take-
all and that one of the important biocontrol traits is the production of an AFM 
(Fig. 5A), likely to be a lipopeptide in nature. Since phase variation may be a 
frequently occurring phenomenon that hampers the optimal production of the 
AFM of PCL1171 as well as optimal colonization and biocontrol of 
P. chlororaphis PCL1391 (43, 56), phase variation may be a major factor in the 
inconsistent biocontrol observed in several field trails (214, 268). Thus, phase 
variation not only plays a role in escaping animal and human defence by 
enabling pathogens to adapt to heterogeneous or hostile environments (140, 
204) but it also appears to play a vital and much broader role in the ecology of 
bacteria producing exoenzymes, antibiotics, and other secondary metabolites.  
We plan to investigate the genetic basis of phase variation in more detail in 
order to determine which traits are involved in regulation of phase variation and 
which target genes are regulated by it. Hopefully this research will result in 
more insight in traits required for robustness of biocontrol strains. The result 
may also be of importance for the efficient production of industrial enzymes 
such as protease and lipase, and of antibiotics and biosurfactants. Similarly, 
since vaccines frequently contain cell surface proteins of which the synthesis 
can be under control of phase variation, an enhanced control of phase variation 
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ABSTRACT 
 
Pseudomonas sp. strain PCL1171 displays colony phase variation between 
opaque phase I and translucent phase II colonies, thereby regulating the 
production of secondary metabolites and exo-enzymes. Complementation and 
sequence analysis of twenty-six phase II mutants and of thirteen wild-type 
phase II sectors growing out of phase I colonies showed that in all these cases 
the phase II phenotype is caused by spontaneous mutations in gacA or/and gacS. 
The mutation of gac reduced both the length of the lag phase and the generation 
time. Isolation and sequencing of the gacS genes from the phase II bacteria 
revealed one insertion as well as several random point mutations, deletions, and 
DNA rearrangements. Most phase II colonies reverted with a high frequency, 
resulting in wild-type gacA and gacS genes and a phase I phenotype. Some 
phase II bacteria remained in the phase II phenotype but changed genotypically 
as the result of (re-)introduction of mutations in either gacA or gacS. The 
reversion of gacA/S to the wild type was not affected by mutation of recA and 
recB. We conclude that in Pseudomonas sp. PCL1171 mutations in gacA and 
gacS are the basis for phase variation from phase I to phase II colonies and that, 
since these mutations are efficiently removed, mutations in gac result in 
dynamic switches between the “wild-type” population and the sub-populations 
harbouring spontaneous mutations in gacA and or gacS, thereby enabling both 
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INTRODUCTION 
 
Phase variation is a process of reversible, high-frequency phenotypic switching 
that is mediated by mutation, reorganization or modification of DNA. Phase 
variation is used by several bacterial species to generate population diversity 
that increases bacterial fitness and is important in niche adaptation (211). Phase 
variation can sometimes be observed by the appearance of morphologically 
distinct colonies or sectors within a colony (72, 98). In contrast to spontaneous 
mutations, which occur at a frequency of approximately 10-7 mutations per cell 
per generation, phase variation occurs at frequencies higher than 10-5 switches 
per cell per generation (98). Four mechanisms of phase variation are known 
(98). (i) Slipped-strand mispairing, dependent on variations in the length of a 
repeat tract, switching a gene on or off as a result of frame-shifts, or regulating 
the level of expression by altering promoter spacing. (ii) Genomic 
rearrangements, based on invertable elements or recombination events resulting 
in gene conversions. (iii) Differential methylation, based on the presence of 
methylation sites within a promoter, which can regulate the binding of 
regulatory proteins, and (iv) random un-programmed variation, which can 
switch traits on and off via random reversible mutations (27).  
Phase variation has been described to regulate the production of pili (170), outer 
membrane proteins (170), flagella (123), fimbriae (1), surface lipoproteins and 
other surface exposed structures (72, 97, 204), secondary metabolites (38, 250), 
and of secreted enzymes such as proteases, lipases and chitinases (38, 250). In a 
previous paper (250), we described that out of forty six Pseudomonas strains 
antagonistic against the wheat pathogenic fungus Gaeumannomyces graminis 
pv. tritici R3-11A (192), forty three displayed colony phase variation. One of 
these strains, PCL1171, was selected to study the molecular basis of phase 
variation. In this strain antagonistic activity, morphology, and expression of 
secondary metabolites such as a lipopeptide with antifungal activity, 
biosurfactant activity, and the exo-enzymes chitinase, lipase, and protease are 
regulated via phase variation, and only expressed in the phase I phenotype. 
Estimation of the phase variation frequencies showed approximately 5.0x10-5 
and 9.0x10-2 switches per cell per generation for phase I to II and for phase II to 
I, respectively (250).  
A preliminary genetic analysis of the phase variation mechanism in PCL1171 
showed that transposon mutation of the gacS gene resulted in the phase II 
phenotype, whereas mutation of mutS strongly increased the frequency of 
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switching between phase I and phase II (250). The gacA/gacS two-component 
regulatory system consists of a sensor kinase GacS and a reponse regulator 
GacA belonging to the FixJ family of transcriptional regulators (138), and 
regulates secondary metabolism and production of exo-enzymes (24, 130, 138, 
200, 250). Phase variation via a homolog of gacS, pheN, which regulates 
pathogenicity and colony morphology in P. tolaasii, is dependent on a 
spontaneous duplication in this gene (92). Furthermore, it has been described 
that the gacA/S system is subject to the accumulation of mutations in several 
Pseudomonas sp. (33, 64, 138, 200, 216). However, neither reversibility of 
these gac mutations nor the molecular nature of mutations in the gacS gene, 
have been reported. In this paper we analyse the role of gacA/S in a phase 
switching, and give a detailed description of the molecular nature of mutations 




MATERIALS AND METHODS 
 
Bacterial strains and plasmids 
Bacterial strains and plasmids are listed in Table 1. Pseudomonas strains were 
grown in King’s medium B (KB) (128) at 28°C. E. coli strains were grown in 
Luria-Bertani (LB) medium (208) at 37°C. Solid growth media contained 1.8% 
(wt/vol) agar (Difco Laboratories, Detroit). Kanamycin, tetracycline, and 
carbenicillin (Sigma, St. Louis, MO) were added for antibiotic selection in final 
concentrations of 50, 40, and 50 µg/ml, respectively. Growth in liquid medium 
was analysed in triplicate by measurement of the optical density (OD620) in 
time. The numbers of viable cells in the starting culture were counted. The 
growth experiments were carried out three times in triplicate. 
 
Measuring frequencies of phase variation 
Bacteria from a colony with phase I or phase II morphology were inoculated 
from plate in 20 ml of KB and grown overnight at 28°C. The morphology and 
the initial number of bacteria was determined after dilution plating of an 
average of 500 cells per plate. At least 1,500 colonies were counted for the 
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Bacterial strains  
PCL1171 Antagonistic Pseudomonas strain isolated from the 
rhizosphere of maize from a Mexican agricultural field. 
Colony morphology varies between two distinct phases, 
defined as phases I (opaque) and II (translucent)  
(250) 
PCL1572 Derivate of PCL1171 in which a Tn5luxAB transposon is 
inserted into a gacS homologue, Kmr
(250) 
PCL1586 PCL1171 derivate harboring a mutation in a recA 
homolog, Kmr
This study 
PCL1589 PCL1171 derivate harboring a mutation in a recB 
homolog, Kmr
This study 
S17-1 E. coli MM294, RP4-2 Tc::Mu-Km::T7 chromosomally 
integrated 
(224) 
DH5α E. coli endA1 gyrSA96 hrdR17(rK-mK-) supE44 recA1; 
general purpose E. coli host strain 
(93) 
Plasmids  
pRL1063a Plasmid harboring a promoterless Tn5luxAB transposon 
Kmr, and a p15A origin of replication 
(277) 
pMP5285 pME3049 derivate, lacking the Hgr gene,used for single 
homologous recombination, Kmr
(137) 
pME6010 E. coli / Pseudomonas shuttle vector, stably maintained in 
Pseudomonas species, with an estimated copy number of 
4-8, Tcr
(95) 
pMP6562 pME6010 harboring a 3.2kb PCR product from  strain 
PCL1171 which contains the gacS homologue from 
PCL1171,Tcr
(250) 
pMP5565 pME6010 harboring a 1.2kb PCR product from 
Pseudomonas sp. strain PCL1446 which contains a gacA 
homologue  
Kuiper et al. 
unpublished 
data 
pMP6603 pME6010 harboring a 1.2kb PCR product from 
Pseudomonas sp. PCL1446 containing a gacA 
homologue and a 3.2kb PCR product from Pseudomonas 
sp. PCL1171 containing a gacS homolog  
This study 
pMP6604 pMP5285 harbouring a 1.2kb EcoRI fragment of a recA 
homologue of Pseudomonas sp. PCL1171  
This study 
pMP6605 pMP5285 harbouring a 1.2kb PCR fragment of a recB 




Isolation and characterisation of phase II Tn5luxAB transposon mutants 
A mutant library of strain PCL1171 was constructed using plasmid pRL1063a 
(250), which harbours a Tn5 transposon with promoterless luxAB genes and a 
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kanamycin resistence marker (277). Mutants with a phase II morphology were 
selected, replated several times and grown in liquid medium to select those 
mutants locked in the phase II phenotype. General DNA recombinant 
techniques were performed according to Sambrook et al. (208).  
 
Complementation of Tn5luxAB transposon mutants and wild-type phase II 
sectors 
Phase II bacteria were complemented using pMP6562 (gacS) and pMP5565 
(gacA) by parental mating. Primers oMP716  
(5’-GGAATTCAGGATGTCCATCAACACCA-3’) and oMP717  
(5’-GGAATTCATCGTTGATGAAGGCACACA-3’) both containing a HindIII 
site (GGAATTCA) were used to obtain a 3.2 kb PCR fragment harbouring a 
gacS homologue from Pseudomonas sp. PCL1171. The PCR product was 
cloned into pMP5565 using HindIII. The resulting construct pMP6603, 
harbouring both the gacA and the gacS gene under their own promoters, was 
electroporated into E. coli S17-1 (224) and used to transform phase II bacteria 
by parental mating. Morphology of the transformants was judged after two days 
of growth at 28°C on King’s medium B (128) supplemented with tetracycline.  
 
Analysis of the gacS gene of phase II bacteria 
Primers oMP716 and oMP717 were used to amplify the complete gacS gene 
from phase II sectors and phase II mutants from PCL1171 by PCR. The PCR 
product was cloned into pMP5565 using HindIII and transformed to PCL1572 
(gacS::Tn5luxAB) by electroporation for complementation analysis. 
Morphology was judged after two days of growth at 28°C. Those constructs 
which did not restore the phase I phenotype in PCL1572 were selected. The 
gacS PCR product was sequenced using oMP716 and oMP717, and internal 
primers oMP698 (5’-ACCCAATCCCTGGAACAAC-3’), oMP699  
(5’-GAGTTCCTGGCCAACATGAG-3’), oMP700 (5’-GAGCAGATGGG 
TGGTGAGAT-3’), oMP701 (5’-CAAACCCTGCTGGAAGACAT-3’) 
annealing at nucleotide position 220, 859, 1456, 2047, respectively, and reverse 
primers oMP723 (5’-GGTCCACTTCAACACCACCTG-3’), oMP722  
(5’-GTAATGCCGTTGGTCAGGTTC-3’), oMP721 (5’-GTTGATGA 
TGCCCAACAGGT-3’), oMP720 (5’-CCGATAGGTGGCTGATTGAG-3’) 
annealing at nucleotide positions 2353, 1692, 995, and 309 of the gacS 
sequence of PCL1171 (Genbank accession number AY236957) respectively. 
All found mutations were sequenced at least two times. 
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Isolation and construction of mutants 
To isolate genes from PCL1171 a plasmid library was constructed. 
Chromosomal fragments of PCL1171 phase I bacteria, 3-5 kb in length, were 
obtained after partial digestion using EcoRI. After ligation of the fragments into 
pBluescript, the clones were pooled and isolated. The partial recA gene was 
isolated from this library via PCR using two primers specific for pBluescript, 
T7 (5’-TAATACGACTCACTATAGGG-3’) and oMP61 (5’-GTTTTCCCA 
GTCACGAC-3’), and two internal primers for recA oMP529 (5’-GGGGTACC 
AGCGCACCAGCAT-3’) and oMP530 (5’ GGAATTCCAGATCGAACGCC 
AATTCGG-3’). A second PCR was performed using the internal primers to 
select the correct PCR fragment. A recA mutant was constructed using the PCR 
product of oMP61 and oMP530 to obtain a 1.2 kb EcoRI fragment of the recA 
gene which was cloned into the suicide plasmid pMP5285 resulting in 
pMP6604. This construct was electroporated into S17-1 (224) and transferred to 
PCL1171 by parental mating. After selection on kanamycin, the mutation of 
recA was confirmed via Southern hybridisation (208) using the AlkPhos direct 
labelling kit for detection (Amersham Biosciences, Buckinghamshire, UK) 
according to the manufacturer’s recommendations. The same approach was 
used to isolate the recB gene from PCL1171 using internal primers oMP760 (5’-
TTCGACAGCGGCAGCCTGTTCACCCAGA-3’) and oMP761 (5’-AAGGC 
GTA(CT)AT(GC)GC(AG)TGCTTGGGGTCGCCGAT-3’). To construct a 
recB mutation a 1.2 kb PCR product obtained using oMP840 (5’-CAGGAAT 
TCGAAGGTTGGTG-3’) and oMP761 was cloned into the pGEM-TEasy 
Vector (Promega Crop., Madison, WI, USA) and subsequently transferred to the 
suicide plasmid pMP5285 using EcoRI, resulting in pMP6605. pMP6605 was 
electroporated into S17-1 (224) and transferred to PCL1171 via parental mating. 
After selection on kanamycin, the mutation of recB was confirmed via Southern 
hybridisation (208). To determine the effect of recA and recB mutation on phase 
variation, phase II colonies were re-plated on King’s medium B and the colony 





Isolation and preliminary characterization of stable phase II Tn5luxAB 
transposon mutants 
The frequency of switching between phase I and phase II was determined for 
PCL1171 at 6.0x10-5 and 8.2x10-2 switches per cell per generation for phase I to 
phase II and for phase II to phase I, respectively. To identify genes involved in 
phase variation we constructed a Tn5luxAB transposon library from PCL1171, 
which has a strong preference for the phase I phenotype, using pRL1063a (277). 
From this library, 26 Tn5luxAB transposon mutants expressing a stable phase II 
phenotype were selected out of approximately 1,200 transformants. No mutants 
expressing a stable phase I phenotype were isolated. Observations from both the 
mutant library and growth of the wild type on solid medium indicated that the 
majority of the phase II bacteria switch back with a high frequency to the phase 
I phenotype, while occasionally phase II bacteria can be isolated which are 
more stable. In contrast to the 8.2x10-2 switches per cell per generation as 
observed for the wild type, no switch back to the phase I phenotype was 
observed in these phase II mutants. These mutants will further be referred to as 
stable phase II mutants. Sequencing of the flanking regions of several 
transposon insertions of these stable mutants showed homology to genes with 
widely different functions (data not shown). Since we had previously observed 
that a Tn5 insertion in gacS could lock PCL1171 in the phase II phenotype 
(250), we tested the possibility that, in addition to the Tn5luxAB insertion, at 
least some of the mutants had accumulated mutations in gacS or gacA. For this 
test we used the plasmids pMP6562 (harboring a gacS homolog of PCL1171), 
pMP5565 (harboring a gacA homologue of Pseudomonas sp. PCL1446), and 
pMP6603 (harboring both a gacA and gacS homologue). It appeared that out of 
26 mutants, 13 could be complemented to the phase I phenotype using 
pMP6562 (gacS) and the other 13 mutants could be complemented to the phase 
I phenotype using pMP5565 (gacA). Complementation using pMP6603, 
harboring both the gacA and the gacS genes, restored the phase I phenotype in 
all 26 mutants. Introduction of the empty parental vector pMP6010 did not alter 
the phase II phenotype. Subsequent re-streaking of the complemented mutants 
resulted in phase I colonies from which phase II sectors appeared as in the wild 
type.  
To study the effect of a gacS mutation on growth, we compared the 
growth curve of the previously identified gacS Tn5 mutant PCL1572 and of 
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three other phase II mutants, PCL1574, PCL1575, and PCL1576 with that of 
wild-type phase I bacteria (Fig. 1). It appeared that mutation of the gacS gene 
reduced the length of the lag-phase, and reduced the generation time when 
compared to the wild type (50 ± 4.2 min vs. 60 ± 4.2 min, respectively) (Fig. 1). 
Measuring numbers of CFU’s present at the start of growth showed no 
differences between the gacS mutants and the wild type, indicating that the 
reduced lag phase was not due to higher number of dead cells in the culture of 
the wild type.  
 
 
Figure 1. Growth curve of 
wild-type Pseudomonas sp. 
PCL1171, its Tn5luxAB 
transposon derivate 
PCL1572, and three stable 
phase II mutants (PCL1574, 
PCL1575, and PCL1576) in 
King’s medium B. The 
number of CFU’s was 
determined at the start of 
growth. The results i













Wild type strain PCL1171
PCL1572 (gacS::Tn5luxAB)
PCL1574 (phase II mutant)
PCL1575 (phase II mutant)
PCL1576 (phase II mutant)
 
 
Molecular basis of phase II phenotype of phase II mutants 
Since, only mutations accumulating in the gacA gene have been analyzed (33), 
we decided to focus on the role of gacS in phase II variation of Pseudomonas 
sp. PCL1171. We isolated the gacS gene from ten phase II mutants. Nine of the 
isolated gacS genes cloned into pMP5565 (gacA), could not restore the phase I 
phenotype in PCL1572, showing as a control, that indeed the mutations 
interfered with the GacS function. The gacS gene isolated from PCL1574 did 
restore the phase I phenotype in a small number of transformants. The gacA 
gene was included in the screening to eliminate the effect of possible mutations 
in the gacA gene of PCL1572. Complementation using a wild-type gacS gene in 
pMP5562 always restored PCL1572 to the phase I phenotype. Three of the 
mutated gacS genes were sequenced and aligned to the wild-type gacS 
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sequence. The gacS genes from strains PCL1574 and PCL1575 were found to 
harbor a point mutation (Table 2). The gacS gene from PCL1576 harbored a 
115 bp inversion, which was flanked by an inverted repeat (5’-C327AGCAG-3’ 
and 5’-C442TGCTG-3’). This repeat was created due to a point mutation at 
nucleotide position 329 (aA329c→aG329c) (Table 2 and Figs. 2C). The inversion 
of the 115 bp fragment introduced a stop codon at amino acid position 134 of 
the predicted GacS protein. 
 
Instability of mutations in gacA and gacS  
The stable phase II mutant PCL1574 could be complemented to the phase I 
phenotype using pMP5562 (gacS) (Table 2), complementation of PCL1572 
(gacS::Tn5luxAB) using the gacS gene isolated from PCL1574 resulted in a 
mixture of phase I and phase II colonies. Since this gacS gene did not restore 
the phase I phenotype in all PCL1572 transformants, the construct harboring the 
gacS gene from PCL1574 was re-isolated from colonies in which the gacS did 
complement PCL1572. Sequencing of the gacS gene from these phase I 
colonies showed that the point mutation was no longer present.  
Similar observations were made for the stable phase II mutant PCL1575. 
This strain harbors a point mutation in its gacS gene resulting in a premature 
stop codon (Table 2). Whereas initially introduction of the wild-type gacS gene 
completely restored the phase I phenotype in this mutant, the introduction of 
pMP6562 (gacS) in subsequent complementations also resulted in a number of 
phase II colonies. These could be complemented using pMP5565 (gacA). This 
changed PCL1575 derivate was designated as PCL1575a (Table 2). In addition, 
PCL1575 phase II colonies were found which could neither be complemented 
using pMP5565 nor by using pMP6562. One such derivate was designated as 
PCL1575b (Table 2). Sequencing of the gacS gene of PCL1575a after PCR 
amplification showed that the point mutation identified in PCL1575 has been 
removed (T154aa→C154aa) in PCL1575a while maintaining a phase II 
phenotype. This point mutation was still present in PCL1575b (T154aa) (Table 
2).  
 
Molecular basis of phase II phenotype in wild-type strain PCL1171 
To test whether mutations in the gac system also form the molecular basis for 
the highly unstable phase II phenotype in wild-type strain PCL1171, the gacS 
gene from phase II sectors was amplified using PCR. Since analysis of the 
stable phase II mutants showed that a phase II phenotype could be the result of 
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mutations in either gacA or gacS (Table 2), and since wild-type phase II sectors 
cannot be maintained due to the instability of the phase II phenotype, we needed 
a method to distinguish between gacA and gacS mutations. For this purpose the 
amplified gacS gene from phase II sectors was cloned into pMP5565 
(containing a wild-type gacA) and the resulting construct was used to 
complement PCL1572 (gacS::Tn5luxAB). Out of thirteen gacS genes isolated 
from these phase II sectors, five were unable to complement PCL1572 (Table 
2). One, named sector 16, resulted in a mixture of phase I and phase II colonies, 
whereas the other seven gacS genes complemented PCL1572 to the phase I 
phenotype, showing that in the latter seven sectors the GacS function was not 
affected and that the phase II phenotype is most likely caused by a mutation in 
the gacA gene.  
As controls, the gacS genes from sectors 2 and 5, which could restore the 
phase I phenotype in PCL1572, were sequenced. Sector 2 harbored one point 
mutation, while no changes were identified in the gacS gene isolated from 
sector 5 (Table 2). Analysis of five out of the six non-complementing gacS 
genes revealed various mutations (Table 2). The gacS gene from sector 1 
harbored a total of three mutations, a 12 bp deletion in combination with two 
point mutations, including one silent mutation (Table 2 and Fig. 2A). The gacS 
gene from sector 4 and sector 18 was found to harbor one and two point 
mutations, respectively (Table 2), while the gacS from sector 9 harbored a +1 
frame shift due to a one nucleotide insertion (Table 2 and Fig. 2B), resulting in 
the introduction of stop codons downstream of the insertion. The gacS gene 
isolated from sector 16, re-isolated from PCL1572 colonies not complemented 
by this gene, harbored a 307 bp deletion from nucleotide positions 2236 to 
2542. A 10 bp tandem repeat (5’-G2226CCATCACCG-3’ and 
5’-G2523CCATCACCG-3’) was identified at the borders of the deletion as the 
result of a single point mutation (tT2231a→tC2231a) (Table 2 and Fig. 2D). The 
gacS gene from sector 16, isolated from PCL1572 colonies complemented to 
the phase I phenotype, did not harbor any mutations. In addition, a silent point 
mutation was identified (Table 2).  
Phase II sectors from PCL1171 are highly unstable and re-streaking 
coincides with a high frequency (8.2x10-2 switches per cell per generation) 
switch back to the phase I phenotype. This high frequency enabled us to analyze 
the gacS gene from phase II sectors after switching back to the phase I 
phenotype. The three mutations previously identified in phase II sector 1  
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Table 2. Spontaneous modifications in the gacS gene isolated from phase II sectors and 
phase II mutants of Pseudomonas sp. PCL1171. 
 
Mutation in gacS genea Functional 
gene 
Origin 
Nucleotide Amino acid gacA gacS 
Remarks 
Phase II Tn5luxAB 
mutantsb
     
Wild type 
phase I 
- - + + No mutations 
PCL1574 cT899c – cG899c L300 – R300 + - Point mutation 
PCL1575 C154aa – T154aa Q52 – stop + - gacS mutation 
PCL1575a - - - + gacA mutation 
PCL1575b C154aa – T154aa Q52 – stop - - gacA and gacS 
mutation 
PCL1576 aA329c – aG329c 
115 bp inversion  
N110 – S110
N110 – R147  
(stop134) 
+ - Inverted repeat 
Inversiond
Wild-type phase II 
sectorsc
     
Sector 1 12 bp deletion  





nd  - Deletiond and 
point mutations 
Sector 3 nd nd nd - gacS mutation 
Sector 4 C1981cg – T1981cg P661 – S661 nd - Point mutation 
Sector 9 ct_caat -ctT309caat L103 - 
frameshift 
nd - 1 bp insertiond
Sector 16 tT2231a – tC2231a  





nd - Tandem repeat 
Deletiond
Sector 18 cT182g – cC182g 
gC1124c – gT1124c 
L61 – P61
A375 – V375
nd - Point mutations 
Sector 5 - - nd + gacA mutation 
Sector 2 cT443g – cC443g L148 – P148 nd + gacA mutation 
a Numbers indicate positions in the wild-type gacS sequence. 
b Functional gacA/S component was determined by the introduction of pMP6562 (gacS) 
and pMP5565 (gacA). ‘+’ indicates which component is functional, ‘-’ indicates which 
component harbours mutations and is non-functional. In addition, strains PCL1565, 
PCL1568, and another 8 phase II mutants had a functional gacA gene (gacS mutants), 
while PCL1564, PCL1573, PCL1566, PCL1567, and another 9 phase II mutants had a 
functional gacS gene (gacA mutants).  
c.Functional gacA/S component was determined by complementation of PCL1572 
(gacS::Tn5luxAB) by the gacS gene isolated from a phase II sector. ‘+’ indicates that a 
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phase I morphology was restored in PCL1572, ‘-‘ indicates that a phase II morphology 
maintained after introduction of the gacS gene. In addition, the gacS gene isolated from 
another 5 sectors did complement PCL1572 (gacS::Tn5luxAB), suggesting that mutation 
of the gacA gene was responsible for the phase II phenotype in these sectors. nd, not 
determined. 
d See Figure 1 
 
 
(12 bp deletion and two point mutations) were absent in phase I bacteria 
growing from sector 1 phase II cells. Also, all gacS mutations present in cells of 
sector 4 (single point mutation), sector 9 (1 bp insertion), sector 16 (307 bp 
deletion) and 18 (two point mutations) had been restored to the wild-type gacS 
sequence after switching to the phase I phenotype. 
 
Role of recA and recB in phase variation 
Based on the observation that a wide variety of mutations in the gacS gene, in 
both stable and unstable phase II bacteria, could be restored efficiently to the 
wild-type gacS sequence, we hypothesized that large DNA rearrangements 
could play a role in the switch from phase II to phase I. To test this hypothesis, 
a recA mutation was introduced into PCL1171, using the suicide construct 
pMP6604, which resulted in strain PCL1586. Strain PCL1586 (recA::kmr) 
showed a phase I phenotype from which phase II sectors originated with a high 
frequency. After re-plating of these phase II sectors, phase I colonies and phase 
II colonies with phase I sectors were found. 
The suicide construct pMP6605 harboring a recB fragment was used to 
introduce a recB mutation in PCL1171. Mutation of recB reduced the viability 
of the cells which, however, still showed phase variation resulting in single 
phase I and phase II colonies. Re-plating of the phase II colonies resulted in 





Molecular nature of mutations in gacS 
Pseudomonas sp. strain PCL1171 displays a high frequency of reversible phase 
variation between a thick opaque phase I and a thin translucent phase II colony, 
thereby regulating secondary metabolism and production of exo-enzymes (250). 
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Since we observed that mutation of the gacS gene locked the bacteria in a phase 
II phenotype (250), we studied the role of gacA/S in phase variation. 
Complementation analysis of a total of thirty-nine phase II derivates showed 
that mutations in gacA (20 mutants) and gacS (19 mutants) are responsible for 
the phase II phenotype (Table 2). Introduction of pMP6603 (gacA/gacS) 
restored all mutants to a phase I phenotype, showing that spontaneous mutation 
of the gacA/gacS two component regulatory system forms the basis of the 
switch from phase I to phase II in phase variation of Pseudomonas sp. 
PCL1171.  
The gacS genes isolated from phase II bacteria harbored random point 
mutations, deletions, DNA rearrangements and an insertion (Table 2 and Fig. 
2). In addition to the mutations identified in the gacA gene of Pseudomonas 
fluorescens CHAO by Bull et al. (33) (point mutations, a 3 bp deletion and a 
1bp insertion), the gacS gene of PCL1171 also harbored a 12 and 307 bp 
deletion and a 115 bp inversion (Table 2 and Fig. 2), showing that a large 
diversity of mutations, both in nature and location, can accumulate in the gacA 
and gacS genes (Table 2 and Fig. 2). We observed that not all mutations in the 
gacS gene, for example single mutations in the periplasmic loop (e.g. sector 2), 
affected GacS function, which is consistent with the observation that deletion of 
this domain did not affect GacS function in P. fluorescens CHAO (282). 
Accumulation of mutations in gacA and gacS was reported previously for 
P. syringae pv. syringae strain B728a (200), P. fluorescens CHAO (33, 64, 
138), P. aureofaciens 30-84 (39), and P. chlororaphis isolate SPR044 (216). 
However, for none of these a reversion to the wild-type phenotype was reported. 
In contrast, in our strain the introduction and removal of mutations in gac is the 
basis of the observed phase variation, and the majority of the phase II cells 
switch back to the phase I phenotype at a high frequency, which correlates with 
the complete removal of the mutations from the gacS gene. Interestingly, in 
sector 16 we found that the 307 bp deletion was restored upon the switch to the 
phase I phenotype. But, since complementation of PCL1572, using the gacS 
gene from sector 16, resulted in a mixture of phase I and II colonies, it is likely 
that a mixture of gacS genes was already present before PCR amplification. 
Therefore we cannot exclude that the identified deletion cannot be repaired. 
This deletion mutant could be part of a subpopulation of stable phase II bacteria, 
whereas the majority of the bacteria in this sector harbor other mutations (e.g. 
gacA), and, as observed on plate, can switch back to the phase I phenotype.  
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Figure 2. Complex mutations identified in gacS of Pseudomonas sp. PCL1171. 
Mutations identified in sector 1 (A), sector 9 (B), PCL1576 (C), and sector 16 (D), 
harbouring a 12 bp deletion, a 1 bp insertion, a 115 bp inversion, and a 307 bp deletion, 
respectively are shown. Panels A and B show the phase I wild-type situation and, upon 
switching to a phase II phenotype, the corresponding situation in the gacS gene. 
Indicated are the changes at DNA and amino acid level. Panels C and D show the wild-
type situation of a phase I phenotype in which due to point mutations (*), an inverted 
repeat and a tandem repeat (indicated by arrows), respectively, is created in an 
intermediate stage. A subsequent inversion and a deletion based on these repeats 
resulted in the situation in the gacS gene present in PCL1576 and in sector 16. All 
nucleotide positions correspond with those of the wild-type gacS gene. 
 
 
Occasionally more stable phase II bacteria can be isolated. The isolation 
of stable, phase II derivates of which the genetic basis switched between 
mutations in gacA, gacS and in both gacA and gacS (Table 2) shows that even 
within such a “stable” phase II phenotype mutations still can be removed and 
(re)-introduced. Our results indicate that all mutations in the gacS and gacA 
genes of PCL1171 can be restored spontaneously. This occurs either 
completely, resulting in a switch to the phase I phenotype, or, in the case of a 
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stable phase II phenotype, mutations cannot be removed, or the removal 
coincides with the introduction of new mutations.  
Growth experiments using gac mutants (Fig. 1) showed that mutation of 
gac decreases the length of the lag-phase and increases the growth rate. 
Therefore one explanation for the accumulation of gac mutants at a high 
frequency is an increased growth competitiveness, especially under conditions 
where stationary and exponential growth often switch as may be expected 
colonies and in the rhizosphere. This explanation is consistent with the 
suggestion by Schmidt-Eisenlohr et al. (216) for P. chlororaphis isolate 
SPR044, that having a mixed population could, based on the growth 
characteristics of the gac mutants, provide a competitive advantage, especially 
in changing and heterogeneous environments. The observation that the gac sub-
population does not replace the wild-type population in culture, as found in 
PCL1171 shows the effect of the reversibility of the gac phenotype and 
indicates that, at least under lab conditions, there is no direct environmental 
selection in favor of these mutants.  
 
What is the mechanism of phase variation in PCL1171? 
According to literature phase variation can regulate gene expression via four 
mechanisms: (i) slipped-strand mispairing, (ii) differential methylation, (iii) 
genomic rearrangements, and (iv) random un-programmed variation (27, 98). 
To our knowledge, only two molecular mechanism of phase variation in 
Pseudomonas sp. have been described. In P. putida DOT-T1E the expression of 
flagella is controlled via slipped-strand mispairing (219), and in P. tolaasii, a 
661 bp spontaneous, reversible duplication in pheN, controls colony 
morphology and pathogenicity (92). In addition, although no mechanism is 
described, the sss gene, encoding a site specific recombinase, was indicated to 
play a major role in the phenotypic variation of P. fluorescens F113 during root 
colonisation. The latter variation is combined with a selection for gac mutants 
(209).  
Considering the mechanism of phase variation via gac, none of the 
sequenced gacA/S genes harbors repeat tracts. Since phase variation in 
PCL1171 is dependent on mutation of gac, it is not epigenetic. Therefore, 
slipped-strand mispairing and differential methylation can be excluded as the 
major basis of phase variation via gacA/S in PCL1171. Genomic 
rearrangements were present in some gacS genes isolated from phase II bacteria 
and were based on the presence of inverted or tandem repeats (Table 2 and Fig. 
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2). This suggests a role for site specific recombinases (206) in mutation of these 
gac genes. But, since these rearrangements only could take place after the 
occurrence of point mutations, introducing repeats (Fig. 2) which can be 
recognized by site specific recombinases, we conclude that genomic 
rearrangements only play a minor, secondary role in phase variation of 
PCL1171. This differs from what has been reported for P. fluorescens F113 in 
which a site-specific recombinase is responsible for the majority of the 
phenotypic variation (209). 
In PCL1171, the accumulation of mutations in gacA/S was previously 
suggested to be suppressed by MutS-dependent mismatch repair since mutation 
of the mutS gene resulted in a dramatic increase of the phase variation 
frequency (250). Furthermore, based on the mechanism of repair (174), all point 
mutations identified in gacS (Table 2) could, upon introduction, have been 
recognized by MutS. This suggests that inefficient repair via MutS contributes 
to the mutations we found in gacA/S. In addition, the spontaneous mutation rate 
in PCL1171, measured by the frequency of spontaneous rifampicin resistant 
mutants, increases upon mutation of mutS from 5x10-7 to 3x10-5 mutants per cell 
per generation (S. de Weert, personal communication). This frequency is 
comparable to the frequency of phase variation in the wild-type (6x10-5 switches 
per cell per generation) supporting the notion that inefficient repair of 
replication-related mismatches via MutS is responsible for the accumulation of 
random mutations in gacA/S. This observation supports the hypothesis that the 
gacA and gacS genes are not hot-spots for mutations. But, under growth limiting 
conditions micro-organisms can increase their mutation frequency (131, 178). 
Under these conditions gac mutants could be selected for, either on the basis of 
their growth characteristics or by preventing restoration of the mutations. Our 
observations suggest that the mechanism of phase variation in PCL1171 is 
random and un-programmed variation based on the introduction and restoration 
of random point mutations, insertions, deletions, and rearrangements in gacA/S. 
Un-programmed variation is not dependent on specific DNA features, and 
spontaneous duplications and deletions have been described to control for 
example capsule genes in Streptococcus pneumonia (262), the pathogenicity 
and colony morphology in P. tolaasii and Ralstonia solanacearum (92, 191), 
and virulence of Bordetella bronchiseptica (175).  
Un-programmed phase variation, as observed in PCL1171, is reversible, 
in the sense that the original sequence of the wild-type gene is restored. At this 
moment no molecular mechanism for the restoration of the mutations in the 
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mentioned strains has been elucidated. A preliminary study on the reversion of 
the phase II phenotype in PCL1171 focused at the possible role of homologous 
recombination. To test this idea we constructed a RecA and a RecB mutant. 
Both genes are involved in homologous recombination (136) and in some cases 
in phase variation (98, 135, 168). Mutation of neither recA nor recB affected the 
ability of phase II bacteria to switch back to the phase I phenotype. Although 
this result cannot exclude that recombinational processes are involved in this 
phase variation, it shows that RecA and RecB are not essential for the repair of 
mutations in gacS and gacA of PCL1171. A similar observation was made for 
P. tolaasii (225) where RecA was not needed for the removal of the duplication 
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RpoS and MutS in phase variation 
ABSTRACT 
 
Pseudomonas sp. strain PCL1171 undergoes reversible colony phase variation 
between opaque phase I and translucent phase II colonies, which is dependent 
on spontaneous mutations in the regulatory genes gacA and gacS. Mutation of 
the mutS gene and constitutive expression of rpoS increases the frequency at 
which gac mutants appear, 1,000- and 10-fold, respectively. Experiments were 
designed to study the relationship between gacS, rpoS and mutS. These studies 
showed that (i) a functional gac system is required for the expression of rpoS, 
(ii) RpoS suppresses the expression of mutS, and therefore increases the 
frequency of gac mutants, and (iii) upon mutation of rpoS and gacS the 
expression of mutS is increased. Mutation of gacS abolishes suppression of 
mutS expression in stationary growth, suggesting that additional, gac dependent 
factors are involved in this suppression. In conclusion, inefficient mutation 
repair via MutS, of which the expression is influenced by gacA/S itself and by 
rpoS in combination with other factors, contributes to the high frequency of 
mutations accumulating in gacA/S. The role of RpoS in the growth advantage of 
a gac mutant was analyzed and mutation of rpoS only reduced the length of the 
lag-phase but did not affect the growth rate, suggesting a role for RpoS and a 




RpoS and MutS in phase variation 
INTRODUCTION 
 
Phase variation is a process of reversible, high-frequency phenotypic switching 
that is mediated by mutations, reorganizations or other modifications of DNA. 
This process is used by several bacterial species to generate population diversity 
that increases bacterial fitness and plays a role in niche adaptation (211). Phase 
variation in Pseudomonas sp. PCL1171 is dependent on the accumulation and 
subsequent removal of mutations in the gacA and gacS genes (249). These 
genes affect production of secondary metabolites such as a lipopeptide with 
antifungal activity, a biosurfactant, and the exo-enzymes chitinase, lipase, and 
protease (250).  The gacA/gacS two- component regulatory system consists of a 
membrane-bound sensor kinase GacS and a reponse regulator GacA. The latter 
protein belongs to the FixJ family of transcriptional regulators (138, 200). The 
gac system regulates secondary metabolism and production of exo-enzymes 
(111, 138, 198, 215).  
In several Pseudomonas sp. the gacA and gacS genes are subject to 
spontaneous mutation and gac mutants appear for example in nutrient-rich 
liquid medium (33, 63, 250) and on plant roots (39, 216). In PCL1171, 
spontaneous mutation of the gacA/S system is the basis for phase variation. 
Information on factors influencing the introduction of mutations in the gac 
genes of Pseudomonas sp., as part of a phase variation mechanism or 
phenotypic selection, are scarce.  
Previously we have reported that MutS-dependent mismatch repair plays 
a role in phase variation (249, 250). MutS is involved in methyl-directed 
recognition of DNA mismatches related to replication, which include base 
mismatches and small insertion and deletion mispairs (174). Expression of 
MMR systems can be negatively influenced by stress or growth limiting 
conditions, resulting in increased genetic and population diversity (131). For 
example, in E. coli mutS is negatively regulated by the general stress response 
sigma factor RpoS (247). In Pseudomonas the regulatory link between RpoS 
and MutS, and the role of these proteins in bacterial phase variation has not 
been studied. To identify and understand genetic factors which influence the 
high frequency of spontaneous mutations accumulating in gacA/S, and the 
switch from phase I to phase II, we studied the regulatory relationship between 




MATERIAL AND METHODS 
 
Bacterial strains and plasmids 
Bacterial strains and plasmids are listed in Table 1. Pseudomonas strains were 
grown in King’s medium B (KB) (128) at 28°C. E. coli strains were grown in 
LB (208) at 37°C. Solid growth media contained 1.8% (wt/vol) agar (Difco 
Laboratories, Detroit). Kanamycin, tetracycline, gentamycin, and carbenicilin 
(Sigma, St. Louis) were added for antibiotic selection in final concentrations of 
50, 40, 10, and 50 µg/ml, respectively. Growth in liquid medium was analyzed 
in triplicate by measuring the optical density (OD620) in time. To determine the 
numbers of bacteria at the start of growth, samples of the culture were plated 
and the number of viable cells was established as colony forming units.  
 
Construction of mutants 
PCL1587 (rpoS::kmr) was constructed using pMP7418, the suicide plasmid 
pMP5285 harboring a 0.5 kb PCR product from the rpoS gene of 
P. chlororaphis strain PCL1391. pMP7418 was transferred to PCL1171 by 
parental mating. Mutation of rpoS was confirmed by Southern hybridisation 
(208) using the AlkPhos direct labelling kit for detection (Amersham 
Biosciences, Buckinghamshire, England) according to the manufacturer’s 
recommendations. Colony morphology was judged after at least two days of 
growth at 28°C. Parental mating with E. coli S17-1 (224), harboring pMP7420 
(pBBR1MCS5 harboring PtacrpoS; G. Girard, unpublished), was used to 
introduce pMP7420 into PCL1171 and PCL1555, resulting in PCL1585 and 
PCL1590, respectively. 
 
Expression studies using a bioluminescent Tn5luxAB reporter 
The expression of the mutS gene was measured using the promoterless luxAB 
genes (277) inserted behind the mutS promoter. Bacteria were inoculated in 20 
ml of KB to an optical density (OD620) between 0.05 and 0.1, and grown under 
aeration at 28°C. Growth was monitored by measuring the optical density. To 
determine gene expression, 100 µl samples were taken in triplicate. A volume of 
100 µl of a solution containing 0.2% n-decyl-aldehyde (Sigma, St. Louis, MO) 
and 2.0% bovine serum albumin (Sigma, St. Louis, MO) solution was added. 
After mixing, bioluminescence was determined in time using a MicroBeta 1450 
TriLux luminescence counter (Wallac, Turku, Finland) and normalized to 
luminescence counts per OD620 unit. 
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Bacterial strains   
PCL1171 Antagonistic Pseudomonas strain isolated from the 
rhizosphere of maize from a Mexican agricultural field. 
Colony morphology varies between two distinct phases, 
defined as phases I (opaque) and II (translucent).  
(250) 
PCL1555 Derivative of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a mutS homolog; 
Kmr
(250) 
PCL1572 Derivative of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a gacS homolog; 
Kmr
(250) 
PCL1587 Derivative of PCL1171 in which a rpoS mutation is 
introduced using pMP7418; Kmr
This study 
PCL1585 Derivative of PCL1171 harboring pMP7420; Gmr  This study 
PCL1590 Derivative of PCL1555 harboring pMP7420; Kmr, Gmr  This study 
S17-1 E. coli MM294, RP4-2 Tc::Mu-Km::T7 chromosomally 
integrated 
(224) 
Plasmids   






pME6010 E. coli / Pseudomonas shuttle vector, stably maintained in 
Pseudomonas species, with an estimated copy number of 
4-8; Tcr
(95) 
pMP6603 pME6010 harboring a 1.2 kb PCR product from 
Pseudomonas sp. PCL1446 containing a gacA 
homologue and a 3.2 kb PCR product from Pseudomonas 
sp. PCL1171 containing a gacS homologue  
(249) 
pMP7418 pMP5285 harboring a 0.5 kb PCR fragment of the rpoS 





pMP7420 pBBR1MCS5 harboring a rpoS homologue of P. 











Quantification of the frequencies of phase variation 
A volume of 20 ml KB medium was inoculated with bacteria from a colony 
with phase I or phase II morphology and the bacteria were grown overnight at 
28°C. After dilution plating of an average of 500 cells per plate the morphology 
was analyzed and the initial number of bacteria was determined. At least 1,500 
colonies were examined and counted for the estimation of frequencies as 
number of switches per cell per generation.  
 
Isolation of total RNA and Real-Time PCR (RT-PCR) 
Erlenmeyer flasks containing 20 ml of KB medium were inoculated from 
colonies on plate and grown under aeration at 28°C. A 5 ml sample was 
harvested at an OD620 of 0.35, and the second sample was taken after 24h. To 
stop RNA degradation, 0.625 ml of ice-cold EtOH/phenol was added. Cells 
were spun down and the pellet was frozen in liquid nitrogen and stored at  
-80°C. Total RNA was isolated using the Qiagen RNeasy mini kit including an 
on column DNaseI digestion (Qiagen, GmbH, Hilden, Germany) according to 
the manufacturer’s recommendations. Total RNA was stored at -20°C. The 
amount of isolated RNA was measured at OD480 using an Ultrospec 2100pro 
photospectrometer (Amersham Biosciences, Buckinghamshire, England). Real-
time PCR was performed using a real time PCR machine (Lightcycler, Roche 
GmbH, Penzberg, Germany) on 500 ng of total RNA using the Lightcycler 
RNA master SYBR Green I (Roche GmbH, Penzberg, Germany) according to 
the manufacturer’s recommendations. All experiments and each measurement 
were carried out at least three times. 
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RESULTS 
 
RpoS plays a role in phase variation of Pseudomonas sp. PCL1171 
To study the possible role of the general stress response sigma factor RpoS in 
the regulation of MutS-dependent mismatch repair in PCL1171, and its role in 
the accumulation of mutations in gacA/S, strains PCL1587 and PCL1585 were 
constructed. Strain PCL1587 harbors a mutation in the rpoS gene, and the rpoS 
over-expressing strain PCL1585 was obtained by the introduction of pMP7420 
(pBBR1MCS5-derivative harboring a rpoS homologue expressed under the 
constitutive tac promoter) into PCL1171. Wild-type strain PCL1171 displays a 
high frequency of switching from phase I to phase II, whereas the switch back 
frequency to phase I is even higher (Table 2). On plates, rpoS mutant PCL1587 
was found primarily as phase I colonies, out of which phase II sectors appeared. 
Mutation of rpoS decreased the frequency of the switch from phase I to phase II 
(Table 2). Phase II colonies of a rpoS mutant of PCL1171 appeared to be of two 
classes with respect to their rate of reversal to phase I. In the first class only 
phase I colonies were found after re-plating the start mix from liquid culture, 
whereas in the other class cells appeared to be locked in the phase II phenotype 
(Table 2).  
Constitutive expression of rpoS in the wild type, studied using pMP7420, 
increased the frequency of phase variation from phase I to phase II 10-fold, but 
had no significant effect on the frequency of the reverse switch (Table 2). 
Complementation of phase II colonies from PCL1585 (PCL1171 PtacrpoS) with 
pMP6603 (pME6010 harboring both the gacA and gacS gene under their own 
promoters) (249) restored the phase I phenotype in these bacteria. Introduction 
of the parent vector pME6010 did not affect the phase II phenotype in these 
phase II colonies. 
 
Expression of rpoS is dependent on growth phase and gac 
Real-time polymerase chain reaction (RT-PCR) was used to study the effect of 
gacA/S on rpoS expression in the exponential and stationary growth phases. It 
appeared that in wild type strain PCL1171 rpoS expression was increased 
approximately 4-fold in stationary phase cells when compared to exponentially 
growing bacteria (Table 3). In mutant PCL1572 (gacS::Tn5luxAB), locked in 
phase II, the expression of rpoS in the exponential phase was approximately  
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5-fold lower than in phase I wild-type cells whereas only a small induction of 
rpoS expression was observed in the stationary phase as compared to the 
exponential phase (Table 3).  
 
Table 2. Influence of rpoS and mutS on the frequency of colony phase variationa
 
Frequency of phase variation  
(switch per cell per generation) 
Strain 
Phase I → Phase II Phase II → Phase I 
PCL1171 (wildtype) 6.4x10-5 8.2x10-2
PCL1587 (rpoS::kmr) 3.8x10-6 -b
PCL1585 (PCL1171 PtacrpoS) 6.2x10-4 6.9x10-2
PCL1555 (mutS::Tn5luxAB) 8.3x10-2 6.2x10-2
PCL1590 (PCL1555 PtacrpoS) 7.8x10-2 2.0x10-2
a The frequencies are shown as the number of switches per cell per generation 
b Phase II colonies of PCL1587 (rpoS::kmr) appeared to be of two classes, with respect 
to their reversal rate to phase I phenotype. One class was locked in the phase II 
phenotype, while in the other class only phase I colonies were found after re-plating 
from culture. 
 
RpoS regulates mutS 
The effect of a mutS mutation on the frequency of switching was analysed using 
PCL1555 (mutS::Tn5luxAB). Mutation of mutS increased the switching 
frequency from phase I to phase II approximately 1,000-fold whereas the switch 
from phase II to phase I was unaltered (Table 2). To study the effect of 
constitutive rpoS expression on the frequency of phase variation in a mutS 
background, strain PCL1590 was constructed by introduction of pMP7420 
(PtacrpoS) in PCL1555 (mutS::Tn5luxAB). Constitutive expression of rpoS did 
not alter the frequency of switching from phase I to phase II (Table 2).  
The expression of the mutS gene during growth could be studied in 
PCL1555 (mutS::Tn5luxAB) (250) which harbors a Tn5 transposon with 
promoterless luxAB genes (277). Expression of mutS in different growth stages 
of strain PCL1555 was compared with its expression in its derivate strain 
PCL1590 harboring pMP4720 (pBBR1MCS5 PtacrpoS). In PCL1555, the mutS 
gene is highly expressed during the exponential growth phase, but expression 
was decreased approximately 2-fold upon transition to stationary growth (Fig. 
1).  
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Table 3. Relative expression of gacS, rpoS and mutS in Pseudomonas sp. PCL1171 
and derivates during exponential and stationary growth  
 
Relative expression levels in exponential and stationary growth 
phasesa
Strain 
gacS rpoS mutS 
 Exp. Stat. Exp. Stat. Exp. Stat. 
PCL1171 
(wildtype) 
1 0.62 ±0.2 1 4.0 ±0.7 1 0.44 ±0.2 
PCL1572 
(gacS::Tn5luxAB) 
0b 0 0.20 ±0.1 0.30 ±0.2 2.7 ±1.4 2.5 ±0.5 
PCL1587 
(rpoS::kmr) 
ndc nd 0 0 3.4 ±1.2 1.4 ±0.2 
PCL1555 
(mutS::Tn5luxAB) 
nd nd nd nd 0 0 
a Expression levels, determined using RT-PCR, are related to the expression level of the 
indicated gene during exponential growth in the wild-type situation 
b No detectable expression 
c nd, not determined 
 
 
Figure 1. Expression of 
mutS, and the influence of 
constitutive rpoS 
expression, as a function 
of growth phase. 
Expression of the mutS 
gene in PCL1555 
(mutS::Tn5luxAB) and in 
PCL1590 (PCL1555 + 
PtacrpoS) was measured 
using the bioluminescent 
Tn5luxAB reporter in the mutS gene. The Y-axis shows the number of luminsescence 
counts per second (LCPS) divided by the optical density (OD). 
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In strain PCL1590, in which rpoS is constitutively expressed, the expression of 
mutS during exponential growth was as low as during stationary growth (Fig. 1).  
To determine the effect of rpoS on the expression of mutS in more detail, 
RT-PCR of mutS was used. In wild-type strain PCL1171, mutS was expressed 
during exponential growth and expression was reduced approximately 2- to  
3- fold in the stationary phase, whereas in PCL1555 (mutS::Tn5luxAB), used as 
a control, expression was abolished (Table 3). In the rpoS mutant PCL1587 
(rpoS::kmr) the expression of mutS was 2-to 4-fold increased compared to that 
of the wild type in the exponential phase (Table 3). In the stationary phase mutS 
expression in PCL1587 (rpoS::kmr) was 2- to 3- fold reduced compared to 
expression in the exponential phase (Table 3). 
 
gacS and mutS expression in the wild type and in a gacS mutant 
In wild-type phase I cells the gacS gene is primarily expressed during the 
transition from exponential to stationary growth (data not shown) after which 
the expression decreases to a 1.6 fold lower level after 24h of growth as shown 
by RT-PCR (Table 3). Expression of gacS in PCL1572 (gacS::Tn5luxAB) was 
abolished (Table 3). In the gacS mutant PCL1572, the expression of mutS was 
2- to 3-fold increased in both exponential and stationary phases, when compared 
to the wild type (Table 3).  
Time (min)












Figure 2. Growth of 
Pseudomonas sp. PCL1171 and 
its derivates PCL1572 
(gacS::Tn5luxAB) and PCL1587 
(rpoS::kmr) in liquid KB-







Influence of gacS and rpoS on growth 
When the growth of the wild-type strain PCL1171 was compared to that of 
PCL1572 (gacS::Tn5luxAB) a reduction in the length of the lag-phase and a 
decrease in generation time (from 60 ± 4 to 50 ± 4 min. respectively) was 
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observed for PCL1572, and this mutant reached a lower cell density after 24h of 
growth (Fig. 2). Mutation of the rpoS gene in PCL1587 slightly reduced the 
length of the lag-phase and, compared to the wild type, a reduction in the 
growth rate was observed (the generation time increased from 60 ± 4 to 





Results of a previous paper (250) indicated that MutS-dependent mismatch 
repair plays a central role in colony phase variation in Pseudomonas sp. 
PCL1171, which occurs via the accumulation of spontaneous reversible 
mutations in gacA and gacS (249). The mutations accumulated in the gacA/S 
genes result in a growth advantage under certain conditions (249). To identify 
genetic factors involved in the accumulation of mutations in the gacA/S genes, 
we analyzed the roles of gacA/S, rpoS and mutS in phase variation of strain 
PCL1171, by analyzing their effects on the phase variation frequency and 
expression of each other.  
The introduction of pMP7420 (PtacrpoS) into PCL1171 resulted in a  
10-fold increase in the frequency of switching from phase I to phase II, while 
mutation of rpoS decreased the frequency of phase variation (Table 2). The 
conclusion that rpoS increases the accumulation of mutations in gacA/S, was 
further supported by the introduction of pMP6603 (harboring gacA and gacS), 
into phase II colonies of PCL1585 (PCL1171 PtacrpoS), which appeared to 
restore the phase I phenotype.  
An even stronger effect on phase variation frequency was observed by 
mutating mutS, which increased the frequency of switching from phase I to 
phase II 1,000-fold (Table 2). Additional over-expression of rpoS, by 
introducing pMP7420 (PtacrpoS), did not further increase this frequency (Table 
2), indicating that the effect of RpoS in phase variation is mainly dependent on 
its regulatory effect on mutS. Subsequent studies showed that constitutive 
expression of rpoS suppresses the transcription of the mutS gene (Figs. 1 and 3), 
whereas mutation of rpoS increased the expression of mutS (Fig. 3 and Table 3), 
thereby increasing and decreasing, respectively, the frequency of gac mutants 
(Table 2). We conclude that mutS expression is directly or indirectly repressed 
by RpoS in PCL1171, thereby increasing the phase variation frequency (Fig. 3). 
Considering the role of RpoS as a sigma factor (145) this regulation is likely to 
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be indirect. Our results show that changes in mutS expression directly correlate 
with the frequency at which gac mutants appear (Fig. 3 and Tables 2 and 3), 
indicating that levels of MutS-dependent repair are a determinant for the 
frequency of phase variation.  
The effect of mutation of gac on rpoS expression was analyzed using 
PCL1572 (gacS::Tn5luxAB). It appeared that a functional gacA/S system is 
necessary for the expression of rpoS (Fig. 3 and Table 3). This suggests that in a 
phase II phenotype RpoS will be present in limited amounts, or even not at all. 
That this is likely, was shown for gac mutants of rpoS expression in gac 
mutants were described for P. fluorescens Pf-5 (271), P. chlororaphis isolate 
SPR044 (216), and P. chlororaphis O6 (124).  
The expression of mutS was increased in the gacS mutant PCL1572 in 
both exponential and stationary growing bacteria when compared to the wild-
type (Table 3), indicating that in a phase II phenotype (in which gacA and/or 
gacS is mutated) MutS-dependent repair is increased. Under these conditions 
the mutation frequency will decrease, thereby limiting possible negative effects 











Figure. 3. Model for the genetic regulation of spontaneous mutations accumulating in 
gac. A schematic representation of the regulatory roles of GacA/S, RpoS and MutS in 
phase variation of PCL1171. Phase I cells harbor intact gacA and gacS genes that are 
required for expression of rpoS, which, in combination with additional factors, in 
stationary phase negatively regulates mutS expression. Inefficient repair of mutations 
due to down regulation of MutS, results in a decreased repair of spontaneous mutation 
which will result in the accumulation of mutations in gacA/S (indicated with an asterix). 
As a result the cell switches to the phase II phenotype. Mutation of the gacA/S genes 
decreases rpoS expression and a subsequent increase in the expression of mutS, thus 
limiting the mutation rate. 
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This increase is probably the result of the low RpoS levels in these mutants 
(Table 3). However, since the repression of mutS in stationary phase, as 
observed in a rpoS mutant, was no longer observed in a gacS mutant, it is likely 
that in addition to RpoS other gacA/S dependent factors are involved in 
stationary phase repression of mutS. Our results show that the high frequency of 
mutations accumulating in gacA/S is the result of inefficient repair via MutS, as 
a result of expression of rpoS, and possibly, additional, unknown factor(s), 
which are, in addition, all influenced by the mutation of gacA/S itself (Fig. 3).  
Since we previously observed a growth effect of the mutation of gac 
(249), and this was for P. chlororaphis SPR044 (39) hypothesized to be the 
result of altered rpoS expression, we tested the growth behavior of a rpoS 
mutant. Both in our strain PCL1171 (249) and in P. chlororaphis strain SPR044 
(216) mutation of the gacS gene abolishes rpoS expression (Table 3). In 
PCL1171 mutation of the rpoS gene slightly decreased the length of the lag-
phase, but not as drastic as observed in a gac mutant (Fig. 2). In addition, the 
generation time decreased when compared to the wild type. The same 
differences in growth were observed in minimal medium (data not shown). In 
contrast to the hypothesis, in strain PCL1171 the lack of RpoS can only partially 
explain the growth behaviour of a gac mutant. We hypothesize that the selective 
advantage of spontaneous gac mutants is a combination of the lack of RpoS and 
a reduction of other (RpoS independent) genes regulated by gac, resulting in a 
reduction of metabolic load. 
Our observation that RpoS plays a role in phase variation in Pseudomonas 
sp. PCL1171 indicates that the accumulation of mutations in gacA/S will be 
influenced by stress and stationary growth conditions. Consistent with this is the 
observation that avoiding nutrient stress in liquid cultures increases the genetic 
stability of gacA/S in P. fluorescens (64). Increasing the frequency of mutation 
of gacA/S under growth limiting conditions will result in a subpopulation with a 
high growth rate which is able to re-initiate growth more easily (Fig. 2). The 
appearance of these mutants under laboratory conditions is likely to be the result 
of the increased growth competitiveness (249). In a heterogeneous and highly 
competitive environment such as the rhizosphere, this might enable a population 
to be more successful in competition and to establish itself via these mutants in 
new, less limiting environments. Since this trait is combined with the possibility 
to revert to the phase I phenotype, the gac mutants can, when conditions 
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ABSTRACT 
 
Pseudomonas sp. PCL1171 displays a reversible phase variation between thick 
opaque phase I and a thin translucent phase II colonies. Spontaneous mutations 
in the two-component regulatory system formed by gacA and gacS, results 
exclusively in phase II colonies. In a screening to identify genes that determine 
phase I and/or phase II morphology we selected a mutant that shows only phase 
II morphology but that could not be complemented by gacA/gacS. Introduction 
of gacA/gacS resulted in an intermediate colony morphology, designated as 
phase I’, which is less translucent than phase II, and not opaque like the phase I 
colonies. Genetic analysis showed that the transposon in this mutant was 
inserted in a prtR homolog, transcriptionally coupled to an upstream prtI 
homolog, encoding a sigma factor. Analysis of cell envelope proteins, 
lipopolysaccharide, flagella, and extra-cellular polysaccharides (EPS) showed 
that mutation of prtR interfered with EPS production. The phase I’ phenotype 
appeared to be dependent on the absence of negative regulation of PrtI: 
constitutive expression of prtI in the wild-type resulted in a phase I’ 
morphology. PrtI does not affect EPS in a gacS or in a rpoS background 
suggesting that these genes play a role in the regulation of this sigma factor. Our 
results indicate that EPS production in PCL1171 is involved in the 
determination of the colony morphology, but, by itself is not sufficient to 
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INTRODUCTION 
 
Pseudomonas sp. PCL1171 displays phase variation between a thin translucent 
phase II and a thick opaque phase I. In addition to the morphological difference, 
secondary metabolites such as an anti-fungal factor, biosurfactant and exo-
enzymes such as protease, lipase and chitinase are only expressed in the phase I 
phenotype. Previously, we showed that phase variation of PCL1171 is 
dependent on spontaneous, reversible mutations in gacA/gacS (250). The 
gacA/gacS two-component regulatory system consists of a cognate sensor 
kinase GacS and a reponse regulator GacA, the latter protein belongs to the FixJ 
family of transcriptional regulators (138, 200) which regulate secondary 
metabolism and the production exo-enzymes (24, 111, 138, 215).  
The biochemical basis of colony morphology in bacterial species can be diverse. 
For example, expression of an extra-cellular polysaccharide (EPS) matrix 
determines colony morphology in Vibrio cholerae (195), V. parahaemolyticus 
(75), and in P. aeruginosa (87). Furthermore, the composition of the bacterial 
capsule polysaccharides (79, 176) and outer membrane proteins (141) can 
influence the colony morphology.  
Phase variation is often described to result in morphologically distinct colonies 
(72, 98). In several Pseudomonas species colony morphology is affected by 
mutation of gac (92, 209, 250). Phase variation via gac is, to our knowledge, 
only described in Pseudomonas sp. PCL1171 (249, 250) and for a homolog of 
gacS in Pseudomonas tolaasii (92). In these strains, no genes, except 
gacA/gacS, have been identified which affect colony morphology.  
In the present study a phase II locked transposon mutant was identified that 
could not be complemented by gacA/gacS. Here we describe our attempts to 
identify genes and traits other than gacA/gacS involved in determining the 
colony morphology of PCL1171.  
 
 
MATERIAL AND METHODS 
 
Bacterial strains and plasmids 
Bacterial strains and plasmids are listed in Table 1. Pseudomonas strains were 
grown in King’s medium B (KB) (128) at 28°C. Solid growth media contained 
1.8% (wt/vol) agar (Difco Laboratories, Detroit). Kanamycin, tetracycline, 
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gentamycin and carbenicillin (Sigma, St. Louis) were added for antibiotic 
selection in final concentrations of 50, 40, 10 and 50 µg/ml, respectively. 
 





Bacterial strains   
PCL1171 Antagonistic Pseudomonas strain isolated from 
the rhizosphere of maize from Mexican 
agricultural fields. Colony morphology varies 
between two distinct phases, defined as phases I 
(opaque) and II (translucent).  
(250) 
PCL1578 Derivate of PCL1171 harboring pMP6611 
(PtacprtI), Gmr
This study 
PCL1580 Derivate of PCL1588 (prtR::Tn5luxAB) 
harboring pMP6611 (PtacprtI), Kmr Gmr
This study 
PCL1579 Derivate of PCL1572 (gacS::Tn5luxAB) 
harboring pMP6611 (PtacprtI), Kmr Gmr
This study 
PCL1581 Derivate of PCL1587 (rpoS::kmr) harboring 
pMP6611 (PtacprtI), Kmr Gmr
This study 
PCL1588 Derivate of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a prtR 
homolog, Kmr
This study 
PCL1572 Derivative of PCL1171 in which a promoterless 
Tn5luxAB transposon is inserted into a gacS 
homolog, Kmr
(250) 
PCL1587 Derivative of PCL1171 in which a rpoS mutation 
is introduced using pMP7418, Kmr
van den 
Broek et al., 
In Press 
PCL1591 Derivate of PCL1171 in which a prtI mutation is 
introduced using pMP6606, Kmr
This study 
PCL1597 Derivate of PCL1588 (prtR::Tn5luxAB) 
harboring pMP6603 (gacA/gacS), Kmr, Tcr
This study 
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Table 1. Continued 
plasmids Characteristics Reference 
pMP5285 pME3049 derivate, lacking the Hgr gene, used for 
single homologous recombination, Kmr
Kuiper et al., 
unpublished 
data 
pME6010 E. coli / Pseudomonas shuttle vector, stably 
maintained in Pseudomonas species, with an 
estimated copy number of 4-8, Tcr
(95) 
pMP6603 pME6010 harboring a 1.2 kb PCR product from 
Pseudomonas sp. PCL1446 containing a gacA 
homolog and a 3.2 kb PCR product from 
Pseudomonas sp. PCL1171 containing a gacS 
homolog.  
(249) 
pMP6609 Suicide construct pMP5285 harboring a  200 bp 
EcoRI fragment from the prtI gene 
This study 
pMP6610 Suicide construct pMP5285 harboring a 700 bp 
EcoRI fragment from the alga gene 
 
pMP6611 pBBRMCS5 harboring the complete prtI gene 
under a constitutive tac promoter 
This study 
pMP7420 pBBRMCS5 harboring a rpoS homologue of 
P. chlororaphis PCL1391 expressed under a 
constitutive tac promoter 





Isolation and characterization of PCL1588 (prtR::Tn5luxAB) 
A mutant library of strain PCL1171 was constructed using plasmid pRL1063a 
(250), which harbors a Tn5 transposon with promoterless luxAB genes and a 
kanamycin resistence marker (277). Mutants expressing the phase II phenotype 
were re-plated several times and grown in liquid medium to select those mutants 
locked in the phase II phenotype. DNA regions flanking the transposon were 
isolated by recovering the transposon with its flanking regions from the 
chromosomal DNA of the transposants using EcoRI or ClaI, followed by 
ligation and transformation to E. coli strain DH5α. Since the Tn5 transposon 
harbors an origin of replication (p15A), the plasmid can replicate and maintain 
itself in E. coli. The flanking chromosomal regions were sequenced using 
primers oMP458 (5’-TACTAGATTCAATGCTATCAATTGAG-3’) and 
oMP459 (5’-AGGAGGTCACATGGAATATCAGAT-3’) directed outwards of 
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the transposon ends. Sequencing was carried out by ServiceXS or BaseClear 
(Leiden, The Netherlands). General DNA modification techniques were 
performed according to Sambrook et al. (208).  
 
Analysis of cell envelope proteins and lipopolysaccharides 
To analyse lipopolysacharide (LPS) and membrane protein patterns, cells of 
different phases were separately harvested from plates after two days of growth 
at 28°C and resuspended in 50 mM Tris/HCl - 2 mM EDTA, pH 8.5. Cell 
suspensions were sonicated and centrifuged for 20 minutes at 2,700 rpm. The 
resulting supernatant fluid was centrifuged for one hour at 10,000 rpm. The 
obtained pellets were resuspended and stored in CE (cell envelope)-buffer (2 
mM Tris/HCl, pH 7.8). To visualize LPS patterns, the cell envelope preparation 
was incubated for 15 min at 100°C in 125 mM Tris/HCl, pH 6.8 - 4.0% SDS – 
20% glycerol - 0.02% bromophenol blue, followed by a proteinase K (Sigma, 
St. Louis) treatment. The LPS fractions were separated in a denaturing 11% 
SDS-PAGE gel using a Mini-ProteanTM 3 Cell system (BioRad lab., 
Richmond, CA). The LPS pattern was visualized by silver staining (246). Cell 
envelope proteins were denatured by adding β-mercaptoethanol to the cell 
envelope mixture to a final concentration of 0.1%, followed by incubation for 
10 minutes at 100°C. Proteins were separated on a 11% SDS-PAGE denaturing 
gel using a Mini-ProteanTM 3 Cell system (BioRad lab. Richmond CA) and 
visualized using Coomassie-Blue staining (208).  
 
Analysis of extra-cellular polysaccharides 
Extra-cellular polysaccharides were isolated following the protocol of Enos-
Berlage et al. (75). Briefly, bacteria were grown on solid medium for 72 hours 
at 28°C and the distinct morphological colony phases were harvested and 
resuspended separately in 4.5 ml PBS. After vigorous shaking, the samples were 
incubated under shaking at 28°C for two times 1.5 hours. Samples were spun 
down, and the supernatant was treated by proteinase K (200 µg/ml) for 1.5 hour 
at 56°C. Four and a half ml of a 1:1 (v/v) phenol-chloroform mixture was added 
and the precipitate was spun down. This step was repeated, after which 2.5 
volume of ethanol was added to the supernatant to precipitate the EPS. The 
pellet was washed using 70% ethanol, and resuspended in MilliQ. The phenol-
sulfuric acid method of Dubois et al. (62) was used to quantify the amount of 
sugar. The EPS was visualized using a denaturing 11% SDS-PAGE gel, with a 
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5% stacking gel and visualized using a silver staining (246) (Biorad Lab., 
Richmond, CA). 
 
Construction of pMP6611 (pBBR1MCS5 PtacprtI) 
The chromosomal regions flanking the Tn5luxAB transposon of PCL1588 after 
reisolation of the transposon (see above) were used as a template to amplify prtI 
by polymerase chain reaction (PCR). The primers oMP833 (5’-
TTCGCTGGGGGGCAGGCTGATCATT-3’) and oMP822 (5’-
TTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGA
TAACAATTTTCACACAGGAAACAGCTAAATGCATGAACTCGACGAA
CAGTTACGTGAACTCATCCCCAGGTTGCGGCGTTTTGCC-3’) used for 
prtI amplification, harbored the tac promoter sequence directly in front of the 
ATG of prtI. The 600 bp PCR product was inserted into the pGEM-TEasy 
Vector (Promega Crop., Madison, WI), and subsequently cloned into 
pBBR-MCS5 using ApaI and SacI resulting in pMP6611. The PCR fragment 
was sequenced to exclude mutations occurring during the PCR process. 
Subsequently, pMP6611 was transferred to S17-1 by electroporation and the 
resulting strain was used to transfer pMP6611 by parental mating to 
Pseudomonas.  
 
Construction of mutants 
PCL1591 (prtI::kmr) was constructed by homologous recombination using 
pMP6609, which consists of a 200 bp EcoRI prtI fragment from the PCR 
product resulting from primers oMP802 (5’-GTGAACTCATCCCCAGGTTG-
3’) and oMP803 (5’-ATGTCGGCGACTTCCTTGTA-3’) cloned into the 
suicide vector pMP5285. PCL1594 (algA::kmr) was constructed using 
pMP6610, which consists of a 700 bp EcoRI, algA fragment from the PCR 
product of oMP830 (5’-ATGTTCCTGTTCCGCGCCAGCCGCT(AT)CCT-3’) 
and oMP831 (5’-AGCGGCCGCCAATGTCCACCGAGTCGTA-3’) cloned 
into pMP5285. The plasmids pMP6609 and pMP6610 were transferred to S17-1 
and introduced into PCL1171 by parental mating. Correct incorporation into the 





Isolation and characterization of a stable PCL1171 phase II Tn5luxAB 
mutant 
PCL1588 was isolated from a Tn5luxAB transposon library of PCL1171 as a 
mutant expressing a phase II phenotype. In contrast to previously isolated 
mutants (249), transformation of PCL1588 with pMP5565 (gacA), pMP6562 
(gacS) or pMP6603 (gacA and gacS) resulted in an intermediate morphology of 
phases I and II, further referred to as phase I’. In the non-transformed PCL1588, 
phase I’ sectors were observed after growth for several days. The phase I’ 
morphology is less translucent than that of phase II (Fig. 1B), but 
morphologically also different from wild-type phase I colonies (Fig. 1A) since 
the colonies are not opaque (Fig. 1C). Phenotypic characterization of PCL1588 
showed that this mutant had neither lost its anti-fungal activity, nor its capacity 
to produce biosurfactant, protease, or lipase, all of which are characteristic for 
the phase I phenotype. So apparently only its colony morphology was affected. 
 
Figure 1. Colony morphologies of wild-
type strain PCL1171 and its derivate phase 
I’. The colony morphologies of the wild-
type phase I (Panel A), the wild-type phase 
II (Panel B) is shown, and the intermediate 









Re-isolation of the Tn5luxAB transposon and subsequent sequencing of the 
chromosomal regions flanking the transposon showed that the transposon had 
inserted in an ORF which encodes a protein showing highest homology to the 
prtR gene product (73% identity and 78% similarity at the amino acid level) of 
P. fluorescens (Genbank accession number AAF81073). Using the Entrez 
conserved domains database (159) the predicted protein was shown to align 
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with domains of predicted anti-sigma factors (COG5662, COG03806, and 
COG3712). Therefore it seems reasonable to predict that in PCL1171 the 
identified open reading frame encodes a transmembrane anti-sigma factor (34). 
Sequence analysis of the region downstream of this open reading frame 
revealed another open reading frame, transcribed in the opposite direction and 
encoding a protein showing highest homology  to a hypothetical protein (73% 
identity and 80% similarity at amino acid level) of P. fluorescens (Genbank 
accession number AAF81076). Sequence analysis of the region upstream of the 
prtR gene identified an open reading frame transcribed in the same direction, 
showing highest homology (83% identity and 86% similarity at amino acid 
level) to the prtI gene product of P. fluorescens (Genbank accession number 
AAF81076). Using the Entrez conserved domains database (159) the protein 
aligned with RpoE (COG1595), a well known ECF sigma factor in E. coli 
required for high temperature survival (112). In addition it aligned with a sigma 
70-r2 and r4 domain (pfam04542 and pfam04545) involved in the binding of 
the -10 and -35 promoter recognition sites. Therefore it seems reasonable to 
predict that in PCL1171 the identified open reading frame encodes an 
extracytoplasmic-function (ECF) sigma factor (34). The region upstream of the 
prtI gene (approximately 1 kb) did not show any substantial ORF and/or amino 
acid similarity to data base entries. Sequence analysis showed, similar to other 
known ECF sigma factors and their regulators (112), that the stop codon of the 
prtI was overlapping with the start codon of the prtR, indicating that 
transcription of the prtI and prtR genes in PCL1171 is coupled (Fig. 2).  
 
 
Figure 2. Genomic organization 
of the prtI/R operon in 
Pseudomonas strain PCL1171. 
 
 
After prolonged growth of PCL1588 (prtR::Tn5luxAB) in the absence of 
kanamycin, phase I sectors appeared which had grown out of phase II and phase 
I’ colonies. Re-plating of these phase I sectors on plates containing kanamycin 
showed that these bacteria had lost their kanamycin resistence. Re-plating on 
plates without antibiotic showed growth of bacteria with a phase I morphology 
indistinguishable to that of the wild-type strain. No kanamycin resistant phase I 
sectors could be isolated. We conclude that spontaneous removal of the 
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transposon coincided with a switch back to a phase I phenotype, showing that 
the phase II phenotype of PCL1588 (prtR::Tn5luxAB) is indeed dependent on 
mutation of prtR. 
Effect of prtR on cell surface traits 
To study the role of prtR in phase I and phase II colony morphology, cell-
envelope proteins, outer membrane proteins, lipopolysaccharide (LPS) ladder 
patterns, flagella, and production of EPS were analyzed. Previously, analysis of 
cell envelope proteins expressed in phase I and phase II morphologies had 
shown similar patterns with small differences in the amounts of a number of 
proteins produced (250). Mutation of the prtR gene in PCL1588 
(prtR::Tn5luxAB) did not appear to have a detectable effect on the cell envelope 
protein pattern (data not shown) compared to those of phase I and phase II wild-
type cells. Furthermore, analysis of LPS ladder patterns and production of 
flagella did not show detectable differences between wild-type phase I, wild-
type phase II, PCL1572 (gacS::Tn5luxAB) and PCL1588 (prtR::Tn5luxAB). 
Analysis of the EPS showed that the EPS of PCL1588 (prtR::Tn5luxAB) (Fig. 3, 
lane 3) differed from the EPS isolated from wild-type phase I (Fig. 3, lane 1), 
wild-type phase II cells (data not shown), and PCL1572 (gacS::Tn5luxAB) (Fig. 
3, lane 2). The EPS of PCL1588 was only present as smaller fragments in the 
lower part of the SDS-PAGE gel (Fig. 3, lane 3). Introduction of pMP6603 
(gacA/gacS) into PCL1588 (prtR::Tn5luxAB), resulted in strain PCL1597 which 
expressed a phase I’ morphology. The EPS isolated from PCL1597 (Fig. 3, lane 
5) was indistinguishable from that of the wild-type (Fig. 3, lane 1). 
 
Characterization of a prtI mutant  
Mutation of the prtI gene using pMP6609 resulted in strain PCL1591 
(prtI::kmr). This strain expresses phase I morphology and produces antifungal 
activity, biosurfactant, proteases, and lipase. In addition, the EPS isolated from 
PCL1591 (prtI::kmr) (Fig. 3, lane 9) did not differ from the EPS isolated from 
wild-type phase I bacteria (Fig. 3, lane 1).  
To study the role of PrtI in the phenotype of PCL1588, we constructed 
pMP6611, a pBBR1MCS5 vector harboring the prtI gene under a constitutive 
tac promoter. pMP6611 (PtacprtI) was introduced into PCL1171 (wild-type 
phase I) and PCL1591 (prtI::kmr). These derivates appeared to express a phase 
I’ morphology, whereas introduction of the empty parental vector pBBR1MCS5 
did not alter the phase I phenotype of these strains. After prolonged growth of 
PCL1578 (PCL1171 PtacprtI) it appeared that the phenotype was not stable since 
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Figure 3. Analysis of EPS using SDS-PAGE.  The EPS of (1) the wild-type strain 
PCL1171 with a phase I morphology was compared with these of (2) the stable pShase 
II mutant PCL1572 (gacS::Tn5luxAB) and (3) PCL1588 (prtR::Tn5luxAB). In addition, 
the EPS’s from (4) PCL1580 (PCL1588 (prtR::Tn5luxAB) + PtacprtI), (5) PCL1588 
(prtR::Tn5luxAB) + pMP6603 (gacA/gacS), (6) PCL1588 (prtR::Tn5luxAB) + PtacprtI + 
gacA/gacS, (7) PCL1578 (wild-type strain PCL1171 + PtacprtI), (8) wild-type strain 
PCL1171 + PtacprtI + pMP6603 (gacA/gacS), (9) PCL1591 (prtI::kmr), and (10) 
PCL1579 (PCL1572 (gacS::Tn5luxAB) + PtacprtI), were analyzed. 
 
phase I sectors were found growing out of the phase I’ colonies. This was also 
observed upon the introduction of pMP6603 (gacA/gacS) and of the parental 
vector pME6010 into PCL1578 (PCL1171 PtacprtI), in all cases the result was a 
mixture of phase I, phase II and phase I’ colonies. 
The introduction of pMP6611 (PtacprtI) into PCL1588 (prtR::Tn5luxAB), 
resulting in strain PCL1580 (PCL1588 + PtacprtI), did not restore the wild-type 
EPS pattern (Fig. 3, lane 3). However, the subsequent introduction of pMP6603 
(gacA/gacS) resulted in a phase I’ phenotype and the restoration of the wild-
type EPS pattern (Fig. 3, lane 5 and 6).  
 
Effect of constitutive expression of prtI and rpoS 
To study the regulation of prtI/R, pMP6611 (PtacprtI) was introduced into the 
gacS mutant PCL1572 (stable phase II) and the rpoS mutant PCL1578 
(expressing a phase I morphology). This resulted in strains PCL1579 
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(gacS::Tn5luxAB + PtacprtI) and PCL1581 (rpoS::kmr + PtacprtI), respectively. 
The phase II morphology was not affected by the constitutive expression of the 
prtI gene in PCL1572 (gacS::Tn5luxAB). The subsequent introduction of 
pMP6603 (gacA/gacS) into strain PCL1579 (gacS::Tn5luxAB + PtacprtI) 
resulted in a mixture of phase I and phase I’ colonies. Introduction of the empty 
vector, pMP6010, did not alter the phase II morphology of PCL1579 
(gacS::Tn5luxAB + PtacprtI). The EPS isolated from PCL1579 (gacS::Tn5luxAB 
+ PtacprtI) (Fig. 3, lane 10) was not altered when compared to that of PCL1572 
(gacS::Tn5luxAB) (Fig. 3, lane 2). 
Similarly, the phase I morphology of PCL1587 (rpoS::kmr) was not affected by 
the constitutive expression of the prtI gene. In a second approach pMP7420 
(pBBR1MCS5 PtacrpoS) was introduced into PCL1588 (prtR::Tn5luxAB). This 





Phase variation in Pseudomonas sp. PCL1171, observed as a switch in colony 
morphology, is based on the spontaneous mutation of gacA and/or gacS and 
subsequent restoration of the wild-type sequence. It regulates secondary 
metabolism and exo-enzyme production (249, 250). A Tn5luxAB mutant, 
PCL1588 was isolated which (i) expresses phase II morphology, and (ii) 
expresses a phase I’ morphology upon the introduction of gacA/gacS (in 
contrast to other phase II mutants in which gacA/gacS restores a phase I 
morphology), and (iii) produces secondary metabolites and exo-enzymes which 
is normally correlated with the phase I phenotype. Based on these observations 
we hoped to identify a gene determining colony morphology.  
Sequence analysis of this mutant showed that the Tn5 transposon was 
inserted in a prtR homolog. The transposon was lost spontaneously, which 
correlated with a switch back to phase I morphology. Sequencing showed that 
the prtR gene is part of an operon, with an upstream gene showing homology to 
the prtI gene (Fig. 2). The same genetic organisation is present in P. fluorescens 
LS107d2 (34) (Genbank acc. no. AF228766) and P. putida KT2440 (Genbank 
acc. no. NP_745033 and NP_745032).  
Transmembrane anti-sigma factors, such as prtR, interact with extra-
cytoplasmic function (ECF) sigma factors of the σ70 family (34). A membrane-
localized anti-sigma factor functions as a sensor and signaling molecule 
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allowing an adaptive response to specific environmental changes (173). These 
changes include temperature, heat shock, ion levels, oxidation, but the sigma 
factors are also activated upon mutations affecting multidrug efflux pumps or 
misfolding of outer membrane proteins (194). When PrtR is not induced, the 
ECF sigma factor is bound to the anti-sigma factor, located at the inner 
membrane. Upon induction the sigma factor is released, and will associate with 
RNA polymerase core enzymes and thereby regulate the transcription of genes 
to cope with the sensed stress (194). ECF sigma factors identified in 
Pseudomonas include PrtI (34), PvdS (276), AlgU (278), and FecI (162), which 
regulate the synthesis of protease, pyoverdine, and alginate, and iron acquisition 
(194), respectively. Sequence analysis and the presence of conserved domains 
indicate that in PCL1171 the prtR and prtI homologs encode an anti-sigma 
factor and an ECF sigma factor, respectively.  
Analysis of the regulatory relation between PrtR and PrtI indicates that 
the phenotype of PCL1588 is dependent on the absence of negative regulation 
of PrtI. Based on (i) the characteristics of and homology to known anti-sigma 
factors, and the observations that (ii) the mutation of the prtI gene did not alter 
the phase I morphology, (iii) the introduction of pMP6611 (PtacprtI) altered the 
colony morphology of the wild-type strain from a phase I to a phase I’ 
morphology, and (iv) the introduction of pMP6611 into PCL1588 did not affect 
the phenotype, including the altered EPS, of this mutant, we hypothesize that 
PrtR is negatively regulating PrtI. Furthermore, the sigma factor PrtI plays a 
role in the phase I and phase II colony morphology of PCL1171, via a direct or 
indirect effect on the synthesis or secretion of EPS in PCL1171. Interestingly, 
no differences in the EPS pattern were detected when the pattern obtained from 
wild-type phase I colonies was compared with the EPS isolated wild-type phase 
II colonies or from the gacS mutant PCL1572. This indicates that EPS alone is 
not responsible for the difference in colony morphology between phase I and 
phase II. In addition, the introduction of pMP6603 (gacA/gacS) into PCL1588 
resulted in a phase I’ morphology and restored a wild-type EPS pattern. We 
hypothesize that regulation of PrtI, in addition to PrtR, could account for these 
results. Therefore we studied the regulatory relationship between GacS, RpoS, 
and PrtI. In contrast to changes caused by the introduction of pMP6611 into the 
wild-type, the phase II morphology of PCL1572 (gacS::Tn5luxAB), and the 




Figure 4. Work hypothesis for the 
regulation of colony morphology of 
PCL1171. Phase colony morphology 
of PCL1171 is based on spontaneous 
mutation of gacA/S, resulting in the 
phase II morphology. In addition EPS 
is regulated via a membrane bound 
anti-sigma factor PrtR and its ECF 
sigma factor PrtI. In the absence of 
regulation of PrtI via PrtR or RpoS 
the EPS is altered (Fig. 3). But since 
the EPS pattern is not always 
correlated with the expression of a phase I morphology but results in an intermediate 
phase I’ morphology the colony morphology is likely to be dependent on other PrtI or 
GacA/S regulated factors in combination with EPS. 
 
 
This shows that GacS and/or RpoS play a role in the regulation of PrtI. Based 
on these observations and since (i) the introduction of pMP7420 (PtacrpoS) into 
PCL1588 restored a phase I’ morphology, and (ii) the fact that in Pseudomonas 
gacA/S is needed for the expression of rpoS (249), we hypothesize that the 
regulation of PrtI is most likely influenced by RpoS. Our results indicate that 
the PrtI is not only regulated via PrtR, but that the presence of RpoS also 
prevents the activity of PrtI. This is supported by the observation that the EPS is 
only affected in the combination of a prtR mutation and additional mutations in 
gac, illustrated by the restoration of the EPS pattern in PCL1588 (Fig 3. lanes 5 
and 6) after introduction of pMP6603.  
Our results show that the restoration of the EPS pattern is not always 
correlated with the expression of a phase I morphology, but results in a phase I’ 
morphology. Therefore we hypothesize that PrtR and PrtI are regulating 
additional factors involved in colony morphology of PCL1171. This hypothesis 
implies that the phase I colony morphology of PCL1171 is not dependent on a 
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Summary and general discussion 
1.1 Introduction 
Plants secrete a variety of compounds into the soil, making the rhizosphere a 
relatively rich nutritional environment when compared to the surrounding soil 
(150, 153). As a result, the rhizosphere is inhabited by a wide range of 
organisms including protozoa, nematodes, mycorrhizae, bacteria, and fungi. 
These organisms present in the rhizosphere are facing a heterogeneous and 
competitive environment. As a result, micro-organisms have developed traits to 
improve their success in the rhizosphere. Examples of such competitive traits 
are increased growth rates (241), efficient root colonisation (43), and the 
production of secondary metabolites and/or lytic exo-enzymes aimed at limiting 
growth of other species (58, 147). Micro-organisms can thereby suppress the 
propagation of phytopathogens in the rhizosphere, and as a result control plant 
diseases (45, 241).  
In modern agriculture plant diseases are mainly suppressed by the 
application of chemical pesticides. Many of these chemicals are difficult to 
degrade and therefore maintained in the environment for long periods. Some of 
these are harmful and toxic to humans and other non-target organisms. This has 
led to the political decision, on national and international (e.g. EU) level, to 
limit the input of these chemicals into the environment. This measure increased 
the demand for alternatives. The use of micro-organisms to control 
phytopathogens is a promising and environmental friendly alternative for the 
use of chemical pesticides. At this moment, worldwide hundreds of commercial 
products, based on micro-organisms, are available for the control of plant 
diseases. But, the commercial application of this alternative is still limited, due 
to variable results under practical conditions. To improve the performance of 
biocontrol inoculants it is essential to understand mechanisms or processes 
affecting the efficiency and reliability of these bacteria as biocontrol agents.  
One of the factors which affects biocontrol is a site-specific recombinase 
(56, 209), encoded by the sss gene.  Mutation of sss severely decreased the 
occurrence of morphological variants and the root colonisation ability of 
P. fluorescens WCS365 (56) while this mutation in P. chlororaphis PCL1391 
abolished the biocontrol ability of this strain (43). In addition, the sss gene was 
indicated to play a major role in the phenotypic variation of P. fluorescens F113 
during root colonization although a genetic mechanism was not described (209). 
The involvement of a site specific recombinase in these processes suggested 
that mechanisms including DNA alterations could influence root colonisation 
and therefore the performance of biocontrol agents. The characterization of a set 
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of antagonistic pseudomonads indicated that colony phase variation frequently 
occurs in rhizobacteria (Chapter 2). Phase variation is defined as a process of 
reversible, high-frequency phenotypic switching that is mediated by DNA 
mutation, reorganisation or modification. Most known examples of phase 
variation are described in the context of host-pathogen interactions (Chapter 1), 
but phase variation occurs in various environments and can affect a variety of 
processes. It is, for example, used by bacteria to generate population diversity in 
order to increase fitness and it is important in niche colonization and adaptation, 
including immune evasion (211). Since phase variation is a strategy of 
pathogenic micro-organisms to evade host defense systems it poses a problem 
in vaccine production (163). In addition, in industrial production processes of 
microbial molecules, yields can be negatively influenced by the formation of 
non-producing sub-populations. Understanding a process such as phase 
variation can be an essential step towards controlling or limiting the effect of 
such a mechanism on medical, industrial and ecological processes, in this case 
the control of phytopathogens. Therefore, the aim of this thesis was to study the 
mechanism of phase variation in antagonistic Pseudomonas bacteria in relation 
to efficient biocontrol of phytopathogens. 
The results described in this thesis contribute to the understanding of a 
molecular mechanism and the regulation of phase variation in Pseudomonas 
bacteria. A novel example of un-programmed phase variation is described, 
based on spontaneous mutation of the global regulatory gacA and gacS genes, 
which affects the major biocontrol traits of Pseudomonas PCL1171. This 
mechanism of phase variation affected the biocontrol activity of PCL1171, but 
also seems to serve as a mechanism to improve fitness and success in a 
competitive environment such as the rhizosphere.  
 
 
1.2 Influence of phase variation on biocontrol 
Some agricultural fields in Tontotepec, Oaxaca Mixe, Mexico have a history of 
over 700 years of sustainable agriculture. Despite the humid climate, which 
should be beneficial for the growth of (phytopathogenic) fungi, excellent crop 
yields can be obtained from these fields without the application of chemicals. A 
possible explanation for the natural suppressivenes of these fields was provided 
by the isolation of a high percentage of Pseudomonas strains, from maize roots, 
which are antagonistic against important phytopathogenic fungi (21 % of the 
isolated strains). Almost all of these antagonists display colony phase variation. 
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Two distinct colony morphologies could be observed on plates, namely a thick 
opaque phase I and a thin translucent phase II (Chapter 2). The phenotypic 
characterization of a phase I and phase II phenotype showed that the production 
of secondary metabolites and exo-enzymes is correlated with a phase I 
phenotype (Chapter 2). The production of secondary metabolites and exo-
enzymes by PCL1171 phase I cells resulted in a significant suppression take-all 
of wheat, caused by Gaeumannomyces graminis pv. tritici. Seed inoculation 
using PCL1171 phase II cells, or with cells of a PCL1171 mutant derivative 
with a higher frequency of phase variation, did not result in biocontrol activity 
(Chapter 2).  
The antagonistic activity of PCL1171, both on plate and in a bioassay, 
was shown to be dependent on the expression of an antifungal metabolite. This 
metabolite is presumably a lipopeptide since (i) mutation of a homolog of a 
lipopeptide synthase abolished the antagonistic activity, while maintaining the 
phase I phenotype, and (ii) lipopeptides have been described to have anti-fungal 
activity in Pseudomonas fluorescens DR54 (242) (Chapter 2). We conclude that 
the expression of a lipopeptide is a prerequisite for biocontrol activity in 
PCL1171 and that the absence of this lipopeptide in the phase II phenotype is 
the main reason for a lack of biocontrol activity of this phenotype (Chapter 2).  
The structural basis of the phase I and phase II colony morphology in 
Pseudomonas PCL1171 is described in Chapter 5. In a number of other 
Pseudomonas species colony morphology is regulated by phase variation. For 
example, phase variation of P. tolaasii results in smooth and rough colonies 
(92), while in P. fluorescens F113 (209), and Pseudomonas brassicacearum 
(38) translucent and opaque colonies can be isolated. The data presented 
suggests a role for EPS in the colony morphology of PCL1171. The EPS was 
affected by the expression of an extra-cellular sigma factor PrtI, of which the 
effect was influenced by Gac and RpoS, and its membrane bound anti-sigma 
factor PrtR. Based on the results the phase I colony morphology of PCL1171 is 
not determined by a single factor such as EPS, but probably by multiple factors 
(Chapter 5). 
In conclusion, phase variation plays a role in efficient control of take-all 
of wheat and therefore could affect the reliability of a biocontrol strain. This 
was illustrated by the observation that the application of phase I cells 
suppressed the effect of G. graminis pv. tritici on wheat, in contrast to phase II 
cells or a derivate with a high frequency of variation. Phase variation, associated 
with the production of anti-fungal metabolites and secondary metabolism, 
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affecting the control of pathogenic fungi has not been described before. Our 
findings show that phase variation should be considered in a broader ecological 
context, affecting for example a process such as biocontrol and the production 
of secondary metabolites and exo-enzymes.  
 
 
1.3 The molecular mechanism of phase variation in Pseudomonas 
sp. PCL1171 
In Pseudomonas only two molecular mechanism of phase variation have been 
described previously. In P. putida DOT-T1E the expression of flagella is 
controlled via slipped-strand mispairing (219), and in P. tolaasii, a 661 bp 
spontaneous, reversible duplication in pheN, controls colony morphology and 
pathogenicity (92).  
The data presented in Chapters 2 and 3 show that spontaneous mutation 
of the global regulatory genes gacA and gacS is responsible for the switch from 
phase I to phase II. The presence of intact gacA and gacS genes is directly 
correlated with a phase I phenotype and the production of secondary 
metabolism and exo-enzymes. Production of secondary metabolites and exo-
enzymes is also affected by spontaneous mutation of the global regulatory genes 
gacA and gacS in other Pseudomonas species, but in these reports the mutations 
are not described as part of a reversible process such as phase variation (33, 63, 
64, 138, 200, 209, 216).  
In Chapter 3 the spontaneous modifications in the gacS gene of PCL1171 
were analysed. The mutations accumulated in a set of gacS mutant derivatives 
included point mutations, an insertion, deletions, and an inversion. The 
mutations identified in gacA (33) and gacS of PCL1171 (Chapter 3 and Fig. 1) 
show that mutation of gac is random, both in the location and nature of the 
mutation. Based on these observations and the involvement of mismatch repair 
(MMR) (Chapters 2, 3 and 4), it is concluded that phase variation of PCL1171 
is an example of un-programmed spontaneous mutations (Chapter 3). The 
mechanism of phase variation that is described for PCL1171 is novel in the 
sense of its occurrence in Pseudomonas, the nature of the mutations, and the 
targets of mutation. In PCL1171, P. tolaasii (92), and Ralstonia solanacearum 
(191) global regulatory genes are mutated, other examples of un-programmed 
variation involve the spontaneous mutation of biosynthetic genes such as the 
capsule locus in Streptococcus  pneumoniae (263), and the vir locus of 
Bordetella bronchiseptica (175). 
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Figure 1. Spontaneous mutations identified in the gacS gene from phase II transposon 
mutants (PCL1574, PCL1575, and PCL1576) and wild-type phase II sectors (sector 1, 
2, 4, 9, 16, and 18) from Pseudomonas sp. PCL1171. The different domains of the GacS 
protein, the periplasmic loop (M33 – L126), the linker region (L162 – E270), and the 
phosphotransfer domain at the C-terminal end (from E270) harbouring three 
phosphorylation sites (H294, D717, and H863) (282) are indicated. 
 
 
In Pseudomonas PCL1171 two classes of phase II bacteria were isolated, 
unstable sectors (as observed in single colonies, see Chapter 2, Fig. 1) and 
stable phase II mutants. Both classes are based on spontaneous mutation of gac 
genes, in which mutations were spontaneously restored to the wild-type 
sequence. The stability of the phase II phenotype, observed in one class of 
mutants, is the result of restoration and simultaneous introduction of new 
mutations (Chapter 3). The molecular mechanism responsible for this difference 
in stability of the phase II phenotype classes is not clear, but is not likely to be 
dependent on the nature or the location of the mutations, which is random for 
both classes (Chapter 3 and Fig. 1). Only one mutation was identified, a 307 bp 
deletion in the gacS gene, which is likely to lock bacteria in the phase II 
phenotype (Chapter 3). It can be hypothesized that spontaneous mutation or 
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regulation of components of a restoration mechanism responsible for the switch 
from phase II to phase I, prevents these bacteria to return efficiently to a phase I 
phenotype. 
In most cases, as described in Chapters 2, 3 and 4, the phase II phenotype 
in PCL1171 is reversible. Wild-type phase II bacteria switch back with a 
remarkably high frequency to a phase I phenotype, restoring the wild-type gacA 
and gacS genes (Chapters 3 and 4). The molecular mechanism responsible for 
the genetic restoration of the mutated gac genes is not known. Preliminary 
analysis of this switch showed that RecA and RecB are not essential for the 
restoration of a phase I phenotype. This indicates that large DNA 
rearrangements are not essential for the restoration of wild-type gac sequences. 
To our knowledge, for all described examples of un-programmed variation in P. 
tolaasii (92), S. pneumonia (263), R. solanacearum (191), and B. bronchiseptica 
(175), the mechanism for the restoration to the wild-type is unknown. 
Interestingly, in P. tolaasii, RecA was needed for the introduction of the 
mutation (225), but this is not the case in PCL1171 (Chapter 3). Quantification 
of the frequency of reversion showed that the switch from phase II to phase I 
was only affected in a rpoS mutant (Chapter 4). This mutation either locks the 
bacteria in a phase II phenotype, or increases the instability of the phase II 
bacteria. This is an interesting observation since in a phase II phenotype the 
rpoS gene is not expressed (Chapter 4), possibly resulting in a situation in which 
the switch to a phase I phenotype is either stimulated or prevented.  
 
 
1.4 Phase II cells of Pseudomonas sp. PCL1171 have a growth 
advantage 
Growth experiments presented in Chapters 3 and 4 show that mutation of gac in 
PCL1171 reduced the length of the lag-phase and increased the growth rate. 
This is consistent with observations in Pseudomonas chlororaphis (216). The 
data presented in Chapter 4 suggests that this growth effect is dependent on a 
combination of (i) a lack of RpoS activity (as is the case in a gac mutant 
(Chapter 4)) and (ii) a gac dependent reduction in metabolic load. Based on the 
observation that mutation of gac increases the growth rate, we hypothesize that 
the isolation of high numbers of gac mutants under laboratorium conditions can 
be the result of an enrichment of these mutants during culturing (Chapter 3). 
Still, the percentage of gac mutants remains limited, most likely due to the 
reversibility of the phenotype and the absence of a strong and specific selection 
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for these mutants under laboratorium conditions. The effect of increased growth 
competitiveness will be much more apparent under conditions where stationary 
and exponential growth often switch, as may be expected in colonies and in the 
rhizosphere. This explanation is consistent with the suggestion by Schmidt-
Eisenlohr et al. (216) for P. chlororaphis isolate SPR044, that having a mixed 
population could, based on the growth characteristics of the gac mutants, 
provide a competitive advantage, especially in changing and heterogeneous 
environments. Phase variation via spontaneous mutation of gac could therefore 
provide a population with a competitive advantage.  
Spontaneous gac mutants have been isolated in a range of antagonistic, 
rhizosphere competent Pseudomonas species (33, 63, 64, 139, 200, 209, 216). 
Up till now only stable gac mutants have been isolated from these strains. This 
could be due to the growth advantage of these mutants or the lack of a 
restoration mechanism in these species. In PCL1171 a small number of the 
isolated gac mutants was not observed to revert to the wild-type. Since (i) gac 
mutants have been isolated in a wide range of antagonistic and rhizosphere 
competent Pseudomonas species, (ii) mutation of gac results in a growth 
advantage and in most selections only stable mutants will be selected for, (iii) 
gac mutations are reversible in PCL1171, it should be considered that phase 
variation via spontaneous mutation of gac is a conserved mechanism in soil-




1.5 Regulation of the phase variation frequency in Pseudomonas 
sp. PCL1171 
In most examples of phase variation the underlying mechanism is regulated by 
environmental factors to allow a pathogen to express specific traits under the 
right conditions (see Chapter 1). Regulation of the frequency of phase variation 
(the frequency of spontaneous mutation of gac) in PCL1171 was studied 
(Chapters 2, 3 and 4). In Chapter 2 a mutS mutant is described. Mutation of the 
mutS gene results in a strong increase in the frequency of phase variation (appr. 
1000-fold (Chapter 4)). Further analysis of the role of MutS-dependent 
mismatch repair (MMR) in phase variation of PCL1171 showed that inefficient 
MMR directly increases the frequency of gac mutants (Chapters 2, 3, and 4). In 
addition, since the frequency of spontaneous mutations in a mutS mutant was of 
the same order as the wild-type phase variation frequency (Chapter 3), 
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inefficient MMR can be considered (one of) the main mechanism for the switch 
from phase I to II. 
Our results show that mutS expression is, directly or indirectly, negatively 
regulated by RpoS. This RpoS dependent regulation is combined with at least 
one other (sofar unknown) gac dependent factor (Chapter 4). In a phase II 
phenotype, rpoS is not expressed (due to mutation of gac) and as a result mutS 
expression is increased when compared to the wild-type (Chapter 4 and Fig. 2). 
An increase in mutS expression should again suppress the introduction of 
mutations and thereby limit the effect of a high mutational load due to long term 
absence of MMR. This hypothesis is supported by the observation of a limited 
number of mutations present in the gacA and gacS genes and that in almost all 












Figure 2. Work model for the genetic regulation of spontaneous mutations 
accumulating in gac. A schematic representation of the regulatory roles of GacA/S, 
RpoS and MutS in phase variation of PCl1171. Phase I cells harbor intact gacA and 
gacS genes that are required for expression of rpoS, which, in combination with 
additional factors, in stationary phase negatively regulates mutS expression. Inefficient 
repair of mutations due to down regulation of MutS results in a decreased repair of 
spontaneous mutation which in turn will result in the accumulation of mutations in 
gacA/S (indicated with an asterix). As a result the cell switches to the phase II 
phenotype. Mutation of the gacA/S genes decreases rpoS expression and the subsequent 
increase in the expression of mutS, thus limiting the mutation rate. In addition RpoS is 
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The involvement of RpoS in phase variation of PCL1171 suggests that the 
spontaneous mutation of gac is influenced by stress conditions; under such 
conditions the expression of rpoS will increase (99). In addition, the frequency 
of the switch from phase II to phase I was affected in a rpoS mutant (Chapter 4), 
suggesting a role for RpoS in both mutation and restoration of gac. We 
hypothesize that under growth limiting conditions, for example nutrient stress, 
MMR will be suppressed resulting in an increase in the frequency of 
spontaneous mutation and the frequency of gac mutants (Fig. 2). This is 
supported by the observation that a lack of nutrient stress in liquid cultures 
increases the stability of the gac genes (64).  
Increasing the frequency of spontaneous mutation can be one of the 
strategies of micro-organisms to cope with stresses (131, 178). In the 
rhizosphere conditions can show strong fluctuations. For example the 
availability of nutrients, the humidity, temperature, and the presence of other 
organisms creates a stressful environment. Therefore, surviving in the 
rhizophere will depend on adequate responses to these stresses. A strategy can 
be to increase the frequency of spontaneous mutation, via the down-regulation 
of MutS-dependent repair pathways (for example through RpoS), resulting in 
sub-populations of gac mutants. Considering the growth advantages of a gac 
mutant under these conditions, a population including these mutants should be 
able to cope more easily with changes in the conditions, maintain their presence 
in the rhizosphere and enable them to colonize new niches more efficiently.  
 
 
1.6 Role of phase variation in the rhizosphere 
In a heterogeneous and changing environment such as the rhizosphere, 
organisms are in a constant struggle to maintain themselves on the plant root or 
colonize new niches. It can be hypothesized that populations of Pseudomonas 
bacteria present in the rhizosphere or on the plant root, harbor subpopulations of 
gac mutants (33, 39, 139, 216, 250, 250). These gac mutants have a significant 
growth advantage over wild-type bacteria ((216) and Chapters 3 and 4). The 
presence of these subpopulations could enable the population to react more 
efficiently to changes or stress conditions.  
The presence of gac mutants in the rhizosphere has two consequences. 
First these mutants can provide a population with an advantage: (i) an increase 
in the growth rate can improve success in the rhizosphere, (ii) the possibility to 
re-initiate growth more efficiently will increase the chance to maintain a niche 
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when conditions fluctuate and improve success in competition for new niches, 
(iii) when conditions become limiting for a Pseudomonas population, mutation 
of gac could decrease the metabolic load, and (iv) recent work on phenotypic 
variation of Pseudomonas brassicacearum showed that an overproduction of 
flagella in a phase II phenotype, resulted in an improved root colonisation 
pattern of a phase II phenotype (2). Therefore, these mutants are likely to be 
more successful in the colonization of new niches and in maintaining 
themselves under fluctuating conditions in the rhizosphere.  
Secondly, the mutants have a negative effect on the production of 
secondary metabolites and exo-enzymes as the basis for the suppression of other 
organisms and efficient biocontrol activity. But, we suggest that a combination 
of these two consequences for example in a mixture of phase I and phase II 
bacteria is not necessarily negative for biocontrol. This is illustrated by the 
observation that the presence of high numbers of phase variable strains on the 
maize roots isolated from the agricultural sites in Tontotepec, Oaxaca Mixe, 
Mexico still results in a natural protection of the plants against phytopathogens 
(Chapter 2). An optimal mixture is possible since the frequency at which 
mutations are introduced into gac is relatively low and these gac mutants are 
part of a reversible mechanism. Therefore a population can combine the 
production of secondary metabolites of a phase I phenotype with the growth 
advantage of a phase II phenotype. The absence of an optimal mixture of phase 
I and phase II cells, for example a high frequency of phase variation or a stable 
phase II phenotype, was shown to abolish biocontrol (Chapter 2).  
Phase variation as described in this thesis, is a strategy to improve success 
in a heterogeneous, competitive and ever changing environment like the 
rhizosphere. As such, phase variation can improve the efficiency of biocontrol 
and enable a strain to establish itself along the root more easily, at more sites 
and in larger numbers. Especially since phase II bacteria are not locked in this 
phenotype, the production of secondary metabolites and exo-enzymes, and 
therefore biocontrol is not lost upon mutation of gac. Therefore, the presence of 
a subpopulation of phase II bacteria will not necessarily abolish biocontrol. But, 
considering the results presented in this thesis, phase variation has been 
identified as an important factor in efficient biocontrol and could influence the 
reliability of biocontrol agents. Biocontrol activity of PCL1171 is lost when 
(only) phase II bacteria or a derivate with an increased phase variation 
frequency were applied to wheat seeds (Chapter 2). Since these mutants cannot 
maintain the hypothesized optimal mixture of wild-type and gac mutants we 
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could show that phase variation can have a strong impact on the biocontrol and 




The aim of this thesis was to study phase variation and design a strategy to 
control this mechanism in order to improve biocontrol activity in Pseudomonas. 
Our results suggest that locking bacteria in the phase I phenotype will not 
necessarily increase the efficiency of control since it will include a loss of 
competitive advantage. However, since a mutant strain locked in a phase I 
phenotype was not isolated and could not be constructed, the effect of such a 
mutation remains hypothetical. In Chapter 2 we describe the isolation of a mutS 
mutant with a 1000-fold increased phase variation frequency, and a gacS mutant 
locked in a phase II phenotype. In both situations biocontrol was abolished, 
indicating that a moderate frequency of phase variation, and therefore an 
optimal ratio of wild-type bacteria and gac mutants, is not necessarily a 
disadvantage in the control of phytopathogens. Based on the results described in 
Chapters 3 and 4 this frequency of phase variation optimal for biocontrol is 
likely to be dependent on the regulation of MMR activity. MMR will be optimal 
when stress is prevented and rpoS is not highly expressed. Duffy et al., (64) 
showed that the addition of certain nutrients (i.e., zinc, copper, cobalt, 
manganese, and ammonium molybdate) increased the stability of gac. 
Therefore, growth limitation and conditions such as temperature, minerals and 
humidity could affect phase variation. The optimal environmental conditions for 
biocontrol by limiting spontaneous mutation of gac have not yet been 
determined. Alternatively the stability of gacA and gacS can be increased 
genetically by over-expression of mutS, or mutation of rpoS (Chapter 4).  
Under certain circumstances phase variation can form a serious problem, 
for example in vaccine and enzyme production.  Since the variation of epitopes, 
which is the major problem in vaccine production (163), is in most cases not 
based on an ON or OFF switching as described in this thesis, I will not focus on 
utilisation of the presented results with respect to vaccine production. Phase 
variation in industrial production processes can affect the overall yield when 
subpopulations of non-producing bacteria are formed. As for example shown by 
Duffy et al. (64), an up-scaling of production size using Pseudomonas 
fluorescens, can exponentially increase the size of the gac mutant sub-
population even up to 61% of the total viable cells. It is likely that nutrient 
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stress, growth limitation and therefore the expression of rpoS, and suppression 
of MMR, account for this observation. Although in most cases the production of 
microbial metabolites is transferred to microbial species optimal for production 
purposes, to delay, prevent or reduce  phase variation (i) optimal growth 
conditions offering sufficient nutrients to prevent stationary growth should be 
applied, or (ii) genetically modified strains should be constructed, for example 
by mutation of rpoS, or a constitutive expression of mutS.  
 
 
1.8 Concluding remarks 
In this thesis we describe the mechanism of phase variation of a rhizosphere-
competent Pseudomonas strain. Phase variation in these bacteria affects 
secondary metabolism, the production of exo-enzymes, and -as a result- 
biocontrol of take-all of wheat. But, although phase variation strongly 
influences the expression of biocontrol traits, within a competitive, 
heterogeneous, and changing environment like the rhizosphere phase variation 
can be beneficial for strains to establish and maintain themselves in sufficiently 
large numbers on the plant root. The advantage of a sub-population of gac 
mutants is based on their growth effect which could improve the succes in 
competition or survival under fluctuating and stressfull conditions (Chapters 3 
and 4). This strategy is employed under stress conditions (Chapter 4) in which 
the growth advantage will be most effective. Phase variation is likely to affect 
biocontrol in the absence of an equilibrium between phase I (production of 
secondary metabolites and exo-enzymes) and phase II bacteria (growth 
advantage) on the root and could thereby affect the reliability of a biocontrol 
agent in the field. In conclusion, phase variation is a phenomenon, aimed at 
adaptation of a population, either in host-pathogen interactions by evading the 
host defense systems, or in interactions between organisms in a competitive and 
















De bescherming van gewassen tegen ziekteverwekkers speelt een belangrijke 
rol in de moderne landbouw. Bescherming is tot op heden vooral gebaseerd op 
het gebruik van chemische bestrijdingsmiddelen. Deze pesticiden zijn echter 
vaak slecht afbreekbaar en blijven daardoor lang actief in het milieu. Een 
bijkomend probleem is een veelal aspecifieke werking, waardoor het milieu en 
de gezondheid van de mens wordt bedreigt. Op nationaal en internationaal 
niveau is dan ook besloten het gebruik van chemische bestrijdingsmiddelen te 
beperken. Om gewassen tegen ziekteverwekkers te blijven beschermen zijn 
efficiënte alternatieven noodzakelijk. Een veelbelovend alternatief is het 
gebruik van micro-organismen. De beoogde micro-organismen zijn 
oorspronkelijk ontdekt in bodems die van nature de groei van schimmels 
onderdrukken. De werking van deze bodems is gebaseerd op de aanwezigheid 
van specifieke ziekteonderdrukkende micro-organismen. Door middel van 
niche-exclusie, de productie van antischimmelfactoren, predatie, of door de 
activering van de plantenverdedigingsrespons onderdrukken deze biocontrole 
bacteriën de effecten van ziekteverwekkers (45, 241). Wereldwijd zijn er op dit 
ogenblik meer dan honderd producten op basis van deze biocontrole stammen 
commercieel verkrijgbaar. Redenen waarom deze stammen nog niet uitgebreid 
worden toegepast zijn o.a. het moeizaam tot stand komen van regelgeving en de 
variabele betrouwbaarheid in het veld. Veel research richt zich op het 
identificeren van factoren of mechanismen die verantwoordelijk zijn voor de 
variatie in de betrouwbaarheid van deze vorm van gewasbescherming. Ons 
onderzoek richt zich op Pseudomonas bacteriën, een microbiële species die 
onder andere algemeen voorkomt op het worteloppervlak. Eén van deze 
stammen, Pseudomonas fluorescens WCS365, staat bekend om zijn uitstekende 
kolonisatie-eigenschappen (83). Eén van de bij kolonisatie betrokken 
eigenschappen in deze stam is gebaseerd op de werking van een recombinase 
(sss). Mutatie van het sss-gen onderdrukte het voorkomen van morfologische 
varianten, het competitief vermogen de wortel te koloniseren (56) en de 
biocontrole-activiteit (43). Recombinases zijn betrokken bij DNA-recombinatie 
en -herschikking, bijvoorbeeld door inversies en deleties, en worden vaak 
geassocieerd met de vorming van koloniesectoren (72, 98). Deze resultaten 
suggereren dat een mechanisme zoals koloniefasevariatie een belangrijke 
oorzaak zou kunnen zijn van de eerder genoemde variabiliteit van biocontrole.  
Fasevariatie is gedefinieerd als een met een hoge frequentie voorkomend 
(> 10-5 wisselingen per cel per generatie) fenomeen dat gebaseerd is op 
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DNA -mutaties, -reorganisaties, of -modificaties met als resultaat reversibele 
fenotypische variatie (98, 211). Dat een dergelijk mechanisme voorkomt bij 
micro-organismen in de rhizosfeer bleek uit de isolatie van 214 Pseudomonas 
bacteriën van de wortels van mais. Zesenveertig van deze stammen vertoonden 
antagonistische activiteit tegen verschillende ziekteverwekkers. Drieënnegentig 
procent van deze antagonisten vertoonden koloniefasevariatie. Fasevariatie is 
voornamelijk beschreven als een proces in de context van een gastheer – 
pathogeen-interactie (bijv. het ontwijken van de immuunrespons) (52). Dit 
fenomeen kan een verscheidenheid aan eigenschappen reguleren en wordt ook 
gebruikt door micro-organismen om diversiteit binnen een populatie te 
verhogen en speelt een belangrijke rol in adaptatie en kolonisatie van niches 
(207, 211). Fasevariatie vormt een belangrijk probleem in de productie van 
vaccins (163) en kan de opbrengst van industriële productieprocessen negatief 
beïnvloeden. Het laatste is gebaseerd op de vorming van subpopulaties die de 
beoogde metabolieten niet tot expressie brengen. Het begrijpen van fasevariatie 
is een essentiële stap om de nadelige effecten op medische, industriële en 
ecologische processen te kunnen beperken.  
Het doel van dit proefschrift is het bestuderen en begrijpen van het 
mechanisme van fasevariatie in antagonistische Pseudomonas bacteriën in 
relatie tot de efficiënte controle van plantpathogenen. De resultaten beschreven 
in dit proefschrift dragen bij aan het begrip van fasevariatie in Pseudomonas. 
We ontdekten dat een mechanisme gebaseerd op een reversibele spontane 
mutatie van een tweecomponenten regulatiesysteem daaraan ten grondslag ligt. 
Met de spontane mutatie van deze genen produceren de Pseudomonas bacteriën 
geen secundaire metabolieten en extracellulaire enzymen meer. Omdat deze 
eigenschappen de basis vormen voor de biocontrole-activiteit van deze stammen 
heeft dit een belangrijke invloed op de efficiëntie van de biocontrole. Deze 
spontane mutanten blijken echter ook een significant groeivoordeel te hebben in 
vergelijking met de wildtype-bacteriën. Omdat het proces omkeerbaar is kan de 
fasevariatie een competitief voordeel opleveren voor de totale populatie van 
deze Pseudomonas biocontrolebacteriën. De resultaten zoals deze zijn 
beschreven in dit proefschrift worden hier per hoofdstuk besproken. 
 
Hoofdstuk 2 beschrijft de isolatie en karakterisatie van een collectie 
Pseudomonas bacteriën geïsoleerd van de wortels van maïs. Zesenveertig van 
de 214 geïsoleerde stammen (21%) onderdrukte de groei van verscheidene 
plantpathogene schimmels, waaronder Gaeumannomyces graminis pv. tritici en 
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Fusarium oxysporum f. sp. radicis lycopersici die respectievelijk take-all van 
tarwe en voet- en wortelrot bij tomaat veroorzaken. Drieenveertig van deze 
antagonistische stammen vertonen koloniefasevariatie. Deze stammen vormen 
twee kolonietypen, nl. een ondoorschijnende fase I en een doorschijnende  
Fase II. Dat de ene fase uit de andere fase wordt gevormd blijkt uit de isolatie 
van fase-I-kolonies met fase-II-sectoren en fase-II-kolonies met fase-I-sectoren. 
Uit analyse van deze verschillende kolonievormen bleek dat belangrijke 
eigenschappen voor biocontrôle alleen tot expressie komen in een fase-I-
fenotype. Deze eigenschappen omvatten de productie van (i) een lipopeptide 
met antischimmel activiteit, (ii) een biosurfactant, en (iii) de extracellulaire 
enzymen protease, lipase, en chitinase. Door tarwezaden te coaten met cellen 
van een bepaalde stam en op te groeien in aanwezigheid van een 
ziekteverwekker, kan de mate van ziektebescherming door de bewuste stam 
worden bepaald. Voor deze experimenten en voor de verdere moleculaire 
analyse van het mechanisme van fasevariatie werd één van de antagonistische 
stammen geselecteerd. Stam PCL1171 vertoont een sterke antagonistische 
activiteit en een duidelijke fasevariatie met een voorkeur voor een fase-I-
fenotype. Alleen de aanwezigheid van bacteriën met een fase-I-fenotype 
resulteert in een efficiënte controle van take-all. Wanneer bacteriën met een 
fase-II-fenotype werden gebruikt wordt de ziekte niet onderdrukt. De 
biocontrole activiteit van PCL1171 bleek afhankelijk te zijn van de productie 
van een lipopeptide. De mutatie in een lipopeptide synthetase had geen effect op 
de fase-I-morfologie of fenotype behalve op de antagonistische activiteit van 
PCL1171. Afwezigheid van dit lipopeptide in een fase-II-fenotype is 
hoogstwaarschijnlijk de reden voor de afwezigheid van biocontrole activiteit in 
dit fenotype. 
De genetische basis van fasevariatie werd bestudeerd na constructie van 
een transposon bank van Pseudomonas PCL1171 fase I bacteriën. Drie 
mutanten werden geselecteerd: twee op grond van een stabiel fase-II-fenotype 
en één op grond van een verhoogde frequentie van fasevariatie. Mutatie van 
gacS bleek verantwoordelijk te zijn voor een stabiel fase-II-fenotype. GacS 
vormt samen met GacA een tweecomponenten systeem dat het secundaire 
metabolisme en de productie van extracellulaire enzymen in Pseudomonas 
reguleert. Een centrale rol voor gacA/S in fasevariatie bleek uit het herstel van 




Mutatie van mutS in PCL1171 resulteerde in een sterke verhoging van de 
frequentie van fasevariatie. MutS is de eerste stap in het herstel van DNA-
mismatches die ontstaan ten gevolge van fouten in de replicatie van 
chromosomaal DNA. Analyse van de biocontrole activiteit van deze twee 
mutanten laat zien dat zowel een stabiel fase-II-fenotype als een verhoogde 
frequentie van fasevariatie leiden tot een verlies van de biocontrole eigenschap. 
Uit de resultaten blijkt dat (i) fasevariatie een grote invloed op de biocontrôle-
activiteit van Pseudomonas kan hebben, dat (ii) de gacA/S-genen een centrale 
rol spelen in het mechanisme van fasevariatie, en dat (iii) de frequentie van 
variatie wordt onderdrukt door MutS-afhankelijk mismatchherstel. 
 
Hoofdstuk 3 richt zich op de moleculaire basis van de rol die de genen 
gacA/S  in fasevariatie in Pseudomonas PCL1171 spelen. Herstel van het fase-I-
fenotype na de introductie van wildtype-gacA-en/of-gacS-genen in zesentwintig 
fase-II-mutanten en dertien fase-II-sectoren liet zien dat in al deze gevallen het 
fase II fenotype gebaseerd is op mutaties in het gacA- of gacS-gen. Reeds in een 
eerdere publicatie zijn verschillende puntmutaties in het gacA-gen 
geïdentificeerd (33). In het gacS-gen werden verschillende puntmutaties, 
deleties, een insertie en een inversie geïdentificeerd. In bijna alle gevallen 
werden deze mutaties spontaan en efficiënt verwijderd, waarmee een fase-I-
fenotype werd hersteld. Daarnaast werden enkele (meer) stabiele fase-II-
mutanten geïsoleerd. Verdere analyse van deze laatste mutanten liet zien dat  
mutaties wisselden tussen het gacA- en gacS-gen via een stadium waarin beide 
genen mutaties bevatten. In beide klassen kunnen de mutaties in gac worden 
verwijderd ook al valt dit dus niet noodzakelijk samen met een switch terug 
naar een fase-I-fenotype. Ten gevolge van het sterk reversibele karakter van de 
mutaties in de gac genen is het aannemelijk dat er een dynamische relatie tussen 
de wildtype-populatie en de gac subpopulatie bestaat.  
Om het mechanisme achter het herstel van de wildtype gacA- en gacS-
nucleotidevolgorde te achterhalen werd de switch van fase II naar fase I 
bekeken in zowel een recA- als in een recB-mutant. RecA en RecB spelen een 
rol in DNA-herschikkingen die ten grondslag zouden kunnen liggen aan het 
verwijderen van de mutaties uit gac. Echter nóch de mutatie van recA, nóch van 
recB heeft een effect op de switch terug naar fase I, waaruit blijkt dat DNA-
herschikking niet essentieel is in deze switch. 
De groeieigenschappen van alle geteste gac-mutanten vertoonden in 
vergelijking met het wildtype een verkorte lag-fase en een hogere groeisnelheid. 
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Spontane mutatie van gac leidt dus tot een groeivoordeel en daarmee mogelijk 
ook tot een competitief voordeel. De gac-mutanten zijn echter niet in staat om 
de wildtypepopulatie weg te concurreren. Dit is hoogst waarschijnlijk het 
gevolg van (i) de afwezigheid van specifieke, sterke selectie onder 
laboratoriumcondities en van (ii) de reversibiliteit van het fase-II-fenotype.  
 
In Hoofdstuk 4 richten we ons op de regulatie van fasevariatie in 
Pseudomonas. In hoofdstuk 2 is een mutS-mutant beschreven. De mutatie van 
mutS leidt tot een hoge frequentie van fasevariatie. In hoofdstuk 3 bleek ook dat 
de frequentie van spontane mutaties in een mutS mutant overeenkomt met de 
normale frequentie van fasevariatie in het wildtype. Het is dus aannemelijk dat 
de introductie van DNA mutaties (zoals mismatches, puntmutaties, kleine 
inserties) en daarmee de switch van fase I naar fase II afhankelijk is van de 
activiteit van MutS. Aangezien de activiteit van mismatchherstelmechanismen 
vaak wordt beïnvloed door stress is de relatie tussen de algemene sigmafactor 
RpoS, die een rol speelt in stressrespons, gacA/gacS, en mutS bekeken. Dat een 
dergelijke relatie bestaat werd duidelijk toen we vonden dat niet alleen de 
mutatie van mutS de frequentie van fasevariatie met een factor 1000 verhoogde, 
maar dat ook mutatie van rpoS de frequentie 10 maal verhoogde. Uit de 
experimenten bleek dat (i) een functioneel gac-systeem essentieel is voor de 
expressie van rpoS, (ii) RpoS de expressie van mutS onderdrukt waardoor de 
frequentie van gac-mutanten toenam, (iii) de expressie van mutS was verhoogd 
in gacS- en rpoS-mutanten. Daarnaast bleek dat in een gacS-mutant de mutS 
expressie in de stationaire groeifase, in tegenstelling tot die van het wildtype en 
van een rpoS-mutant, in het geheel niet meer werd onderdrukt. Dit suggereert 
dat de regulatie van mutS gebaseerd is op RpoS, gacA/gacS, en tenminste één 
andere, door gac-gereguleerde, factor. De regulatie van mutS heeft een direct 
effect op de frequentie van gac mutanten en daarmee op de frequentie van fase 
variatie. Analyse van de groeieigenschappen van een rpoS mutant en een gacS 
mutant liet zien dat het groeivoordeel van een gac-mutant is gebaseerd op een 
combinatie van afwezigheid van RpoS, en een gac-afhankelijke reductie van de 
metabole last.  
 
Hoofdstuk 5 richt zich op de moleculaire basis van de morfologie van 
een fase I en fase II fenotype. De stabiele fase-II-mutant PCL1588 bleek na 
introductie van gacA/gacS niet, zoals alle andere fase-II-mutanten en sectoren, 
een fase-I-fenotype tot expressie te brengen maar een intermediaire kolonie 
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morfologie. Deze fase-I’-koloniemorfologie onderscheidt zich door een 
morfologie die doorschijnender is dan een fase I maar ook minder 
doorschijnend dan een fase II. Het transposon in PCL1588 bevindt zich in het 
prtR-gen dat een operon vormt met het transcriptioneel daarmee gekoppelde 
prtI-gen. PrtI is een extracellulaire sigmafactor en PrtR is een membraan 
gebonden antisigma factor. Om het fenotype van PCL1588 te bepalen werden 
de celenvelop eiwitten, de lipopolysaccharides (LPS), flagellen en 
extracellulaire polysacchariden (EPS) bestudeerd. De mutatie van prtR had 
alleen invloed op het EPS. Het fase-I’-fenotype lijkt te berusten op de 
afwezigheid van negatieve regulatie door PrtR. Dit blijkt bijvoorbeeld uit de 
expressie van een fase-I’-morfologie bij een constitutieve expressie van prtI in 
het wildtype PCL1171. In een gacS- en een rpoS-achtergrond blijkt het effect 
op het EPS te zijn verdwenen. Alleen de afwezigheid van negatieve regulatie 
van PrtR en RpoS (door mutatie van rpoS of met hetzelfde effect gacS, zie 
hoofdstuk 4) had effect op het EPS. Onze conclusie is dat het EPS een rol speelt 
in de fase I en fase II koloniemorfologie van PCL1171 maar niet de enige factor 
is die de koloniemorfologie bepaald. 
 
Conclusie. Dit proefschrift beschrijft een fasevariatiemechanisme 
gebaseerd op de spontane mutatie van een algemeen tweecomponenten 
gacS/gacA-regulatiesysteem. Deze mutanten zijn niet in staat secundaire 
metabolieten en extracellulaire enzymen te produceren. Uit de resultaten blijkt 
dat de reversibele switch tussen wildtype fase I en fase II bacteriën een 
belangrijke factor is in gewasbescherming door micro-organismen. Deze 
mutanten hebben ook bepaalde groeivoordelen, nl. een verkorte lag-fase en een 
hogere groeisnelheid in de exponentiële fase. In een heterogeen en competitieve 
omgeving zoals de rhizosfeer, kan dit een voordeel zijn en de populatie in staat 
stellen sneller op veranderingen in te spelen en de concurrentie met andere 
organismen aan te gaan. Doordat RpoS, door de regulatie van mutS expressie en 
daarmee in de vorming van gac-mutanten, een centrale rol speelt in fasevariatie, 
zullen stressomstandigheden leiden tot de formatie van gac-mutanten. Onder 
deze omstandigheden zal een grotere diversiteit en een subpopulatie van gac-
mutanten een voordeel zijn om de stresscondities het hoofd te kunnen bieden. 
Echter, een te hoge frequentie van fasevariatie of een te grote populatie fase-II-
bacteriën heeft negatieve gevolgen voor de biocontrôle. Hiermee is niet alleen 
aangegeven dat fase variatie een fenomeen is dat in staat is variatie in de 
veldresultaten te introduceren, maar ook dat een evenwicht tussen fase-I- en 
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fase-II-bacteriën niet noodzakelijk negatief maar ook mogelijk voordelig kan 
zijn voor gewasbescherming. Zo’n evenwicht is aannemelijk ten gevolge van de 
reversibiliteit van de fenotypes. Dat de fasevariatie niet noodzakelijk een 
negatieve factor is in gewasbescherming blijkt ook uit de jarenlange succesvolle 
opbrengsten van de velden waar deze pseudomonaden zijn geïsoleerd. Dat 
mutatie van gac een groeivoordeel met zich meebrengt en er gac-mutanten zijn 
geïsoleerd in antagonistische, rhizosfeer competente, Pseudomonas soorten, 
suggereert dat spontane mutatie van gac een geconserveerd mechanisme is. Het 
is echter niet uitgesloten dat ook in deze andere gevallen, zoals in PCL1171, de 
mutaties reversibel zijn en dat fase variatie via gac een geconserveerd 
mechanisme is, dat voorkomt in Pseudomonas soorten in de bodem, met als 
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